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Bacteriophage 186, like bacteriophage λ, is a UV-inducible temperate bacteriophage of Escherichia coli. At 
the DNA sequence level, these two phages show little similarity. The arrangements of promoters, genes 
and regulatory elements in the genome of the two phages are different, yet show similarity in the 
regulatory network topology. In fact, proteins with equivalent functions can be pinpointed and previous 
studies have shown that these proteins act as key effectors in the lytic-lysogenic decision. Studies 
described in this thesis were aimed at investigating these bacteriophage 186 proteins to understand their 
structure-function relationship. These proteins regulate transcriptional behavior and may be useful as 
parts for the construction of synthetic circuits.  
In 186, the CII protein (analogous to λ CII) is responsible for establishment of lysogeny. It is a transcriptional 
activator that upon binding to a pair of half sites at the 186 pE promoter, activates it to generate the initial 
levels of immunity repressor to allow the phage to enter lysogeny. Its unusual property of binding to half 
sites two DNA turns apart and its potent ability to activate pE over 400-fold, suggests it may possess a novel 
mechanism of promoter activation.  
The X-ray crystal structure of the 186 CII protein was solved. It revealed the protein adopts a tetrameric 
quaternary structure, consisting of rigid dimeric subunits, which further dimerize to form a tetramer. 
Through mass-spectrometry measurements and mutagenesis studies, it was demonstrated that this 
tetrameric state is necessary for its function. Molecular modelling with the crystal structure provides 
insight into how CII may bind DNA and interact with the host RNA polymerase to activate its promoter.  
The role of CII is to generate initial pools of 186 CI (analogous to λ CI). 186 CI is responsible for repressing 
the lytic functions of 186 to maintain lysogeny. Previous studies have shown that CI dimers multimerize 
into a higher order structure that interacts with DNA. High resolution structures of a CI dimer and higher 
order CI CTD oligomer, but no high-resolution structure of the full complex, are available. We used a 
combination of X-ray crystallography, small angle X-ray scattering and mass-spectrometry to demonstrate 
that 186 CI forms a wheel-like dodecameric structure that could act as a scaffold for DNA wrapping, giving 
insight into the mechanism of transcriptional regulation provided by 186 CI.  
Following the structural characterization of 186 CI, a temperature sensitive mutant of 186 CI was 
characterized to show that it can be used for temperature-based induction of gene expression. In addition, 
a temperature-sensitive chimeric repressor containing domains from 186 CI and λ CI was developed. This 
success illustrates the ability of bacteriophage regulatory proteins to be used as a source of biological 
parts.  
X-ray crystallography was extensively used in this PhD project to structurally characterize proteins. When 
solving novel protein structures, the generation of diffraction quality crystals and the derivatization of 
protein crystals with heavy atoms for experimental phasing are two commonly encountered bottlenecks. 
In the final section of this thesis, a technique to simultaneously optimize crystallization and derivatization 
of a protein is presented. Crystalline precipitate of a protein was crushed up to form a microseed stock, 
which was used to promote crystallization by adding it to a sparse matrix crystallization screen of the 
protein. An iodinated compound I3C was added to the crystallization screen, to allow incorporation of I3C 
into the crystal during the crystallization process. This technique was employed to solve the crystal 
structures of Hen-Egg White Lysozyme and a putative lysin domain Orf11 from bacteriophage P68 and 
should be applicable to many other crystallization targets. 
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1 INTRODUCTION 
In this post-genomic era, one of the challenges to tackle in molecular biology is explaining 
the complex regulation of large genomic networks. Examples include understanding cell 
differentiation decisions in mammalian development and how states of dysregulation can 
cause diseases such as cancer. The study of these complicated systems could be aided by 
studying a simpler biological system with well characterized components to better 
understand the underlying principles. A temperate bacteriophage is one such system. 
Although they are one of the simplest biological systems, they can make seemingly rational 
decisions between alternate developmental regimes based on environmental signals.  
Bacteriophage λ, the most extensively characterized bacteriophage, has provided many 
valuable insights into gene regulation. After infecting its host, it can make a decision 
between the lytic and lysogenic modes of reproduction, based on environmental cues. In the 
lytic mode of infection, the bacteriophage coaxes the bacterial host to produce new phage 
particles, ultimately to release them via cell lysis. Alternatively, it can enter the lysogenic 
state, where the λ genome is integrated into the host chromosome and replicates along with 
host replication. The lytic functions of phage λ are repressed in this non-bactericidal state, 
which is stably maintained through bacterial generations. At a later point, bacteriophage λ 
can make a second decision to exit the lysogenic state and reenter lytic development. This 
process often occurs in response to DNA damage (Ptashne, 2004; Oppenheim et al., 2005). 
For a more in-depth review of lysogeny, see Shearwin and Truong (Shearwin and Truong, 
2019) (Appendix A).  
 
Figure 1-1 - A temperate bacteriophage can choose between the lytic and lysogenic developmental regimes. A 
bacteriophage infects a host bacterium by injecting its DNA into the host cell (step 1). In the lytic lifecycle, the host cellular 
machinery is hijacked to replicate the phage genome (step 2), produce new virions (step 3), lysing the cell to release it (step 
4). In the lysogenic state, depicted with blue numbering, the phage DNA integrates into the host chromosome (step 5). This 
state is stable, with prophage DNA maintained in daughter cells over generation (step 6). The phage can exit lysogeny to 
reenter the lytic phase, at a later point in time. 
Bacteriophage λ and the lambdoid family of phages to which it belongs, which include 
HK022, 434, P22 and HK97, broadly present one solution to the requirements of a temperate 
bacteriophage. Comparing how evolutionally divergent bacteriophages tackle these 
problems could provide more general principles that could be applied to larger systems. 
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Temperate bacteriophage 186, belonging to the P2-like family of bacteriophages, also infects 
E. coli and is UV-inducible, like bacteriophage λ. Despite sharing no sequence similarity at 
the nucleotide level, similarities can be identified in the network signaling architecture 
(Trusina et al., 2005). Studying bacteriophage 186 has revealed it as an excellent 
counterpoint model to bacteriophage λ.  
1.1 Bacteriophage λ 
1.1.1  Lytic gene cascade of bacteriophage λ 
The genome of bacteriophage λ contains a key regulatory region involved in the lytic-
lysogeny decision (Figure 1-2). After injection of the phage DNA into the cell, λ undergoes a 
temporally controlled cascade of gene expression, with the default cascade leading into lytic 
development.  
 
Figure 1-2 – Simplified genetic map of the regulatory region of bacteriophage λ. Promoter regions are denoted with bent 
arrows. Transcripts are shown as coloured arrows extending from the promoters. Purple arrows correspond to lytic 
transcripts. Yellow arrows correspond to early lysogenic transcripts. Orange arrows correspond to late lysogenic transcripts.  
Genes and open reading frames are shown by coloured boxes. Transcripts from promoters activated by CII are shown in 
yellow. Lytic and lysogenic genes are coloured green and orange, respectively.  
Early transcription from the pL and pR promoters drives the expression of the cro and N 
regulators. Cro is a repressor that promotes the lytic cycle. It binds to OL and OR operators. 
At OR, the affinity of Cro to the operator sites is in the order of OR3 > OR2 > OR1. This 
preferential binding allows Cro, in lytic development and in prophage induction, to occupy 
OR3 to repress the expression of the cI immunity repressor (Johnson, Pabo and Sauer, 1980; 
Schubert et al., 2007). These early transcripts from pL and pR terminate at the tL1 and tR1 
terminators, respectively. The N antitermination factor and host Nus proteins complex with 
RNA polymerase to overcome these terminators to allow expression of delayed early genes 
(Franklin, 1974; Mishra et al., 2013). The delayed early genes include lysogeny-promoting 
regulators CII and CIII, and lytic late gene regulator Q.  
Here, the cascade can commit to the lytic cycle or divert to the lysogenic cycle. In the default 
lytic cascade, Q alters RNA polymerase to overcome the tR’ terminator downstream of the 
constitutive late lytic promoter pR’ (Roberts et al., 1998). The result is the expression of late 
genes required for virion production and release. An alternative lysogenic cascade is 
described in the next section. 
1.1.2 Establishment of lysogeny in bacteriophage λ by λ CII 
In order for λ to form a lysogen, the bacteriophage λ CI repressor and the Int (integrase) 
protein need to be expressed. The CI repressor is required to repress the lytic promoters, pR 
and pL, to establish and maintain the lysogenic transcriptional state. Int is needed for the 
integration of the phage genome into the host chromosome. The CII transcriptional activator 
and CIII protease inhibitor are required to generate the initial pool of CI and Int. λ plaques 
are normally turbid due to the presence of lysogenic cells. Bacteriophage λ mutants with 
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mutations in CI, CII or CIII give rise to clear plaques (Kaiser, 1957) and have lost the ability to 
enter the lysogenic state.  
The crucial event in this switch to lysogeny is the accumulation of the CII transcriptional 
activator above a threshold level. CII actively inhibits Q activity to pre-empt expression of 
late lytic functions (Kobiler et al., 2005). It also activates the expression of the Int protein 
and CI repressor. CII achieves these three objectives through activation of the paQ (Hoopes 
and McClure, 1985), pI (Schmeissner et al., 1981) and pRE promoters (Schmeissner et al., 
1980), respectively. After this initial pool of CI exists, CI represses lytic functions of the phage 
(including cII) and autoregulates its own expression in the absence of CII.  
The level of CII is central to the lytic-lysogenic decision and is regulated in vivo at many 
levels. It has been reviewed more extensively elsewhere (Oppenheim et al., 2005; Casjens 
and Hendrix, 2015). Transcription of the cII gene is repressed by CI and Cro binding to the OR 
operators. It is activated by the N antitermination factor binding to the nutR site to allow 
RNA polymerase to overcome the tR1 terminator. The stability of CII mRNA is regulated 
through the OOP RNA. OOP is an antisense RNA that can form a double stranded RNA 
complex with cII mRNA, which is recognized and cleaved by RNAse III (Krinke, Mahoney and 
Wulff, 1991). The OOP promoter is repressed by the host LexA repressor. Translation 
initiation of CII requires integration host factor (IHF) (Mahajna et al., 1986), which is also  
required for the phage genome integration reaction. Finally, CII is also regulated at the 
protein level. The transcriptional activator protein is rapidly degraded by the host HlfB (FtsH) 
protease (Kobiler et al., 2002). CIII, which is co-expressed with CII, acts as an inhibitor of FtsH 
to increase CII levels (Kobiler, Rokney and Oppenheim, 2007).  
The structure and function of λ CII 
CII functions as a tetrameric activator, binding to TTGC direct repeats, present in all its 
cognate promoters. Its crystal structure as a tetramer and in a complex with DNA have been 
solved (Figure 1-3) (Datta et al., 2005; Jain et al., 2005). It is a single domain, helix-turn-helix 
(HTH) containing protein. It consists of four α-alpha helices, with the helix-4 from four 
monomers interacting to form a four-helix bundle to mediate tetramerization. This helix can 
move relative to the remainder of the protein due to conformation flexibility afforded by the 
linker between helix 3 and 4. This flexibility allows it to adopt the asymmetric tetramer 
bundle quaternary structure required to bind to direct repeat half sites (Jain et al., 2005). 
The protein ends with an unstructured and flexible tail, around residues 85-97, which acts as 
a recognition site for the protease FtsH (Kobiler et al., 2002).  
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Figure 1-3 – Structure of λ CII with and without DNA. A) Structure of λ CII as a tetramer (PDB ID 1XWR). Each protein chain is 
displayed as a different colour. Figure reproduced from Datta et al. (2005) B) Structure of λ CII in complex with synthetic 27-
mer DNA (PDB ID 1ZS4). -35 annotation based on pRE promoter. CII half sites (TTGC) are shown in magenta. Figure 
reproduced from Jain et al. (2005). 
λ CII is functionally unique in several aspects. Many activators bind as a dimer rather than a 
tetramer. It recognizes direct repeat half-sites instead of inverted repeats more frequently 
observed in prokaryotic activators. In addition, the CII half sites in pI, paQ and pRE straddle 
the -35 hexamer of the promoter, making CII a class II transcriptional activator. These 
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activators normally make direct contacts with domain 4 (σ4) of σ subunit of RNA polymerase. 
However, λ cII binds on the opposite face of DNA relative to the σ subunit and contacts the 
CTD of the α subunit of RNA polymerase. α-CTD contacts DNA at -41 and in turn contacts the 
σ70 subunit (Figure 1-4) (Kedzierska et al., 2004; Jain et al., 2005). 
 
 
Figure 1-4 – Structural model for λ CII recruitment of RNA polymerase to its cognate promoters. Model was reproduced 
from Jain et al. (Jain et al., 2005) A) Model of λ cII-RNA polymerase holoenzyme complex, constructed through 
superimposition the Thermus aquaticus RNA polymerase open promoter complex (Murakami et al., 2002) and E. coli α-CTD 
(Benoff et al., 2002) onto the structure of structure of the λCII-DNA complex. B) Magnified region of (A) showing contacts 
between RNA polymerase and λ CII. λ CII E14 contacts RNA polymerase α-CTD (predicted to be α-CTD residue K271). α-CTD 
contacts DNA via its 265 determinant. α-CTD contacts σ4 via its 261 determinant (D259 and E261). 
1.1.3 Maintenance of lysogeny via λ CI 
λ CII activates the expression of λ CI. If the threshold level of λ CII is reached, a sufficient 
initial pool of CI is established to prevent the lytic transcriptional cascade by repressing the 
pR and pL promoters. CI also positively and negatively autoregulates its own expression from 
the pRM promoter. The pR and pRM promoters are arranged back to back, with the other lytic 
promoter pL positioned 2.3 kb away (Figure 1-5A). The mechanism employed by λ CI to 
efficiently repress its cognate promoters is shown in Figure 1-5B.  
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Figure 1-5 – Regulation of the pR, pL and pRM promoters of bacteriophage λ CI is mediated through multiple cooperative 
interactions between λ CI dimers and long range DNA looping. A) Arrangement of pR, pL and pRM promoters in 
bacteriophage λ. Promoters are depicted with bent arrows. RNA transcripts are depicted as coloured arrows. B) Regulation 
of the pR, pL and pRM promoters by λ CI, shown as red dumbbells. Top - λ CI binds to the OR and OL operators to block 
transcription. Adjacent dimers can form tetramers through oligomerization mediated by the λ CI C-terminal domain. The N-
terminal domain of λ CI at OR2 contacts RNA polymerase (depicted in yellow) to activate pRM to drive expression of 
lysogenic genes including λ CI. Middle – Long range DNA looping mediated by λ CI tetramers bound at OR1 and OR2 at OR 
and OL1 and OL2 at OL further improves the repression of pR and pL. Bottom – DNA looping aligns the OR3 and OL3 sites. At 
high levels of CI, λ CI bound at these two operator sites can interact cooperatively to form a tetramer to repress pRM. Figure 
adapted from Dodd, Shearwin and Egan (2005).  
The λ CI protein consists of two domains connected by a flexible linker. The N-terminal 
domain contains an HTH motif and is responsible for contacting DNA, while the C-terminal 
domain mediates oligomerization (Bell and Lewis, 2001; Nickels et al., 2002). The relative 
affinities of λ CI to its operators follow the order of OR1 > OR2 > OR3 and OL1 > OL2 > OL3. λ CI 
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dimers preferentially bind to OL1 and OL2 operators at OL and OR1 and OR2 operators at OR 
over the OL3 and OR3 operators. These dimers cooperatively form tetramers at OR1-OR2 and 
OL1-OL2. This is the mechanism of pR and pL repression by λ CI. Another level of cooperativity 
is introduced by interaction of the two tetramers to form an octamer, mediated by 2.3 kb 
DNA loop, to further improve the repression of these promoters (Ptashne, 2004). λ CI at OR2 
activates λ pRM. By occupying this operator, the N-terminal domain of λ CI is positioned to 
contact σ4 subunit of RNA polymerase that binds the -35 promoter element (Nickels et al., 
2002; Jain et al., 2004). This allows λ CI to positively regulate its own expression. The 
octameric λ CI aligns the OL3 and OR3 such that in the presence of high λ CI concentrations, λ 
CI can bind and form a tetramer across the OL3 and OR3 operators (Dodd et al., 2004). This 
binding represses the pRM promoter to reduce λ CI levels and is the mechanism of negative 
autoregulation in λ CI. The positive and negative autoregulation of λ CI creates a stable 
lysogenic state, but also prevents λ CI levels to escalate to the point where re-entering the 
lytic cycle (prophage induction) is difficult (Dodd, Shearwin and Egan, 2005).  
Structure and function of λ CI 
Several λ CI protein structures in complex with DNA have been solved (Figure 1-6) (Beamer 
and Pabo, 1992; Jain et al., 2004; Stayrook et al., 2008). In these structures, a protein dimer 
is complexed with OL1 DNA, with each monomer contacting an OL1 half site. The N-terminal 
domain responsible for contacting DNA is made up of five alpha helices. Helices 1-4 forms a 
compact globular domain from which helix 5 extends. Helix 5 forms interactions with helix 5 
from another monomer to mediate weak dimerization (Pabo and Lewis, 1982; Beamer and 
Pabo, 1992). Helix 2 and 3 constitute a HTH motif. Helix 2 makes contacts with the DNA 
backbone and helix 3 (recognition helix) is positioned in the major groove, with side chains 
of the helix contacting the DNA base-pairs. The N-terminal arm (residues 1-6) also forms 
sequence specific contacts with the DNA. In the consensus OL1 half site, the N-terminus 
wraps around the DNA along the major groove (Beamer and Pabo, 1992).   
 
Figure 1-6 – Structure of λ CI NTD dimer in complex with OL1 DN (PDB ID 1LMB). The recognition helix 3 is positioned in the 
major groove of the half sites.  
As described in section 1.1.3 and Figure 1-5, λ CI dimers oligomerise to form tetramers and 
octamers to achieve cooperative transcriptional regulation. The C-terminal domain mediates 
strong dimerization and subsequent higher order oligomerization. Several crystal structures 
containing λ CI CTD as an oligomer have been solved. These structures include the structure 
of full length λ CI with OL1 DNA, λ CI-CTD as a tetramer and λ CI-CTD as an octamer (Figure 
1-7). By superimposing the structure of the λ CI dimer bound to DNA onto the λ CI CTD 
octamer, Stayrook et al. (2008) presented a structural model for the λ CI octamer bound to 
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adjacent operators. Cui et al. (2013) demonstrated that the Stayrook model could not 
physically accommodate the DNA linking the operators. Cui et al. (2013) refined the model 
by modelling conformational flexibility in the linker between the NTD and CTD to generate a 
plausible structural model for a DNA loop mediated by an λ CI octamer in complex with RNA 
polymerase at PRM (Figure 1-8B). This provides structural basis to understand cooperative 
regulation by bacteriophage λ CI.  
 
Figure 1-7 – Structure of full length λ CI with OL1 DNA (PDB ID 3BDN), λ CI-CTD as a tetramer (PDB ID 1F39) and λ CI-CTD as 
an octamer (PDB ID 1KCA).  Dimer-dimer interface and tetramer-tetramer interface have been indicated using a dashed red 
and dashed green line, respectively.  
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Figure 1-8 – Structural modelling was used to investigate how λ CI could bind DNA and RNA polymerase in vivo. A) Model of 
CI tetramer binding OR1-OR2 DNA. B) Structural model of the λ CI octamer in complex with OL1-OL2 and OR1-OR2 DNA and 
RNA polymerase. Figures were adapted from Cui et al. (2013). 
1.1.4 Summary 
The decision making process between the lytic and lysogenic lifecycles in temperate 
bacteriophage λ, a simple genetic switch relative to complex eukaryotic systems, involves a 
small set of regulatory proteins with temporally regulated expression. Two key 
transcriptional regulators λ CI and λ CII have been well structurally characterised. Combining 
this information with other genetic studies has enriched our understanding of mechanisms 
employed by transcriptional regulators to activate and/or repress transcription and 
autoregulate their expression, which involve macromolecular interactions between these 
proteins, DNA and host transcriptional machinery.  
Bacteriophage λ has enriched our understanding of fundamental principles in gene 
regulation. The study of an evolutionary divergent temperate bacteriophage may provide 
novel regulatory mechanisms to the lytic-lysogenic process, to further our knowledge on this 
subject. 
1.2 Bacteriophage 186 
Bacteriophage 186, originally isolated from the sewers of Paris (Jacob and Wollman, 1961), 
has been used as a counterpoint model of a genetic switch to bacteriophage λ. 186 and λ are 
SOS-inducible temperate bacteriophages that infect Escherichia coli and can both make a 
developmental decision between the lytic and lysogenic pathways (Woods and Egan, 1974). 
These two phages are unrelated at the DNA level (Portelli et al., 1998). Therefore, comparing 
them should reveal important features of a genetic switch, as they represent independently 
evolved solutions to the lytic-lysogenic problem (Shearwin, Dodd and Egan, 2002).  
1.2.1 Lytic gene cascade in bacteriophage 186 
Similarly to bacteriophage λ, bacteriophage 186 displays a temporally controlled pattern of 
gene expression in lytic development. This can be divided up into three transcriptional 
phases – early, middle and late (Finnegan and Egan, 1981). A schematic diagram of the 186 
genome is shown in Figure 1-9. 
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Figure 1-9 – Circular map of the bacteriophage 186 genome. Genes are shown as boxes. Promoters are shown as arrows 
pointing in the direction of transcription. Proteins are shown as coloured circles. Early and middle lytic functions are driven 
by the pB and pR promoters. Late lytic functions are driven by the pJ, pV and p12 promoters. Lysogenic functions are 
expressed from the pL promoter. The CI transcriptional activator represses the lytic promoters pB, pR and early lysogenic 
promoter pE. CII protein activates the early lysogenic promoter pE. B activator activates the late lytic promoters pJ, p32, pV 
and p12. Figure adapted from Dodd (unpublished). 
After infection, the early lytic promoter pR is active (Finnegan and Egan, 1981). As a result of 
the convergent arrangement of pR and pL, transcription from the stronger pR promoter 
interferes transcriptional activity from the weaker pL promoter (Callen, Shearwin and Egan, 
2004). The early lytic transcript from pR terminates at the tR cluster of terminators and 
includes the apl, cII, fil and dhr genes. Apl is a repressor of pR and pL and also behaves as an 
excisionase during prophage induction (Dodd, Reed and Egan, 1993; Reed et al., 1997). The 
Fil and Dhr proteins are inhibitors of host cell division and host DNA replication, respectively 
(Richardson and Egan, 1989). The 186 CII protein, similarly to the λ CII protein, is a 
transcriptional activator required to divert 186 off the lytic pathway towards lysogeny. This 
protein will be covered later in more detail. The replicase protein A is expressed from the 
middle lytic region as part of the pR transcript that has extended beyond tR due to an 
antitermination event (Richardson, Puspurs and Egan, 1989). The A protein initiates phage 
genome replication (Sivaprasad et al., 1990).  
Also during the early lytic phase, the B activator is expressed from the pB promoter. This 
transcription activator activates the pV, p32, pJ and p12 promoters to express late lytic genes 
required for cell lysis, DNA packaging and bacteriophage capsid proteins (Dibbens and Egan, 
1992; Portelli et al., 1998).  
1.2.2 Diverting towards the lysogeny cycle in bacteriophage 186 
Diversion from the lytic cascade and establishment of lysogeny requires repression of the 
lytic promoters, pB and pR, and expression of the immunity repressor CI and Int from the 
lysogenic transcript (Figure 1-10). One of the proteins expressed under pR is CII, which 
activates the alternative lysogenic operon promoter, pE (Figure 1-11). Analogous to 
bacteriophage λ, the initial decision to switch into lysogeny is dependent on the 
concentration of CII. The default lytic cascade occurs if CII doesn’t accumulate to sufficient 
levels. However, high CII levels lead to high CI levels, which repress lytic promoters pR and pB,  
as well as expression of the Int integrase protein, which catalyses the integration of phage 
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DNA into the bacterial chromosome. CI repression of pR activates pL by removal of 
transcription interference to sustain its own expression to maintain the lysogenic state. 
 
Figure 1-10 – A schematic of the “switch” region in the bacteriophage 186 genome involved in deciding between the lytic or 
lysogenic cycle. Repressing the lytic promoters, pB and pR, and expression from the lysogenic promoter pL is required for the 
maintenance of lysogeny. 186 immunity repressor CI sites are shown in circles (unfilled circles are poorly defined weak 
sites). Promoter regions are labelled with arrows in the direction in which transcription occurs. Adapted from Wang et al 
(2013). 
The action of CII is 186 is thus similar to lambda. However, the co-location of int with cI in 
the lysogenic operon allows CII to express both these genes from a single promoter, in 
contrast to the two promoters used in lambda. An equivalent to the lambda paQ promoter 
has not been found in 186.  
1.2.3 The 186 CII protein 
CII is a 169 residue protein initially expressed under the control of pR. CII binds to the 186 pE 
promoter to activate it and is capable of upregulating promoter activity about 400 fold 
(Neufing et al., 1996) (Figure 1-11). This activation only requires CII and RNA polymerase  
and allows for the rapid production of immunity repressor CI in sufficient levels to block lytic 
development (Shearwin and Egan, 2000). This process is essential to the establishment but 
not maintenance of lysogeny, as rare lysogens formed by cII mutants are stable.  
 
Figure 1-11 – CII’s role in promoting the establishment of lysogeny in bacteriophage 186. After initial infection, an early lytic 
transcript from the pR promoter is made. One product made is CII, which activates an early lysogenic promoter pE. 
Transcription from this promoter generates the initial pool of CI required to enter lysogeny. CI represses the lytic promoter 
pR to maintain lysogeny. CI levels are maintained by the pL promoter. CII half sites (ATGTTTG) are centered around -38 and 
-58 and are emphasized in bold. Figure reproduced from Murchland et al. (2014). 
186 CII binds to two inverted repeat 7-mer half sites (ATGTTTG) centering at -38 and -58 of 
the pE promoter (Neufing et al., 1996) (Figure 1-11). The -38 half site lies just upstream of 
where the σ70 subunit of RNA polymerase would be expected to contact DNA. Thus, 186 CII, 
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like λ CII, is a class II activator. However, unlike λ CII which binds direct repeats, 186 CII binds 
to inverted repeat half sites spaced two turns of the DNA helix apart. The spacing is 
important for CII binding as changes to the spacing, even an insertion or removal of a single 
base pair, significantly reduced affinity of the sites for CII binding (Shearwin and Egan, 2000). 
This wider spacing between the CII half sites, compared to the single DNA helix spacing 
normally observed, is unique among prokaryotic transcriptional activators, which suggests 
that CII employs a novel mechanism to activate pE.   
Similarly to λ CII, 186 CII is also rapidly degraded in vivo due to a degradation tag at the C-
terminus, which recruits proteases to cleave the protein, initially at reside 135. Truncating 
the protein at residue 145 (to give CII145) eliminates this degradation tag, prolongs the in 
vivo half-life around 14-fold and increases the steady state levels of the protein inside the 
cell. As a result, CII145 shows significantly increased activation of pE (Murchland et al., 
2014). 
There has yet to be a high resolution structure of 186 CII solved, but other biophysical and 
genetic experiments have provided insight into its structure and function. CII is predicted to 
be a two domain protein, consisting of an N-terminal DNA binding domain and a C-terminal 
oligomerization domain (Murchland et al., 2014). The DNA binding domain is predicted to 
contain a helix-turn-helix motif which is used to contact DNA (Neufing et al., 1996).  The full 
length protein can be expressed in E. coli, yet the predicted N-terminal domain and C-
terminal domains could not be purified separately (Murchland et al., 2014). Thus, it is 
unknown if the domains are truly structurally independent.  
CII can self-associate into dimers and tetramers. Sedimentation equilibrium experiments of 
purified CII suggested it exists in a monomer-dimer-tetramer equilibrium in solution 
(Neufing et al., 1996). The tetrameric species of CII could also be detected via Size Exclusion 
Chomatography - Multi-Angle Laser Light Scattering (SEC-MALS) (Murchland et al., 2014). 
Sedimentation equilibrium experiments of purified CII with DNA suggested CII binds DNA as 
a preformed dimer (one monomer binding a half site), with weak binding as a tetramer at 
higher concentrations. Upon DNA binding, CII generates a 41° ± 5 bend in the DNA (Shearwin 
and Egan, 2000). The degradation product of CII, CII135, self-associates into dimers but not 
tetramers. Although CII is thought to bind and activate as a dimer, the CII135 protein was 
unable to activate pE in vivo. Either CII135 has lost a critical activation epitope or CII has two 
independent dimerization interfaces that yield two distinct dimers, only one of which is an 
active dimer (Murchland et al., 2014).  
A genetic screen to identify CII mutants that are activation deficient but still capable of 
binding DNA identified CII residues that contact RNA polymerase. Three residue positions 
R17, E46 and R115 were found to be important. R17 and E46 are thought to cluster on the 
DNA binding domain and are part of an epitope on the N-terminal domain that contacts σ70 
K593, which was validated by charge reversal mutagenesis experiments with K593 and E46. 
R115 is hypothesized to contact the α-CTD of RNA polymerase. The model of pE promoter 
activation by CII proposed by Murchland et al is summarized in Figure 1-12. This model 
proposes that the unusual arrangement of CII half sites two DNA turns apart enables one or 
both α-CTD to bind DNA between the half sites, stabilized by contacts with CII.  
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Figure 1-12 – Current model of 186 CII-pE promoter activation. CII binds to the pE promoter at -38 and -58 and bends the 
DNA. The CII NTD makes contacts with RNA polymerase σ70 subunit, which can bind at -35. The CII CTD can contact α-CTD of 
RNA polymerase, which can bind to the bent AT rich DNA between the half sites. These contacts are used to recruit RNA 
polymerase to the pE promoter. Figure adapted from Murchland et al. (2014) 
A high-resolution structure of CII would be immensely valuable in understanding CII function 
and would test many of the assumptions in the current model. Analysis of this structure 
should inform about CII’s contacts with RNA polymerase and DNA (via cocrystallization, 
cryoEM or docking). It should test whether R17 and E46 are clustered together into an 
epitope and whether CII contains an HTH motif. In a protein crystal, protein molecules are 
arranged in a lattice, which are revealed in a crystal structure. The arrangement of protein 
molecules within a crystal can often reflect their biological oligomeric arrangement. A crystal 
structure of CII could provide insight into functional oligomeric requirements of CII (dimer or 
tetramer). Crystallography is unable to definitively determine the oligomeric state, so 
complimentary techniques such as mass spectrometry would be required to validate 
predictions from the crystal structure. This information would be key to testing the 
proposed novel arrangement of CII and RNA polymerase. Finally, previous CII mutational 
data could be explained by mapping onto a structure. This data includes promoter/binding 
site mutants (Shearwin and Egan, 2000). RNAP contact mutants (Murchland et al., 2014) and 
protease resistant mutants (Keith Shearwin, unpublished data).  
1.2.4 Maintenance of lysogeny with 186 CI 
CII establishes the initial pool of the immunity repressor CI, which is responsible for the 
maintenance of the lysogenic state (Dodd and Egan, 1996). The immunity repressor rapidly 
shuts off lytic functions by repressing the early lytic promoters, pR and pB in the switch 
region (Figure 1-10). The lytic promoter pR and lysogenic promoter pL are arranged face to 
face, with 62 base pairs between their transcriptional start points. Transcription from the 
stronger pR promoter (approximately 10 fold stronger than pL) inhibits transcription from the 
weaker pL promoter by 10 to 20-fold (Dodd, Kalionis and Egan, 1990). Thus, as CI represses 
pR, it indirectly stimulates its own expression by activating the pL promoter through the relief 
of transcriptional interference. This mechanism of positive autoregulation by 186 CI (Dodd 
and Egan, 2002) is distinct from the λ CI mechanism of using direct λ CI-RNA polymerase 
contacts to stimulation of its own expression (Kuldell and Hochschild, 1994). Similarly to λ CI, 
186 CI also displays negative autoregulation at high concentrations (Dodd, Kalionis and Egan, 
1990) 
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Structure and function of 186 CI 
Pinkett et al. (2006) solved the crystal structures of two different variants of the 186 CI 
protein. One structure was of a cooperativity mutant of the full length repressor CIE146K that 
could dimerize but could not form higher order oligomers (Figure 1-13a). The repressor has a 
dual domain topology consisting of an N-terminal helix-turn-helix DNA binding domain with 
a C-terminal oligomerization domain. The NTD contains a single HTH motif which is 
responsible for DNA binding (Figure 1-13b) (Shearwin, Dodd and Egan, 2002; Pinkett et al., 
2006).  
 
Figure 1-13 – Structure of 186 CIE146K. A) Crystal structure of CIE146K forming a dimer. The E146K substitution prevents 
formation of higher order structures. B) The CI NTD contains a helix-turn helix motif consisting of helices 2 and 3, shown in 
red.  Adapted from Pinkett et al. (2006). 
1.2.5 DNA recognition by 186 CI 
There are five regions in the 186 genome where CI can bind – pB, pR, pL, FR and FL (Figure 
1-10). Dodd and Egan (1996) categorized CI operators into three types — A, A’ and B sites. A 
and A’ sites consists of inverted repeats with the same consensus sequence separated by 5 
or 4 bp AT rich spaces, respectively. B sites also have inverted repeats but with half sites 
with a different consensus to the A sites (Figure 1-14). Interestingly, one HTH motif is 
responsible for binding both recognition sequences with variable spacing between the 
operators (Shearwin, Dodd and Egan, 2002). It is speculated that flexibility of the protein 
may allow this variable binding. In the crystal structure of the dimer, the HTH motifs are 
positioned such that they would not be able to contact adjacent half sites. Thus, the linker 
between the NTD and CTD is flexible, as previously suggested by Shearwin and Egan 
(Shearwin, Dodd and Egan, 2002), which may allow different DNA complexes with variable 
half site spacing to form. In addition, the HTH motif itself may be flexible due to a lack of 
structural restraint from helix 5, allowing the adoption of different conformations to bind 
distinct sequences. It may be a combination of these flexibilities that allows recognition of 
two different sequences. Dodd and Egan (1996) observed in DNaseI footprinting that CI 
makes extended contacts with DNA adjacent to the primary CI operators, indicating that CI 
binds to DNA as a multimer. Thus, characterization of the flexibility and high order 
oligomerization of CI is required to fully understand its DNA binding behavior.  
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Figure 1-14 - The sequences of CI binding operators of the pB, pR, FL and FR sites. FL and FR sites each have one A site. PB 
contains two A sites. PR has an A’ site and two B type sites, arranged in a B–A’–B fashion. For the consensus sequences 
mentioned above, R = A or G, y= C or T and w =T or A. The w of the A type consensus sequence in parentheses reflects the 
different spacing between the inverted repeats in A and A' type sites. Adapted from Shearwin et al. (Shearwin, Dodd and 
Egan, 2002). 
1.2.6 Binding to multiple operators 
The crystal structure of the oligomerization domain was also solved (Pinkett et al., 2006) and 
revealed a heptamer of dimers in a ring arrangement (Figure 1-15B), with the arrangement 
consistent with protein mutations that disrupt CI cooperativity in vivo. Combining this CTD 
arrangement with the structure of CI as a dimer suggests CI forms 14mer wheel-like 
structure, with DNA binding domains situated on the outside of the wheel (Figure 1-15B) 
(Pinkett et al., 2006).  
 
Figure 1-15- 186 CI is proposed to form a 14mer wheel. A) X-ray crystal structure of CI CTD forming a 14mer wheel. B) A 
model of DNA wrapping around a CI wheel, based on the crystal structures of the dimer and C-terminal domain 14mer. 
Reproduced from Wang et al. (2013) 
The current model of 186 CI transcriptional regulation represents a very different mode of 
controlling lytic and lysogenic promoters than that seen in lambda or other phages. The 
model is based on the CI 14mer wheel acting as a scaffold for DNA to wrap on and off. The 
availability of DNA binding domains all around the wheel allows the formation of different 
DNA looped species to regulate the lytic and lysogenic promoters (Figure 1-16). The 
operators around pR and pL DNA can wrap onto the CI wheel to give species A, to repress 
both the pR and pL promoters. The operators that flank pR and pL, FL and FR, are proposed to 
displace the more weakly bound pL, to create species C. In this arrangement, pL is 
derepressed whilst maintaining repression of pR, rationalizing the ability of these flanking 
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sites to stimulate pL activity in vivo even in the absence of active pR (Dodd and Egan, 2002). 
At high levels of CI, the FL and FR flanking sites are sequestered by further CI wheels (e.g. 
species D), to eliminate derepression of pL via displacement by FL and FR. This negative 
autoregulation places a limit on CI levels in vivo, preventing the excessive accumulation of CI 
which would hinder prophage induction. This model was supported by the observation of CI 
discs of the correct dimensions by atomic force microscopy (AFM) interacting with DNA to 
give complexes that resemble the proposed species (Wang et al., 2013). In addition, SEC-
MALS measurements of the CI protein estimates the molecular weight of the oligomeric 
complex at 280 ± 8 kDa (12.1 ± 0.4 monomers). This observation supports 186 CI adopting a 
high order oligomeric state, although the estimated complex is slightly smaller than the 
expected 14mer.  
Although the wheel structure is consistent with current observations, there is currently no 
high-resolution confirmation of the proposed wheel structure with or without DNA. 
Determining the quaternary structure from a crystal structure (such as in this case with the 
CI-CTD crystal structure) can sometimes result in erroneous conclusions, as the crystal lattice 
can favour the formation of non-physiologically relevant oligomers (Bahadur et al., 2004). An 
experimental crystallographic or SAXS structure of the whole complex would validate this 
model of an alternative genetic switch, making it a useful counterpoint model to λ CI 
regulation. In addition, a high resolution structure of the full complex would extend the 
model by showing the arrangements of DNA binding domains. This information would 
provide insight into the 186 CI wheel-DNA interactions such as the ideal length of DNA and 
phasing of recognition sites in order for DNA to effectively wrap around the wheel.  
 
Figure 1-16 — Proposed structures formed when 186 switch region binds onto the 186 CI wheel. A corresponding CI-DNA 
complex observed with AFM with consistent dimension is shown below the proposed species. The HTH domains of three 
adjacent CI dimers can bind three major grooves of adjacent pR operators. Weaker binding sites of pL can then wrap onto 
the wheel, to give species a, where pR and pL are repressed. This binding behavior is consistent with CI repressing pL and pR 
in the absence of FL and FR sites (Dodd and Egan 1996). The weakly binding pL sites may unbind (species b) and FL or FR sites 
my bind to the wheel to give species c. pL is active in this state. This agrees with previous data demonstrating the presence 
of FL and FR sites relieves CI repression of pL whilst pR is still repressed (Dodd and Egan 1996). High concentrations of CI even 
in the presence of FL/FR still repress pL and pR and can be explained by the formation of species d. Figure adapted from 
Wang et al. (2013).  
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1.2.7 Summary 
Bacteriophage 186, although being evolutionarily divergent to bacteriophage λ, functions 
very similarly. Both are temperate, UV-inducible, phages that infect E coli. Both phages use a 
transcriptional activator to establish the initial pool of immunity repressor. The immunity 
repressor represses the lytic functions of the phage and activates the lysogenic promoter. 
However, the details of the mechanism of regulation by these proteins differ significantly 
between the two phages. More structural data on the 186 CII and CI proteins would further 
highlight these differences, and would position bacteriophage 186 as a more valuable 
counterpoint model to λ.  
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Abstract 
The temperate bacteriophage 186, after infecting its host bacterium Escherichia coli, can 
follow either the lytic or the lysogenic developmental pathways. Crucial to this developmental 
decision is the lysogeny promoting CII protein. This potent transcriptional activator activates 
the early lysogenic promoter pE at least 400-fold, to build up sufficient immunity repressor 
levels so that a significant fraction of infections commit to lysogeny. Its potency and its unusual 
property of binding to operator sites separated by 20 base pairs, center-to-center, suggest it 
may activate the pE promoter by a novel mechanism. Three crystal structures of the CII protein 
were solved to 2-3 Å resolution. The structures reveal a tetrameric arrangement of CII, shown 
to be necessary for DNA binding by mutational analysis and native mass-spectrometry. CII is 
degraded in vivo into a specific transcriptionally inactive product. The crystal structures reveal 
a reduced self-association of the degradation product and explain the loss of activity. 
Modelling of the CII-RNA polymerase complex at the pE promoter suggests that CII activates 
pE via recruitment of RNA polymerase through both σ70 and α-CTD contacts, in an arrangement 
different to previously studied transcriptional activators.  
Introduction 
Bacteriophage λ has long been used as a model system to study many aspects of prokaryotic 
gene regulation (Ptashne, 1986). As a temperate bacteriophage, λ makes a developmental 
decision between the lytic and lysogenic regimes. In λ, the decision between the lytic and 
lysogenic states is dependent on a transcriptional regulator CII. λ CII is produced soon after λ 
infection, under the control of the lytic promoter λ pR. λ CII activates three promoters pRE, pI 
and paQ, which drive the expression of the immunity repressor (λ CI), integrase (λ Int) for site 
specific integration of the genome, and an antisense RNA (anti-Q) to reduce late gene 
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expression (Oppenheim et al., 2005) (Figure 1A). All three products promote lysogeny in λ 
(Herskowitz and Hagen, 1980). If insufficient λ CII produced, the default lytic cycle is followed. 
 
Figure 1 – Schematic diagram illustrating the role of CII in the developmental switch in 
bacteriophage λ and 186. (A) The λ pR promoter drives the expression λ CII. λ CII activates the 
pRE, paQ and pI promoters to promote lysogeny. The sequence of pRE promoter is shown, with 
-10 and “-35” hexamers in blue, and the direct repeat 4-mer λ CII half sites indicated with red 
arrows. The -35 promoter element is poorly defined. (B) In 186, the pR promoter drives the 
expression 186 CII. 186 CII activates the pE promoter to promote lysogeny. The sequence of pE 
promoter is shown, with -10 and “-35” hexamers in blue, and the inverted repeat 7-mer CII 
half sites indicated with a red arrow. Figure adapted from Murchland et al. (2021). 
Although λ has made many seminal contributions to field of gene regulation, it represents just 
one example of bacteriophage decision making. Bacteriophage 186 is an evolutionarily distinct 
UV inducible temperate phage belonging to the P2 family, that shares a similar network 
topology to λ (Trusina et al., 2005). By studying bacteriophage 186 as a counterpoint to λ, 
more general principles in temperate bacteriophage regulation may be derived. 
186 also depends on a transcriptional activator protein named CII (186CII and λCII will be used 
for clarity) to establish lysogeny, in a concentration dependent manner (Lamont et al., 1993; 
Neufing et al., 1996; Neufing, Shearwin and Egan, 2001; Murchland et al., 2014, 2021). 186 CII 
is produced during early infection from the early lytic promoter 186 pR. 186 CII transiently 
activates the pE promoter to generate initial pools of the immunity repressor and the integrase 
protein (Figure 1B). The immunity repressor represses the lytic promoters, whilst the integrase 
gene catalyzes the integration of the phage genome into the bacterial chromosome (Neufing 
et al., 1996).  
186 CII recruits RNA polymerase (RNAP) to activate transcriptional activity. The mechanism by 
which 186 CII activates the pE promoter is unknown but unusually, mutagenesis studies 
suggest contacts with both RNAP σ70 and the α-CTD (Murchland et al., 2014). 186 CII binds to 
inverted half sites (ATGTTTG) separated by two turns of the DNA helix, bends the DNA and is 
quite intolerant to even small changes to spacing (Neufing et al., 1996; Shearwin and Egan, 
2000). This spacing is very uncommon among prokaryotic activators and when considered 
with its ability to activate its cognate pE promoter approximately 400-fold, suggests a possible 
novel mechanism of RNAP recruitment.  
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In this study, we present several crystal structures of the CII protein to show that CII is 
tetrameric and this oligomeric arrangement, in turn, dictates the half site spacing and the 
protein’s intolerance to spacing changes. Native mass spectrometry and in vivo pE-lacZ 
experiments are used to validate a model of tetrameric CII-DNA binding. Residue specific 
interactions between CII and RNAP were probed via alanine scanning mutagenesis. Finally, 
molecular modelling was used integrate the various structural and biochemical information 
into a model of the promoter-CII-RNA polymerase complex. This model proposes that the 
RNAP is recruited through its σ70 subunit by CII and that additional stabilization contacts are 
made with the α-CTD. Specifically, the α-CTD is proposed to contact promoter DNA between 
the two half sites, positioned into a binding site formed by the CII protein and bent DNA. 
This mechanism of anchoring the α-CTD within a protein-DNA cavity is distinct from other 
well-characterized prokaryotic transcriptional activators. 
Materials and Methods 
Oligonucleotides 
Oligonucleotides used in this study are summarized in Table S 1. 
Plasmids and bacterial strains 
Plasmids and bacterial strains used in this study are summarised in Table 1 and Table 2, 
respectively. A number of variants of 186 CII have been used in this study. The nomenclature 
CIIx, refers to CII truncated at the x-th amino acid. Amino acid substitutions of CII are denoted 
as superscripts (CIIQ93A refers to CII where glutamine 93 has been mutated to alanine. 
CIIQ93A145 refers to CIIQ93A truncated at the 145th amino acid).  
For pE-lacZ reporter assays, CII derivatives were expressed from a pZS45 plasmid (Murchland 
et al., 2014), which follows the modular design and nomenclature of the pZ system (Lutz and 
Bujard, 1997).  
For lacZ assays investigating the interactions between CII and the RNAP α subunit, RNAP α 
subunit mutant variants were expressed in IM50 (IM26 reporter strain, harbouring the pZS45 
CIIE46K expression vector) from pHTf1-rpoA and pREIIα-rpoA plasmids, from a previously 
described scanning alanine mutagenesis library (Kainz and Gourse, 1998). Alanine substitution 
mutants at residues 255-271 and 273-329 were expressed from the pHTf1-rpoA and pREIIα-




Table 1 – Plasmids used in this study 
Plasmid 
name 







Vectors to overexpress 
different truncations of CII. 
Protein expression driven 


























Low copy vector to allow 
IPTG-inducible expression of 
various CII and CII-derivatives 
from the plac promoter. ‘xxx’ 
denotes the amino acid at 
which CII is truncated  (ranges 
between 141 and 169 in this 
study). 
Amino acid mutations are 
written in superscript 
pZ modular plasmid; 
SC101 origin; spectinoymcin 
resistance 
Murchland et 
al. (2014) and 
this work 
pZS45 Low copy vector used as 
parental control in lacZ assays 
pZ modular plasmid; 
SC101 origin; spectinoymcin 
resistance 
Murchland et 
al. (2014) and 
Lutz and Bujard 
(1997) 
pUHA-1 Used to constitutively supply 
lacI from plac promoter in lacZ 
assays 
p15a ori; kanamycin 








pE lacZ reporter construct ; pE 
(-120 to +115) is upstream of 
R6K-γ ori; chloramphenicol 
resistance; can be integrated 




a RNaseIII cleavage site and a 
lacO2- lacZ reporter gene 
pIT3CH-
pCIIR-LacZ 
pCIIR lacZ reporter construct R6K-γ ori; chloramphenicol 
resistance; can be integrated 






Series of alanine scanning 
mutagenesis vectors to 
express single amino acid 
substitutions of RNA 
polymerase α subunit. 
Expression is IPTG-inducible.  





Table 2 – Bacterial strains used in this study 
Strain Genotype Notes Supplier/ 
Reference 
HMS174(λDE3) F- recA1 hsdR(rK12- mK12+) 
(DE3) (Rif R) 
Strain used to overexpress 





fhuA2 lacZ::T7 gene1 [lon] 










BW25113 (F-(araD-araB) 567 
lacZ4787(::rrnB-3)-rph-1 
(rhaD-rhaB)568 hsdR514 
Reporter gene modules were 
integrated into the bacterial 




IM26 BW25113 [pIT3CL-pE-lacZ]λ 
+ pUHA-1 
Strain used to measure in vivo 
activation of pE. 
pE:lacZ reporter integrated at 
the λ attachment site 
Murchland 
et al. (2014) 
IM13 BW25113 [pIT3CH-pCIIR-
lacZ]HK022 + pUHA-1 
Strain to assay CII binding to 
DNA in vivo 
The pCIIR:lacZ reporter was 
integrated at the HK022 
attachment site. pCIIR is an 
artificial promoter repressed 
by CII binding 
Murchland 
et al. (2014) 
IM50 IM26 + pZS45-CIIE146K  Strain used to measure the 
effect of RNA polymerase 
alpha CTD mutants on 
activation of the pE promoter 
Murchland 
et al. (2014) 
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Expression and purification of CII135 and CII145 
CII135 and CII145 were overexpressed in HMS174(λDE3) cells carrying the pLysS plasmid as 
described by Murchland et al. (2014). Selenomethionine labelled CII145 was overexpressed in 
T7 Express Crystal cells. T7 crystal express cells habouring the pET15b CII145 plasmid was 
grown overnight in 5 mL of LB supplemented with 100 µg mL-1 ampicillin. The cells were 
diluted 1 in 200 into M9 media (1 x M9 salts, 0.4% glucose, 1 mM MgSO4, 0.1 mM CaCl2, 
0.0002% ferric ammonium sulfate) supplemented with 100 µg mL-1 ampicillin and 50 µg mL-1 
L-methionine. Cultures were grown at 37°C with shaking until OD600 0.8. Cells were pelleted 
at 5000 x g for 20 mins and resuspended in an equal volume of culture media without 
methionine supplementation. The culture was incubated for 2.5 h to deplete methionine from 
the cells. Solid DL-selenomethionine was added to the culture to give a final concentration of 
100 μg mL-1 and cultures grown for a further 30 mins. IPTG (isopropyl β-d-1-
thiogalactopyranoside) was added to a final concentration of 0.2 mM to induce labelled 
protein expression and the culture was grown overnight at 16°C. Cells from protein 
overexpression were harvested by centrifugation at 5000 x g for 20 mins. Cell pellets were 
stored at -80°C. 
For purification of CII variants from cell pellets, cell pellets were thawed and resuspended in 
START buffer (1 x TBS, 350 mM NaCl, 20 mM imidazole, 5 mM β-mercaptoethanol, pH 7.2). 
Cell resuspensions were lysed by sonication on ice (5 x 30s, 50% duty cycle, Sonifier Cell 
Disruptor B-30). Lysate was clarified by centrifugation at 40 000 x g for 1 hour and subsequent 
filtration through a 0.2 µM syringe filter (Sartorius Minisart) using a disposable syringe. 
Supernatant was subjected to Ni2+-IMAC chromatography on a 5 mL HisTrap FF column (GE 
Healthcare) using NGC chromatography FPLC system (BioRad). The column was washed with 
10 column volumes of START buffer. The protein was eluted from the column with START 
buffer with a gradient of imidazole from 70 mM to 220 mM over 8 column volumes, followed 
by a gradient of imidazole from 220 mM to 500 mM over two column volumes. Fractions 
showing UV absorbance A280 above baseline were tested for purity using SDS-PAGE. Fractions 
containing the purified protein were pooled, dialysed against 1 x TBS, 50 mM EDTA pH 8, 10% 
glycerol, 5 mM β-mercaptoethanol. In the case of CII145, the protein was further purified 
using size exclusion chromatography on the Enrich 650 size exclusion column (Biorad) into 
TEG150 buffer (1 x TBS, 50 mM EDTA, 10% glycerol, 5 mM BME). For crystallography, CII135 
and CII145 proteins were concentrated to 8.5 and 10-24 mg mL-1 respectively using the 
Amicon Ultra-15 centrifugation units (Millipore). For mass spectrometry analysis, proteins 
were dialysed into 0.3 M ammonium acetate and concentrated to 80-120 µM using the 
Amicon Ultra-15 centrifugation units (Millipore). Prior to use in crystallography or mass-
spectrometry, proteins were flash frozen in liquid nitrogen and stored at -80⁰C.  
Crystallization of CII145, CII135 and selenomethionine derivatized CII145 
Crystallization screening for the CII135 and CII145 protein was conducted at 16⁰C using the 
sitting drop vapor diffusion method in 96-well Intelliplates (Art Robbins) using conditions from 
commercial screens. Commercial screens used were PEG/ION HT, Index, Natrix HT, Crystal 
screen HT (Hampton Research) and the MCSG suite (Microlytic). 1 µL of protein was added to 
1 µL of reservoir solution and equilibrated over 75 µL reservoir solution. Crystals were 
observed in several conditions. Diffraction from several of those crystals were acquired and 
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used to solve the structure of the CII protein. Details of the crystallization conditions and 
cryoprotection procedures were summarized in Table 3. A notable attempt to derivatize the 
CII135 crystal with polyiodide ions was made by adding 0.1 µL 0.47 M I2/0.67 M KI solution 
directly to the crystallization drop before cryoprotection (Evans and Bricogne, 2002). The 
crystal visually degraded after 30 seconds so the crystal was immediately cryoprotected and 
frozen in liquid nitrogen.  
Table 3 – Crystallization and cryoprotection conditions for CII proteins 
Protein Concentration 








CII135 8.5 0.2 M ammonium 
acetate, 0.1 M 















10 8% Tascimate pH 
8.0, 20% PEG 3350 
Crystals 
observed 











9.9 8% Tascimate pH 
8.0, 20% PEG 3350 
Crystals 
observed 
within 3 days 
and reach 
maximum 











4.8 2 M ammonium 
sulfate, 0.1 M Bis-









and freezing in 
liquid nitrogen 
 
Solving the structure of selenomethionine-labelled CII145 
A 3.2 Å resolution MAD data set for selenomethionine CII145 protein was collected at 
wavelengths of 0.9790 Å (peak), 0.9791 Å (inflection) and 0.9537 Å (high-energy remote) using 
an ADSC Quantum 210r CCD on the macromolecular beamline MX1 at the Australian 
Synchrotron. For each dataset, 360 diffraction images with a 1° oscillation width were 
collected with the crystal-to-detector distance set to 250 mm (Table 4). The diffraction data 
was processed using XDS (Kabsch, 2010). The initial phases were obtained using 3W-MAD 
phasing protocol of the Auto-Rickshaw server (Panjikar et al., 2005, 2009). Twenty eight 
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selenium atoms were placed using SHELXD (Schneider and Sheldrick, 2002) in space group 
P21. The sites were refined using BP3 (Pannu and Read, 2004), density modification and two-
fold NCS averaging was performed on the resulting phases using RESOLVE (Terwilliger, 2004). 
The density-modified phases were then used for model building in BUCCANEER (Cowtan, 
2006). The resulting model was further improved manually in COOT (Emsley et al., 2010). The 
improved model was then used as a starting model in the MRSAD protocol of Auto-Rickshaw 
(Panjikar et al., 2009) against the PEAK dataset for further iterative phase improvement, 
model building and model refinement. After 5 MRSAD iterative cycles including SAD 
refinement, the model resulted with 90% of complete model with R/Rfree 23.4%/29.0%.  
Solving the structure of CII145 (condition 1) 
A 2.1 Å resolution data for native CII145 protein was collected at 0.95 Å wavelength using an 
ADSC Quantum 315 CCD on the micro-focus beamline MX2 at the Australian Synchrotron. 358 
diffraction images were collected with a 1° oscillation width, with crystal-to-detector distance 
set to 300 mm. Diffraction data was processed and scaled using iMosflm and Scala (Battye et 
al., 2011; Evans and Murshudov, 2013). The resolution limit was chosen to ensure CC1/2 > 0.3. 
The data processing statistics of the diffraction from this crystal are listed in Table 4. The 
crystal structure was solved by molecular replacement using Phaser MR (McCoy et al., 2007), 
with the model built for the selenomethionine-labelled protein used as a search model. Each 
asymmetric unit contained 4 monomers. The model was iteratively refined and rebuilt using 
phenix.refine (Afonine et al., 2012) and COOT (Emsley et al., 2010), respectively, until R factors 
converged. Molprobity was used for model validation (Chen et al., 2010). Final refinement 
statistics are shown in Table 5.  
Structure solution of CII145 (condition 2) 
A 2.1 Å resolution data for native CII145 protein in condition 2 was collected at 1.4586 Å 
wavelength using an ADSC Quantum 315 CCD on the micro-focus beamline MX2 at the 
Australian Synchrotron. 360 diffraction images were collected at 1° oscillation width, with 
crystal-to-detector distance set to 200 mm. Diffraction images were processed as described 
for CII145 condition 1, with processing statistics summarized in Table 4. The structure was 
solved using the MR-SAD module of Auto-Rickshaw (Panjikar et al., 2009). The SAD procedure 
of the module was not used. Molecular replacement was performed using MOLREP (Vagin and 
Teplyakov, 1997), with chains A and D of the CII145 (condition 1) structure used as a search 
model. CNS (Brünger et al., 1998), REFMAC5 (Murshudov et al., 2011) and  phenix.refine 
(Afonine et al., 2012) were used to refine to structure to a model with Rwork/Rfree 
0.2627/0.3135. An attempt to identify heavy atom sites was performed with Phaser (McCoy 
et al., 2007),  with heavy atom refinement performed with MLPHARE (Collaborative 
Computational Project Number 4, 1994), SHARP (De La Fortelle and Bricogne, 1997) and BP3 
(Pannu and Read, 2004), without successfully identifying any heavy atom sites. Iterations of 
model rebuilding and refinement were completed using COOT (Emsley et al., 2010) and 
phenix.refine (Afonine et al., 2012), respectively, until R factors converged. Molprobity was 
used for model validation (Chen et al., 2010). Final refinement statistics are shown in Table 5.  
Structure solution of CII135 
A 2.75 Å resolution native data for native CII135 protein was collected at 0.95 Å wavelength 
using an ADSC Quantum 210r CCD detector on the MX1 beamline at the Australian 
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Synchrotron. 241 diffraction images were collected at 1° oscillation width, with crystal-to-
detector distance set to 250 mm. Diffraction images were processed as described for CII145 
condition 1, with processing statistics summarized in Table 4. The structure was solved using 
the MR module of Auto-Rickshaw (Panjikar et al., 2009). The search model for molecular 
replacement used was CII145 structure in condition 1, with residues after E106 removed. 
Molecular replacement was performed using MOLREP (Vagin and Teplyakov, 1997). CNS 
(Brünger et al., 1998), REFMAC5 (Murshudov et al., 2011) and  phenix.refine (Afonine et al., 
2012) were used to refine to structure to a model with Rwork/Rfree 0.2939/0.2925. Iterations of 
model rebuilding and refinement were completed using COOT (Emsley et al., 2010) and 
phenix.refine (Afonine et al., 2012), respectively, until R factors converged. Molprobity was 
used for model validation (Chen et al., 2010). Final refinement statistics are shown in Table 5. 
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Table 4 – Data processing statistics for crystallography datasets. Statistics for highest 
resolution shell are shown in parentheses.  













0.95 0.9790  0.9791  0.9537  0.95 0.95 
Total images 358 360 360 360 360 241 
Oscillation (°) 1.00 1.00 1.00 1.00 1.00 1.00 
Space group P21 P21  P21 P21  C2 P3221 





































Resolution (Å)  2.10 3.20  3.20   3.20  2.21 2.75 





























Redundancy 6.5 (6.6) 3.86 
(3.85) 
3.88 (3.86) 3.87 
(3.88) 





























CC1/2anom - 54 (20) 19 (10) 29 (6) - - 










R-measb (%) 27/162.2 13.5 
(41.1) 






Wilson-B (Å2) 22.51 41.33  43.19  43.00  18.601 20.363 
 
a𝑅𝑚𝑒𝑟𝑔𝑒 = ∑ ∑ |𝐼𝑖(ℎ𝑘𝑙) − 〈𝐼(ℎ𝑘𝑙)〉|𝑖ℎ𝑘𝑙 ∑ ∑ 𝐼𝑖(ℎ𝑘𝑙)𝑖ℎ𝑘𝑙  (Arndt, Crowther and Mallett, 1968) 
b𝑅𝑚𝑒𝑎𝑠 = ∑ {𝑁(ℎ𝑘𝑙)/[𝑁(ℎ𝑘𝑙) − 1]}
1/2  ×  ∑ |𝐼𝑖(ℎ𝑘𝑙) − 〈𝐼(ℎ𝑘𝑙)〉|/ ∑ ∑ 𝐼𝑖(ℎ𝑘𝑙)𝑖ℎ𝑘𝑙𝑖ℎ𝑘𝑙  
(Diederichs and Karplus, 1997) 
c CC1/2 = ∑(𝑥 − 〈𝑥〉)(𝑦 − 〈𝑦〉)/[∑(𝑥 − 〈𝑥〉)2 (𝑦 − 〈𝑦〉)2]1/2 (Karplus and Diederichs, 2012) 
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Table 5 – Refinement statistics of CII structures. Statistics for the highest-resolution shell are 
shown in parentheses.   
 CII145 (condition 1) CII145 (condition 2) CII135 
Molecular mass (kDa) 18.33 18.33 17.33 
Resolution (Å) 2.1 2.21 2.75 
Reflections used in 
refinement 
35898 (3562) 14296 (1395) 6481 (642) 
Reflections used for R-free 1995 (194) 1421 (139) 1092 (118) 
R-worka 0.2209 (0.2944) 0.2280 (0.2656) 0.2122 (0.2771) 
R-freeb 0.2606 (0.3489) 0.2829 (0.3243) 0.2651 (0.2867) 
Number of non-hydrogen 
atoms 
   
  total 4899 2340 1402 
  macromolecules 4596 2191 1338 
  ligands 16 6  
  solvent 287 143 64 
Protein residues 594 285 167 
RMSD bonds (Å) 0.002 0.005 0.004 
RMSD angles (°) 0.49 0.66 0.94 
Ramachandran favored 
(%) 
97.61 96.80 97.55 
Ramachandran allowed 
(%) 
2.05 2.49 2.45 
Ramachandran outliers (%) 0.34 0.71 0.00 
Rotamer outliers (%) 0.00 0.42 0.00 
Clashscore 4.16 9.69 4.98 
Average B-factor (Å2)    
  overall 37.71 43.21 33.59 
  macromolecules 37.50 43.59 33.92 
  ligands 64.78 56.76  
  solvent 39.66 36.79 26.69 
Number of TLS groups 31 10 9 
a 𝑅𝑤𝑜𝑟𝑘 = ∑ |𝐹𝑜 − 𝐹𝑐 |/ ∑ |𝐹𝑜| for all data with 𝐹𝑜 > 2𝜎 (𝐹𝑜), excluding data to calculate 𝑅𝑓𝑟𝑒𝑒 
b Rfree = ∑ |𝐹𝑜 − 𝐹𝑐 |/ ∑ |𝐹𝑜| for all data with 𝐹𝑜 > 2𝜎 (𝐹𝑜), calculated with 5% of reflections that 
are randomly chosen (Brünger, 1992). 
 
PDB codes 
The coordinates and structure factors for CII145 (condition 1), CII145 (condition 2) and CII135 
have been deposited in the Protein Data Bank as entries 6VLI, 6VPE and 6VHM, respectively.  
Molecular modelling 
Intramolecular residue-residue contacts between different CII monomers were investigated 
with the Protein Interaction Calculator webserver (Tina, Bhadra and Srinivasan, 2007). The 
crystal structure of CII145 (condition 1) was modified to remove residues from the N-terminus 
of the protein corresponding to the hexahistidine tag and thrombin cleavage sites, not present 
in the wild-type protein. This altered crystal structure was used for subsequent modelling. The 
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pE promoter -67 to -29 DNA was modelled using 3D-DART (van Dijk and Bonvin, 2009). The 
protein was docked onto the DNA using HADDOCK webserver (De Vries, Van Dijk and Bonvin, 
2010; van Dijk and Bonvin, 2010). Full details on docking parameters used are outlined in the 
Supplemental Materials. The same segment of pE DNA was modelled in its native 
conformation using the bend.it server (Vlahoviček, Kaján and Pongor, 2003).  
Thermus aquaticus RNAP polymerase was initially modelled onto the docked CII-DNA 
complex. The -35 DNA promoter element from a T. aquaticus σ4/-35 DNA complex (PDB ID 
1KU7) (Campbell et al., 2002) was superimposed onto the -35 promoter element of the CII-
DNA complex. The positioned σ4/-35 structure was then used to position the structure of the 
E. coli RNAP holoenzyme open promoter complex (PDB ID 4YLN) (Zuo and Steitz, 2015) by 
superimposing the σ4 subunit of both structures.  
Hotspot residues in the putative tetramerization interface of CII were predicted using the KFC 
(Darnell, LeGault and Mitchell, 2008) and Robetta alanine scanning (Kim, Chivian and Baker, 
2004) webservers. In silico mutagenesis of CII was carried out through ICM-Pro (Molsoft).   
Molecular visualization 
UCSF Chimera (Pettersen et al., 2004) and PyMOL (DeLano, 2002) were used to analyse and 
visualize the crystal structures, CII-DNA and CII-DNA-RNAP structural models.  
Preparation of DNA for mass-spectrometry 
Single stranded oligonucleotides were chemically synthesized (Integrated DNA Technologies). 
Oligonucleotides were resuspended in IDTE buffer (10 mM Tris pH 8, 0.1 mM EDTA) to a final 
concentration of 3 mM. Complementary nucleotides were then mixed in a 1:1 ratio, heated 
to 90-95°C and allowed to slowly cool to room temperature. The annealed oligonucleotides 
were buffer exchanged into 0.3 M ammonium acetate using Illustra MicroSpin G-25 columns 
(GE Healthcare). 
Mass-spectrometry examination of CII 
Mass-spectrometry measurements were performed on a Synapt HDMS system (Waters, 
Manchester, UK). Electrospray from in-house prepared gold coated borosilicate capillaries was 
used to introduce the samples (Hernández and Robinson, 2007). The instrument parameters 
were optimized to remove adducts while preserving noncovalent interactions and were 
typically as follows: capillary voltage, 1.5 kV; cone voltage, 50 V; trap collision energy, 10 V; 
source temperature, 20°C; and backing pressure, 6 mBar. 
Complementation assays 
The functional activity of CII was tested by complementation. cII473 is a bacteriophage 186 
clear-plaque mutant, with a gene encoding for defective cII (Huddleston, 1970). As expected, 
cII473 formed clear plaques when IM26 was used as an indicator. When IM26 carried the 
pZS45-CII plasmid, encoding functional CII, cII473 plaques were turbid, showing that plasmid-
derived CII can complement the lack of active CII on the phage. Activity of various CII mutants 
was tested by plating cII473 onto IM26 strains expressing the mutant CII from pZS45 plasmids. 
Strains were grown on solid LB agar media supplemented with 100 µM IPTG to induce CII 
expression. The activity of CII was qualitatively assessed from the turbidity of the plaques.  
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Kinetic lacZ assays  
Kinetic lacZ assays were performed in 96 well microtitre plates, as previously described 
(Dodd et al., 2001), with modifications described here. Details of reporter strains and growth 
media supplementation with antibiotics and IPTG for different lacZ experiments are 
summarized Table S 2 and Table S 3, respectively. All bacterial culture incubations were 
carried out at 37°C. Reporter strains were restreaked from glycerol stocks onto selective LB 
agar plates and incubated overnight. Fresh colonies from the selective plates were used to 
inoculate 100 µL of selective media in a well of the 96 well microtiter plate. Plates were 
sealed and incubated overnight with shaking. After overnight incubation, cells were diluted 
to OD600 0.003 in 100 µL fresh selective media, supplemented with a defined concentration 
of IPTG, in a microtitre plate well. Plates were sealed and incubated at 37°C until culture 
OD600 reached 0.6-0.9. Cultures were assayed for lacZ activity as previously described (Dodd 
et al., 2001). Two different lysis-assay reagents were used in this study. The original method 
for lysing cells involved adding 20 μL of culture to well of a microtitre plate containing 30 μL 
LB media, 150 μL of TZ8 (100 mM Tris-HCl, pH 8.0, 10 mM KCl, 1 mM MgSO4), 40 μL of o-
nitrophenyl-β-D-galactopyranoside (ONPG) (4 mg mL−1 in TZ8), 1.9 μL of 2‐mercaptoethanol 
and 0.95 μL of polymyxin B (20 mg mL−1). To more accurately measure high lacZ units, some 
assays used an improved lysis reagent, where each well contained 20 μL LB media, 88 μL of 
TZ8, 60 μL of ONPG (4 mg mL−1 in TZ8), 2 μL of hen egg white lysozyme (10 mg mL−1 in TZ8), 
4 μL of polymyxin B (20 mg mL−1) and 6 μL MQ water. 
Western blot assays 
IM26 cells with pZS45 plasmids, containing variants of the CII gene under the control of the 
plac promoter (Table 1), were grown in LB supplemented with 50 µg mL-1 spectinomycin, 50 µg 
mL-1 kanamycin and 100 µM IPTG. Cell were harvested by centrifugation (7000 x g, 3 min) and 
pellets were stored at -20°C. Cells were incubated at 37°C to mid-log phase. Cells were lysed 
with B-PER (Pierce) and Benzonase (0.25 unit µL-1) (Sigma Aldrich) and lysate was analyzed on 
4-15% Tris-glycine gels (Bio-Rad) in Tris-glycine running buffer. After electrophoresis, a semi-
dry transfer to a PVDF membrane was performed using Trans-Blot Turbo Transfer System (Bio-
Rad) with PVDF transfer pack (Bio-Rad). The membranes were blocked with 5% BSA. 186 CII 
primary detection used anti-CII rabbit antisera (IMVS Veterinary Services). Secondary 
detection used Cy5-labelled ECL Plex Goat anti-rabbit IgG antibody (GE Healthcare). The 
membranes were scanned on a Chemidoc imaging system (Bio-Rad) using the system’s Cy5 
channel (Epi-red illumination at 625-650 nm with 695/55 emission filter) and images analysed 
by ImageLab (Bio-Rad). 
Results 
Truncating CII results in higher in vivo activity 
In order to study the structure-function relationship of 186 CII, one of the aims of this study 
was to obtain an atomic resolution structure of 186 CII. 186 CII has a natural degradation tag 
at its C-terminus, which if truncated, extends the half-life of the protein leading to higher 
expression levels and higher transcriptional activity in vivo (Murchland et al., 2014). Thus, the 
optimal construct to trial for crystallography is likely to be the CII truncation that displays the 
highest in vivo activity.  
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The 169 amino acid long 186 CII protein was systematically truncated, residue by residue, to 
give truncated proteins of between 141 and 168 residues long. The activities of these 
truncated proteins were assayed using an in vivo pE lacZ reporter gene assay (Figure 2). 
Truncating CII even by one residue resulted in a statistically significant 38% increase in pE 
activation. A further statistically significant increase of 32% was observed for CII166 to CII165, 
suggesting that the degradation tag at the C-terminus can be gradually removed. Further 
gradual increases in the activity of CII were observed, up to a maximal activity corresponding 
to CII145 and CII146. Truncating the protein to residue 141 resulted in a sharp reduction in 
activity. No statistically significant activity of CII141 was seen, relative to the empty control 
(Figure 2).  
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Figure 2 – Truncation of CII results in increased in vivo activation of the pE promoter. Activity 
of pE was measured using an E. coli in vivo pE lacZ reporter system using lysis buffer containing 
hen egg white lysozyme (HEWL) to lyse cells. CII expression was induced by growing cells in 80 
µM IPTG. Bars represent the mean. Error bars represent the 95% CI (n ≥ 8). * denotes p > 0.05. 
** denotes p > 0.01.  
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CII forms a dimer of dimers 
CII145 was chosen as a target for crystallization on the basis that it displayed the highest in 
vivo activity. 186 CII145 was crystallized and solved in two independent conditions, conditions 
1 and 2 (Table 3) (see Material and Methods for full description of the conditions), with the 
structure within the asymmetric unit shown in Figure 3A and B, respectively. The crystals have 
the symmetry of the spacegroups in the space group P21 and C2, respectively. The structure 
of CII contained alpha helices and loops, with two separate domains joined by a linker. The N-
terminal domain, containing 5 helices, is the DNA binding domain, containing a helix-turn-helix 
motif, made by helices 2 and 3 (Figure 3C). A typical section of the electron density map for 
both structures is shown in Figure S 1.  
Previous studies have attempted to define the oligomeric state of the 186 CII protein. The best 
fit for data from sedimentation equilibrium experiments of the CII protein was a monomer-
tetramer equilibrium (Neufing et al., 1996). Subsequent SEC-MALS experiments with CII145 
and CII169 detected tetramers in solution (Murchland et al., 2014). Our native mass 
spectrometry measurements of CII reaffirm this tetrameric oligomeric state (Figure 4B). With 
this information, we attempted to define the CII biological assembly from the crystal 
structures using the PISA webserver (Krissinel and Henrick, 2007).  
PISA analysis of CII145 structure from condition 1 and condition 2 predicts three potential 
quaternary complexes being stable in solution, two dimer complexes and a tetramer complex. 
In both cases, the tetrameric complex was predicted to be the most probable state. The 
tetramer predicted for the crystal structures in condition 1 and condition 2, corresponded to 
the structure in Figure 3A and Figure 3D, respectively.  
In discriminating between a crystal contact and a true oligomeric interface, an interface area 
(defined as half the difference in total surface area and interfacing surface area) cutoff of 856 
Å2 has been used to differentiate between dimer interfaces and artifacts of crystallization 
(Ponstingl, Henrick and Thornton, 2000). In the proposed tetrameric structures, two pairs of 
monomers (A/B and C/D in condition 1 and A/B in condition 2) have large interface areas 
between 2548 to 2949 Å2, strongly suggesting an oligomeric interface. The interface area 
between monomers across these pairs is significantly lower than the cutoff, ranging from 
175.8 Å2 – 422.5 Å2. Thus, it is possible that a tetramer  interface is only established after the 
initial dimerization of the pair of monomers with the larger interface areas.  
Our evidence supports the CII protein oligomerizing into dimers and tetramers (as a dimer of 
dimers), with tetramerization mediated by a methionine zipper forming a four-helix bundle. 
There are eight methionine residues at the core of this tetramerization interface. Each 
monomer provides two methionine residues, M97 and M100 (Figure 4A). One notable aspect 
of the CII145 structure in condition 2 is the presence of two intramolecular disulfide bonds in 
each dimer. C78 forms a disulfide bond with C81 from the other protein chain in the dimer. 
However, these disulfide bonds are absent in the crystal structure of CII145 in condition 1. 
This suggests that when the CII proteins are purified from E. coli, disulfide bonds are not 
present. The disulfide bonds observed in condition 2 are likely to be artifacts of oxidation of 
protein during crystallization. 
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Figure 3 – Two crystal structures of 186 CII145. (A) Crystal structure of CII145 in condition 1 
(8% Tascimate pH 8.0, 20% PEG 3350). (B) Crystal structure of CII145 in condition 2 (2 M 
ammonium sulfate, 0.1 M Bis-Tris: HCl, pH 5.5). (C) Ribbon representation of a subunit of CII 
with helix-turn-helix motif in red. The helix-turn-helix motif is predicted using the Dodd and 
Egan weight matrix (Dodd and Egan, 1990). (D) Tetrameric quaternary structure of CII145 
(condition 2) proposed by PISA to be stable in solution (Krissinel and Henrick, 2007).  
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Figure 4 – CII145 forms a tetramer. A) Tetramerization interface in the CII145 (condition 1) 
crystal structure. CII145 tetramerization is mediated by a methionine zipper. Each monomer 
contributes two methionine, M96 and M100, which interact to form a four-helix bundle. B) 
Native ESI-MS of the CII145 protein (17 μM) in 300 mM ammonium acetate detects CII145 
forming a tetramer. 
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Docking suggests that CII binds to DNA as a tetramer 
The CII145 crystal structure revealed a tetrameric protein, mediated by a methionine zipper 
interface. Previous studies have defined two DNA half sites that CII recognises at the pE 
promoter (Shearwin and Egan, 2000). We hypothesized that the CII145 tetramer could be the 
DNA binding species in vivo that mediates transcriptional activation. To investigate this, 
HADDOCK (De Vries, Van Dijk and Bonvin, 2010) was used to dock the CII145 structure in 
condition 1 onto in silico models of pE DNA bent at various angles, modelled using 3D-DART 
(van Dijk and Bonvin, 2009), with the optimal predicted complex shown in Figure 5. In this 
model, each constituent dimer in the CII tetramer supplies a single helix-turn-helix (HTH) motif 
that contacts a pE half site. HTH motifs within a constituent dimer are too close to one another 
to contact half sites with the spacing observed in pE, without extreme distortions to the DNA. 
To accommodate the HTH motifs, the DNA is bent at 40 degrees, consistent with the 
experimentally measured 41±5° (Shearwin and Egan, 2000). The model shows CII helix 3, the 
recognition helix of the HTH motif, slotting into the major groove of the pE binding site. This 
model is consistent with previous DNAseI footprinting data (Neufing et al., 1996; Shearwin 
and Egan, 2000), and with data showing that mutagenesis of key HTH residues  (CII169V36E/Q37S) 
gives a protein which cannot bind or activate the pE promoter (Murchland et al., 2014). These 




Figure 5 - Model of 186 CII binding to the 186 pE promoter. CII tetramer structure (CII145 
structure 1) docked onto pE DNA modelled with 3D-DART (van Dijk and Bonvin, 2009). Docking 
was carried out on the HADDOCK webserver (De Vries, Van Dijk and Bonvin, 2010). One helix-
turn-helix motif from each CII dimer contacts a pE half site. DNA is shown in grey with CII half 
sites are coloured in black. Residues V36 and Q37 (shown in magenta) if mutated to glutamate 
and serine abolish DNA binding (Murchland et al., 2014). 
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Native mass spectrometry was used to investigate DNA binding by CII in vitro. Similar 
approaches have successfully been employed to characterize protein-DNA interactions (Craig 
et al., 1999; Satiaputra et al., 2019). CII145 was mixed with annealed oligonucleotides 
containing the CII binding site. The minimum DNA fragment length required for binding is 
unknown, so two lengths of 31 bp and 35 bp were tested (subsequently referred to as pE31 
and pE35) (Figure 6A). In each case, two DNA bound species could be detected, with one 
species apparently much more abundant than the other (Figure 6B and Figure 6C). The most 
abundant species corresponds to the mass of a CII145 tetramer bound to one single piece of 
DNA, consistent with the model of binding proposed in Figure 5. It should be noted that this 
result does not differentiate between a tetramer binding to one or two pE sites. The low-
abundance species corresponds to the mass of a CII tetramer bound to two separate DNA 
molecules. This binding may occur through one dimer within the tetramer interacting with 
one DNA fragment and the second dimer with a different DNA fragment. This mode of binding 
would be facilitated by the very short lengths of the DNA fragments used here. The caveat to 
judging abundance from mass spectra is that the ease of ionization between the species may 
be different and thus relative ratios cannot reliably be determined. 
A CII tetramer binding to DNA may introduce significant strain into the DNA due to the 40° 
bend. The native conformation of pE DNA was modelled using the bend.it server (Vlahoviček, 
Kaján and Pongor, 2003). The predicted conformation showed a 21° bend in the DNA in the 
same direction as in the predicted CII-DNA complex. If pE DNA possessed an intrinsic bend 
that was complementary to the CII tetramer, it would maximise the probability of one CII 
tetramer occupying both half sites. The extra strain required to bend pE to 40°C for CII to 
occupy both half sites may reduce this probability, and hence contribute to the observation 
of pE DNA bound by 2 CII tetramers..   
To confirm that the CII binding seen here is specific, CII145 was mixed with a 35 bp DNA 
fragment from the FtsK gene (FtsK35), a sequence unrelated to the pE promoter sequence. No 
binding to this non-specific DNA sequence was detected via mass spectrometry, with only free 
DNA and free CII145 detected (Figure 7).   
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Figure 6 –Mass spectra of native CII145-DNA complexes. (A) The DNA sequences of the 
oligonucleotides used in the mass spectrometry experiments below with the CII operator sites 
highlighted in red. (B) ESI-MS spectra of CII145 (34 µM) as a mixture with 31 bp pE DNA (17 
µM). (C) ESI-MS spectra of CII145 (34 µM) as a mixture with 35 bp pE DNA (17 µM).  Two 





Figure 7 – No non-specific binding of CII to DNA could be detected via mass spectrometry. ESI-
MS spectra of CII145 (34 µM) as a mixture with 35 bp FtsK DNA (17 µM). Free DNA and a CII145 
tetramer were the only species detected.  
In vivo proteolysis disrupts CII’s ability to form tetramers 
Murchland et al. (2021) showed recently that CII has a sequence at the C-terminal region that 
recruits the RseP protease, resulting in cleavage of the protein at residue 135. The degradation 
product (referred to as CII135) is further degraded by the FtsH protease. Based on the CII145 
structure, this cleavage point lies within helix 7. In the CII tetramer, the α-helical methionine 
zipper bundle that mediates tetramerization is surrounded by four helix 7, one supplied by 
each monomer. Thus, cleavage within helix 7 was hypothesized to disrupt the methionine 
zipper tetramerization interface of CII, preventing tetramerization. In reporter gene assays, 
CII135 was shown to display minimal transcriptional activation, although there was a statistical 
significance slightly above basal promoter levels (Murchland et al., 2014). To investigate the 
structural basis of this post-translational regulation, the crystal structure of CII135 was 
determined. 
The structure of CII135 was solved. The crystals have the symmetry of space group P3221. The 
asymmetric unit contained a dimer of CII135 (Figure 8A). A typical section of the electron 
density map for the CII135 structure is shown in Figure S 1.  In the structure of CII135, electron 
density for residues after E86 was not observed. The truncation may result in residues after 
E86 no longer adopting a defined secondary structure and generating extremely flexible 
regions in the protein that cannot be seen in the crystal structure. To check that the protein 
had not become further truncated during overexpression or purification, the molecular mass 
of the CII135 protein used for crystallization was determined by mass spectrometry under 
denaturing conditions (Figure 9A). The observed mass of the denatured protein was only 
slightly smaller than the theoretical molecular mass of His-tagged CII135, suggesting that the 
initiator methionine is cleaved in vivo, but that no further degradation had occurred. 
Examination of the crystal packing of CII135 shows that the protein does not adopt the same 
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tetrameric oligomerization in the crystal lattice as observed for CII145. The next protein 
molecule in the crystal lattice is present in the region where the methionine-zipper helices 
would be expected (Figure 8B and C). This change in oligomeric state to a dimer was confirmed 
in vitro using native mass spectrometry (Figure 9B).  
 
Figure 8 – Crystal structure of CII135. (A) Crystal structure of CII135 was solved as a dimer. 
Electron density for residues after E86 was not observed. Residues after this point could not 
be modelled into the structure. (B) Crystal structure of CII135 superimposed onto the 
structure of CII145 (condition 1). CII135 chains are shown in green and blue. CII145 structure 
is shown in magenta. (C) CII135 does not adopt the same tetrameric quaternary state as CII145 
in the crystal lattice. The packing of CII135 in the lattice excludes the possibility of a CII 




Figure 9 – CII135 forms dimers. (A) Mass spectra of denatured CII135 suggests that initiator 
methionine of CII is removed. The spectra also confirms that CII135 was not degraded prior to 
crystallization trials. Protein was denatured by mixing protein solution with a methanol/acetic 
acid solution in a 1:1 ratio. (B) Native ESI-MS spectrum of CII135 shows the presence of CII135 
monomers and dimers. No CII135 tetramers were observed.   
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Superposition of the CII dimer units from all three CII crystal structures onto each other reveals 
that they adopt the same conformation (Figure 10A). As described earlier, residues after 
residue E86 were not observed in the crystal structure of CII135 and the methionine zipper 
oligomeric interface is disrupted in this degradation product. However, even in the absence 
of a functional methionine zipper segment, the remainder of the CII135 protein can adopt the 
same dimeric conformation. This result suggests the possibility of the NTD and/or the linker 
region play a role in CII dimerization. To investigate the oligomerization, possible residue-
residue interactions between different monomers were computationally defined using the 
crystal structures. Interactions including ionic bonds, hydrogen bonds, aromatic interactions 
(such as π- π stacking) and hydrophobic interactions were observed throughout the structure 
and not isolated to just the CTD (Figure 10B). Thus, interactions in the NTD and linker region 
may assist in dimerization. There is a salt bridge between E14 in the NTD and H143 in the CTD 
of the other protein chain, which would significantly restrict the movements of one NTD 
relative to the tetramerization interface. This interaction, in addition to other intramolecular 
interactions between the NTDs and between the linker regions, could contribute to a CII dimer 
acting as a rigid body.  
The crystal structure of CII135 contained the same two intramolecular disulfide bonds as the 
structure of CII145 in condition 2. As explained for the structure of CII145 in condition 2, these 
disulfide bonds are likely due to oxidation of the protein after purification. 
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Figure 10 - A CII dimer adopts the same conformation in different crystal conditions. (A) The 
structures of the CII dimers found in CII145 condition 1, CII145 condition 2 and CII135 were 
superimposed onto each other. (B) Plausible intramolecular contacts, defined using the 
Protein Interaction Calculator (Tina, Bhadra and Srinivasan, 2007), exist throughout the 
protein dimer. In the dimer, there are intramolecular contacts between the two CTDs, the 
NTDs and between the linkers. There is also a salt bridge between an NTD residue and the CTD 
of the other monomer. Residues involved in forming disulfide bonds, which are hypothesized 
to be the result of oxidation of cysteine residues after protein purification, are also shown in 
blue.  
Tetrameric CII is required for efficient DNA binding and transcriptional activation 
CII145, shown here to adopt a tetrameric oligomeric state, is a functional truncation of CII that 
retains the same mode of activation as the wild-type protein. CII135 is the natural degradation 
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product of CII and displays minimal activity (Murchland et al., 2014). Our experiments show 
the cleavage of CII at residue 135 allows dimerization but prevents subsequent 
oligomerization into a tetramer. An attempt to investigate DNA binding by CII135 via mass-
spectrometry was made. However, the resulting spectra was too noisy to interpret confidently 
(see Figure S 3 for details). To examine if a change in oligomeric state affects the ability of the 
protein to activate pE, mutagenesis was carried out to disrupt the tetrameric interface of CII. 
The key residues in the tetramerization interface were computationally predicted with KFC 
(Darnell, LeGault and Mitchell, 2008) and Robetta scanning alanine (Kim, Chivian and Baker, 
2004) webservers. A combined total of six key residues were predicted- Q93, V96, M97, M100, 
V111, S112. Site directed mutagenesis was used to substitute these residues with alanine. The 
methionine residues were also mutated to cysteine.  
As judged qualitatively by western blot, the mutants V96A, M97A, M100A, V111A and S112 
are solubly expressed in vivo, at levels similar to thewild-type protein (Figure 11A). The activity 
of these mutants was first qualitatively assessed using phage complementation assays (Table 
6). The V96A, M97A and M100A mutants of CII were unable to complement a CII-deficient 
phage. M97C and M100C could produce turbid plaques with visually reduced turbidity 
compared to wild-type CII. The inability of V96A, M97A and M100A mutants to complement 
a CII-deficient phage arises from their loss of transcriptional activation of pE (Figure 11B). 
These three CII mutants showed vastly reduced levels of pE activation (0-1.4% of wild-type CII). 
Two residues, M97 and M100 are proposed to be key residues in the putative methionine 
zipper interface depicted in Figure 4A. Mutating these residues to alanine likely prevents a 
tetramer formation. These results support the hypothesis that CII binds to DNA and activates 
pE as a tetramer. All other mutants Q93A, M97C, M100C, V111A, and S112A display 
intermediate pE activation activity between wild-type CII protein and the no CII control, 
retaining enough activity to form turbid plaques in complementation assays. The functional 
tetramerization interface is likely retained in these mutants, possibly with reduced affinity for 
self-association.  
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Table 6 – Phage complementation assays to measure the effect of tetramerisation interface 
mutants on CII activity in vivo. Mutagenesis of some residues within the putative 
tetramerization interface of 186 CII results in loss of transcriptional activation activity of the 
protein. CII-deficient 186 phage (cII473) was plated onto lawns of IM26 expressing either wild-
type or variants of CII from a pZS45 plasmid. Bacteria were grown on LB agar media 
supplemented with 100 µM IPTG to induce CII expression. Active CII would complement the 
CII-deficient phage and give turbid plaque morphology, or no plaques if all infections result in 
lysogeny. Inactive CII results in clear plaque morphology 
CII variant expressed Morphology of cII473 plaque 
Wild-type Turbid 




M97C Weakly turbid  
M100A Clear 







Figure 11 – Measuring pE activation and DNA binding of CII with amino acid substitutions in 
the putative tetramerization interface in vivo. A) Mutants of CII are solubly expressed by pE 
lacZ reporter strains. Western blot analysis of CII expression in pE-lacZ reporter strains grown 
in media containing 100 µM IPTG, show qualitatively that the mutants of CII are expressed 
and that the protein is soluble. The soluble fraction of cell lysate was obtained by 
centrifugation of whole cell extract (21,130 g, 10 min) to pellet insoluble material. B) pE-lacZ 
reporter assays reveal that mutagenesis of V96, M97 and M100 reduces the activation ability 
of the protein. Bar represents the mean. Error bars represent the 95% CI. n=9. **** denotes 
p > 0.001. Statistical significance was determined using a paired two-tail t-test.  
CII interacts with the RNAP σ70 subunit and α-CTD 
A common mechanism employed by prokaryotic transcription factors to activate a promoter 
is to bind to DNA and ”recruit” (RNAP) to the promoter by making direct protein-protein 
contacts (Lee, Minchin and Busby, 2012). This is the basic mechanism used by CII to activate 
pE, however the unusual 20bp operator spacing and set of existing CII activation-deficient 
mutants suggest an unusual set of contacts may be involved (Murchland et al., 2014).  
To model how a CII tetramer bound at pE may interact with RNAP to activate the promoter, 
the crystal structure of E. coli RNAP was modelled onto the CII-DNA docked complex from 
Figure 5 (Figure 12A). Murchland et al. (2014) have previously proposed that CII residues E46 
and R17 interact with K593 of the E. coli σ70 subunit, based on CII mutants isolated from 
genetic screens. The modelling presented here provides further evidence of an interaction 
between these three residues. In this docked complex, it is found that one of the CII E46 
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residues is spatially positioned such that it can interact with σ70 residue K593 (Figure 12B). R17 
contacts E46 and may be have a role in positioning it correctly for the K593 interaction. 
 
Figure 12 - Model of 186 CII binding and activation of the 186 pE promoter.  (A)  Model of the 
arrangement of CII and RNAP at the 186 pE promoter. RNAP model used is E. coli RNAP crystal 
structure (PDB ID 4YLN), positioned by placing σ70 over the -35 sequence of pE. The σ70 subunit 
of RNAP is in green, and CII in red. (B) CII residues E46 and R17 are positioned in the model 
close enough to plausibly contact RNA polymerase σ70 K593.  
55 
To further validate the E46 contact, this residue was mutated to the other 19 natural amino 
acids and the transcriptional activation ability was assayed via lacZ reporter assays (Figure 
13A). Mutating CII at this position generated mutants with varying levels of activity. An acidic 
residue in the 46th position, either glutamate (the wild-type residue) or aspartate is necessary 
for strong transcriptional activation. Interestingly, the aspartate mutation resulted in 13% 
higher activity than wild-type protein. The structural model indeed predicts that the E46D 
mutant would retain activity, as D46 should maintain the salt bridge with K593. Placing a non-
acidic residue at position 46 resulted in a significant reduction in activation ability by over 65%. 
These mutants still retained significant activity, suggesting that E46-K593 is not the only 
stabilizing contact that CII provides to RNAP at the pE promoter.  These lower activity mutants, 
such as E46G which does not have a side chain to form extra interactions, may have lost the 
stabilizing interaction from the 46th residue but still provide RNAP recruitment through other 
contacts. The most significant loss of function occurred when E46 was mutated to a basic 
residue, arginine or lysine. A basic residue at this position is predicted to create an antagonistic 
interaction with the key σ70 residue. The effect of the E46K mutation on the protein complex 
was modelled using ICM-Pro (Molsoft). In silico energy minimization of the mutant and wild-
type complexes show a 2 Å shift of K593 away from the CII 46K residue. In summary, the E46K 
mutation repels the RNAP σ4 helix, opposing recruitment at pE (Figure 13B).  
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Figure 13 – CII recruits RNA polymerase via an activation epitope at E46. (A) CII requires an 
acidic residue at the 46th position for effective transcriptional activation. Basic residues in the 
46th position resulted in maximal loss of function as measured by pE-lacZ activity. CII 
expression was induced by growing cells in 200 µM IPTG. Error bars represent the 95% CI (n ≥ 
8). ** denotes p > 0.01. (B) In silico simulations show the E46K mutation creates an 
antagonistic interaction that pushes K593 away by 2.0 Å. The energy minimization of the 
RNAP-DNA complexes with mutant and wild-type CII was carried out using ICM-Pro (Molsoft). 
The wild-type and E46K complex are depicted in tan and blue, respectively. 
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Even with the loss of an important contact between CII residue 46 and σ K593, a significant 
amount (~20%) of transcriptional activity remains, suggesting another contact between CII 
and RNAP. Combined with the observation that CII loss-of-transcriptional activity mutants 
map to different regions of CII (Murchland et al., 2014), additional contacts with the alpha 
subunit of RNAP was proposed. The alanine scanning mutagenesis library constructed over 
the studies of Tang et al. (1994), Gaal et al.  (1996), Kainz and Gourse (1998) and Savery et al. 
(1998), were used in this study to investigate possible contacts the α subunit may have with 
186 CII, using the pE lacZ reporter system, and expressing CIIE46K (Figure 14). The E46K mutant 
of CII was selected to measure the effect of α-CTD mutations, as σ70 dependent promoter 
activation masks the contribution of α-CTD to promoter activation in lacZ assays with wild-
type CII (Murchland et al., 2014).  
The results show that alanine substitutions at residue positions 265, 268, 269, 295, 296, 298, 
299 and 302 resulted in a 46-61% loss in activity. These residues lie within the well-known 265 
DNA-binding determinant of α-CTD (Gaal et al., 1996; Murakami, Fujita and Ishihama, 1996), 
indicating that DNA binding by α-CTD is important in pE activation. Alanine substitutions at 
positions 262, 281, 289, 303 and 307 result in >40% loss in activity and have sidechains 
directed towards the core of the protein. These effects are likely to be indirect and not a result 
of loss of contacts with CII. Alanine substitutions at residues 262 and 303 in a previous screen 
have been shown to result in a moderate loss of activity and were proposed to have indirect 
effects on DNA binding (Ross et al., 2003). Other mutations at residues 281, 289 and 303 may 
alter the position of α-CTD helix 2, which contains D280. As will be explained later, D280 is 
predicted to interact with CII. Alanine substitutions at positions with surface exposed side 
chains (residues 273, 280, 287, 291, 293, 314 and 320) also resulted in >40% loss of activity. A 
subset of these residues may be forming stabilizing contacts with CII to stabilize RNAP at the 
pE promoter. Interestingly, alanine substitutions at position 264 and 271 gave an increase in 
pE activity. V264 is positioned next to the main DNA binding residue R265 and could plausibly 
contact DNA. Thus, V264 mutations could have improved DNA binding. This improvement was 
not observed in other screens using this library and may be specific to the pE promoter 
sequence (Gaal et al., 1996; Savery et al., 1998, 2002; Ross et al., 2003). The K271A mutation 
is likely to be generating a new contact or removing an antagonistic interaction to CII.   
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Figure 14 - Alanine scanning mutagenesis to identify RNA polymerase α-CTD residues involved 
in CII-dependent activation of pE. (A) Activity of pE was measured using an E. coli in vivo pE lacZ 
reporter system expressing CIIE46K (IM50) and RNA polymerase α subunit mutants where each 
residue was replaced with alanine, encoded by pHTf1 and pREIIα plasmids. Mutants 255-271 
were expressed from the pHTf1 vector system. Mutants 272-329 were expressed from the 
pREIIα vector system. All mutant activities are normalized to the wild-type activity of their 
respective plasmid system. The activities presented are the average of four independent 
experiments. The error bars represent the 95% confidence interval (CI). A gap in the mutant 
axis indicates a residue untested because of poor growth of that strain. CII and RNA 
polymerase α subunit expression was induced by growing cells in the presence of 200 µM 
IPTG. Blue bars indicate where alanine naturally occurs (same as wild-type α). The red bars 
correspond to residues within the DNA‐binding determinant (Gaal et al., 1996; Murakami, 
Fujita and Ishihama, 1996) 
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The structural model of CII activation of the pE promoter was extended to include the α-CTD, 
with the positioning of the subunit driven by the α-CTD mutagenesis data and known DNA 
binding contacts of the α-CTD. The α-CTD model was derived from a crystal structure of a 
catabolite activator protein (CAP), α-CTD and DNA complex (Benoff et al., 2002) (PDB ID 1LB2). 
The α-CTD was positioned such that DNA binding determinants, most importantly R265, were 
contacting the A-T rich minor groove of the DNA, between the pE half sites. R115 is an epitope 
used by CII to contact α-CTD (Murchland et al., 2014). Different α-CTD positions were tested 
to evaluate possible contacts with CII R115, with the final model shown in Figure 15A. Due to 
the rotational symmetry of the CII-DNA complex, CII can contact two α-CTDs, with each dimer 
providing a R115 contact epitope.  
In the proposed model, α-CTD D280 forms a salt bridge with R115 of CII. Thus, mutation of α-
CTD D280 to alanine (this work) or CII R115E (Murchland et al., 2014) abolishes this salt bridge 
and reduces CII activity. In the model, α-CTD K271 also forms a repulsive interaction with K46 
of the CIIE46K mutant (Figure 15B). This prediction is consistent with the K271A mutant of α 
providing increased pE activation in lacZ assays, as the CTD mutant would abolish this repulsive 
interaction. Remarkably, K271 is predicted to form a stabilising salt bridge with the crucial E46 
residue in wild-type CII. The E46 residue from one dimer of a CII tetramer is involved in the 
interaction with σ70 K593 and may be unable to interact with α-CTD. However, the CII dimer 
subunit distal to the σ70 has a free E46 to interact with α-CTD.    
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Figure 15 – Proposed structural model of 186 CII anchoring α-CTD at the pE promoter. (A) α-
CTD is positioned within a binding site formed between 186 CII and the bent pE DNA. The E. 
coli α-CTD of RNAP (PDB ID 1LB2) was modelled into the CII-DNA complex using PyMOL 
(DeLano, 2002). The R115 epitope of CII that contacts α-CTD is shown in green. Region of 
interest where α-CTD interacts with CII, denoted in a black box, is magnified in (B). The model 
proposes that CII R115 contacts D280 of the α-subunit. The K46 residue in the CIIE46K mutant 
used in alanine scanning lacZ assays is proposed to form an electrostatic repulsive interaction 
with K271, which would be abolished in the K271A mutant of α. In the wild-type situation α 




Rationale for structurally characterized CII truncations 
The 186 CII protein is 169 residues long containing two functional domains – an N-terminal 
DNA binding domain and a C-terminal oligomerization domain. The C-terminal region of 186 
CII contains a degradation signal that leads to CII being degraded rapidly in vivo to give a 
specific degradation product, CII135. Rapid degradation presents technical difficulties in 
overexpressing wild-type CII, both in terms of obtaining sufficient quantities for structural 
studies, and in purifying it away from its degradation product. Murchland et al. (2014) 
demonstrated that CII145 functionally activates the pE promoter in the same manner as the 
wild-type protein. In lacZ reporter assays from the current study (Figure 2), CII145 was shown 
to be one of the most active truncations and thus potentially most amenable to crystallization. 
The CII145 truncation was used throughout this study as it was straightforward to purify, and 
its structure should be reflective of the full-length protein. The degradation product CII135 
was also structurally characterized to understand the structural changes that occur as a result 
of site-specific degradation.  
Currently, no structural data on CII residues after residue 145 is available. A secondary 
structure prediction suggests an α-helix spanning residues 151-160 (Murchland et al., 2014). 
Sequential single amino acid truncations back to residue 145 increased in vivo activity. Thus 
the structural elements after residue 145 are likely to be involved in the degradation tag 
recognition by proteases. These structural elements would be shortened or disrupted as the 
C-terminus is progressively truncated. Attempts to crystallize full-length CII were unsuccessful, 
as were attempts to co-crystallise CII with DNA. Future studies could employ alternative 
techniques such as NMR to characterize this C-terminal sequence in isolation.  
The active species of 186 CII is a tetramer 
186 CII forms a dimer of dimers. The crystal structures suggest that 186 CII initially dimerizes 
into a rigid body. This dimerization is mediated by residues in both domains of the protein and 
can occur in the absence of a structured CTD. The presence of the salt bridge in the protein 
between the NTD and CTD indicates the domains may be structurally dependent and could 
explain how the NTD and CTD fail to overexpress, each expressed on their own (Murchland et 
al., 2014). Half of a methionine zipper interface is created in the dimeric protein to mediate 
subsequent dimerization into a tetramer (Figure 4A). This order of assembly from monomer 
to dimer to tetramer was previously shown for CII (Shearwin and Egan, 2000) and is almost 
universally the pathway that homotetrameric proteins use to assemble (Powers and Powers, 
2003). A tetrameric CII oligomeric state has previously been observed via analytical 
ultracentrifugation (Shearwin and Egan, 2000) and SEC-MALS (Murchland et al., 2014). In this 
study, native mass-spectrometry further validates that CII forms a tetrameric species.  
In the tetramer, an HTH motif from each dimer is positioned to bind to an inverted repeat DNA 
half site, spaced two turns of the DNA apart (Figure 6). Computational modelling of DNA 
showed that a DNA bend of 40° gave the optimal spatial arrangement for DNA binding by a 
CII145 tetramer (Figure 5). This angle is consistent with the experimentally determined CII 
induced DNA bend of 41⁰±5 (Shearwin and Egan, 2000). The rigidity of the dimers within the 
tetramer places physical constrains on the positions of the HTH motif, explaining the 
intolerance of CII to changes in half site spacing.  
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Native mass-spectrometry analysis of CII145 with pE DNA identified a complex of a tetramer 
of CII with DNA as the predominant species (Figure 6) consistent with the complex predicted 
by protein-DNA docking (Figure 5). To investigate the role of tetramerization in CII function, 
residues predicted to mediate tetramerization were mutated. Mutagenesis of residues in the 
methionine zipper (dimer-dimer) interface abolished the transcriptional activation ability of 
CII, and the ability to complement a CII deficient phage, indicating that the tetramer is needed 
to function effectively as an activator.  
λ CII, like 186 CII, also exists as a dimer of dimers. The unique arrangements of binding sites in 
λ CII and 186 CII (Figure 1) are the result of the positioning of the λ CII and 186 CII dimers in 
their tetramers. Despite both λ CII and 186 CII binding DNA through a helix-turn-helix motif, 
the overall topology of the proteins differs (Figure 16B).  λ CII multimerizes into a dimer of 
dimers, to form an asymmetric tetramer bundle mediated by a single helix (helix 4) from each 
monomer. The dimers are arranged such that the HTH motifs that contact the major groove 
of DNA face the same direction, resulting in λ CII binding direct DNA repeats (Jain et al., 2005) 
(Figure 16A). 186 CII forms a tetrameric species, mediated by two helices (helices 6 and 7) 
from each monomer. In this species, the HTH motifs are pointed in opposite directions, 
resulting in the protein binding inverted repeats (Figure 5).  
A commonality between the mechanism of λ CII and 186 CII is that they act through the 
stabilization of both the σ70 subunit and α-CTD of RNAP. 186 CII makes direct contacts to both 
σ70 (CII E46 forms an ionic interaction with σ70 K593) and α-CTD (CII E46 and R115 is predicted 
to form ionic interactions with α residues K271 and D280, respectively). λ CII, on the other 
hand, binds to the opposite side of DNA relative to RNAP and only contacts an α-CTD subunit 
of RNAP (Figure 16C). λ CII is predicted to contact the same residue (α K271) as 186 CII. α-CTD 
helps to stabilize the σ70 subunit (Figure 16D). Thus, λ CII indirectly exerts its effect on the σ70 




Figure 16 – Mechanism that λ CII uses to bind DNA and recruit RNA polymerase. (A) Structure 
of λ CII tetramer bound to DNA (PDB ID 1ZS4) (Jain et al., 2005). λ CII binds to TTGC direct 
repeat half site that flank the -35 promoter element. (B) Structure of a monomer of λ CII (PDB 
ID 1ZS4; chain A), shown in blue, and a monomer of 186 CII (condition 1; chain A), shown in 
pink. The helix-turn-helix (HTH) motifs in the proteins are shown in red and are positioned in 
the same orientation. (C) Structural model of RNA polymerase recruitment by λ CII. λ CII binds 
DNA and contacts the α-CTD subunit of RNA polymerase on the opposite face of the DNA to 
recruit it to the promoter. (D) Magnified region from (C) showing a predicted contact between 
RNA polymerase λ CII residue E14 and α residue K271. α-CTD contacts σ4 via its 261 
determinant (D259 and E261). Models shown in (C) and (D) were reproduced from Jain et al. 
(2005).  
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A tetrameric activator may present useful regulatory features to the lytic-lysogenic 
decision 
The role of the CII proteins in bacteriophage λ and 186 is to influence the decision between 
the lytic and lysogenic cycles. If the effective concentration of the activator protein does not 
reach a threshold concentration, the phage commits to the lytic cycle. In this context, CII 
providing an ultrasensitive response may be beneficial, where at high CII levels, it decisively 
begins the lysogenic cascade. Evidence from our laboratory indicate that 186 CII can provide 
an ultrasensitive response (Crooks, 2006; Murchland et al., 2014). A tetrameric arrangement 
may provide increased ultrasensitivity compared to a dimer. The degree of ultrasensitivity due 
to cooperative binding is less than or equal to the stoichiometry of the reaction. This property 
is described by Hill coefficient, nH, which have maximal values of 2 and 4 for a dimer and 
tetramer, respectively.  
The stability of 186 CII and λ CII have important roles during the lytic-lysogenic decision stage 
of infection. Both proteins have a short in vivo half-life of around 2 minutes (Shotland et al., 
2000; Murchland et al., 2014). λ CII is quickly degraded by the host protease FtsH (HflB) 
(Banuett et al., 1986; Shotland et al., 2000). It has been hypothesized that FtsH, which is 
upregulated during times of increased nutrition, allows λ CII to sense nutrient levels and skew 
development toward the lytic development in times of nutrient abundance (Bandyopadhyay 
et al., 2011). Mutations in FtsH which increase λ CII half-life, have been shown to promote 
lysogeny (Herman et al., 1993). 
186 CII, like λ CII, is also regulated at the proteolysis level. It is degraded by a site-specific 
protease RseP recruited by a degradation signal present at the C-terminus of the protein 
(Murchland et al, 2014; 2020), and also by FtsH. The rapid clearance of CII is required for the 
lytic-lysogenic switch to work efficiently. A modified 186 phage where the wild-type CII was 
replaced with the stabilized CII145 always entered lysogeny after initial infection. The ability 
of this prophage reenter into the lytic cycle (prophage induction) after UV irradiation was also 
severely impaired. Stable CII145, in initial infection and prophage induction, will build up to 
levels to drive enough CI expression to force the phage almost permanently into lysogeny 
(Murchland et al. 2020). The structural data explains how proteolysis inactivates the CII 
protein.  
In the crystal structure of the 186 CII135 degradation product, the CTD helices that form the 
tetramerization interface is not observed and are likely to be unstructured. It however can still 
dimerize through contacts found in the NTD and linker region. Truncating the protein at 
residue 135 disrupts this interface, preventing the CII135 dimers from forming the active 
tetramer. This is consistent with SEC-MALS data showing CII135 forms a dimer (Murchland et 
al., 2014). Any truncation of CII past residue 141 results in a reduction in activation activity by 
over 90%, likely due to the inability to form the methionine zipper helix for tetramerization.  
It is possible that the degradation product itself plays a minor role in shutting down CII activity. 
If CII135 exists as a monomer, it may be able to sequester a CII169 monomer into an inactive 
dimer. This would further reduce levels of active CII in the cell.  
Site-specific proteolysis of 186 CII provides a rapid way for the phage to inactivate CII. Similar 
to λ CII, it is likely the proteases involved are regulated by environmental signals and that 
protease activity is an input in the lytic/lysogenic decision. Bacteriophage λ produces a 
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protease inhibitor CIII that inhibits the FtsH protease involved in degradation of λ CII (Kobiler, 
Rokney and Oppenheim, 2007), whereas 186 does not appear to have a CIII equivalent. Future 
studies could investigate whether 186 has any direct regulatory effects on the proteases that 
degrade 186 CII.  
186 CII presents a novel mechanism of contacting RNA polymerase 
In this study, experimentally determined structures of 186 CII and the RNAP holoenzyme, 
including the σ70 and αCTD subunits was used generate a structural model of CII activation of 
the pE promoter (Figure 12 and Figure 15). Computational modelling and docking were driven 
by data from mutagenesis studies. Bacterial activators that activate σ70 dependent promoters 
often do so via direct contact with RNAP as it engages with the promoter. The two major 
targets of this activation are domain 4 of the σ70 subunit and CTD of the α subunit of RNAP 
(Lee, Minchin and Busby, 2012).  
Class II activators tend to bind around the -41 element and activate a promoter by recruitment 
of RNAP through direct contacts with domain 4 of σ70 subunit (Browning and Busby, 2004). 
This contact is the primary mode of activation of pE by 186 CII. CII uses the E46 epitope to 
contact σ70 K593 on the face of the α-helix adjacent to the interface between domain 4 of σ70 
and the pE -35 element. The crystal structure of CII shows that R17 also lies in this epitope and 
plays a role in positioning E46 to make contacts (Figure 12B). Interactions with this face of the 
α-helix are conserved in many other class II activators including λ cI in the activation of λ pRM 
promoter, bacteriophage Mu Mor protein and AraC (Lonetto et al., 1998; Dove, Darst and 
Hochschild, 2003; Lee, Minchin and Busby, 2012).  
Class I transcriptional activators bind upstream of the -10 and -35 sites and achieve activation 
through a direct contact to the α-CTD of RNAP (Browning and Busby, 2004). α-CTD binds to 
promoter UP elements and class I activators to stabilize this interaction. Examples of class I 
transcriptional activators include the E. coli catabolite activator protein (CAP) (Busby and 
Ebright, 1999) and λ CII (Jain et al., 2005). 186 CII, in addition to making contacts with domain 
4 of σ70, also contacts the α-CTD using its R115 epitope (Murchland et al., 2014). In this study, 
we proposed that the α-CTD binds the pE promoter around the -40 and/or -56 position 
between the pE half sites, with CII residue R115 contacting D280 residue on the α-CTD. 
Another contact may exist between K271 and E46. It would be difficult to measure the 
contribution of E46 to class I transcriptional activation in vivo, as it is also a key epitope in 
contacting the σ70 subunit. The unusual spacing of pE half sites of two turns of the DNA helix 
apart may be selected to allow CII to contact both α-CTDs simultaneously. α-CTD contacts 
promoter UP elements which tend to be AT rich (Estrem et al., 1998), which is the case for the 
DNA between the pE half sites. CII binding to this DNA also generates a DNA bend (Shearwin 
and Egan, 2000) and it has been noted that the curve conformation of DNA upstream of a 
promoter may affect its interactions with RNAP α-CTD (Gaal et al., 1994; Katayama et al., 1999; 
Asayama and Ohyama, 2007). α-CTD binds the minor groove of DNA (Gourse, Ross and Gaal, 
2000), of which there are two between the pE half sites on the same face that RNAP 
polymerase binds. Above each minor groove, there is an accessible R115 activation epitope. 
Thus, CII is likely to contact both α-CTD of RNAP simultaneously. 
How does the structure of CII beget its function as an effective decision point in the lytic 
lysogenic cascade? A single CII tetramer upon binding the pE promoter could potentially 
simultaneously stabilize three subunits of RNAP, the σ70 subunit and both α-CTDs, to provide 
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potent activation of the pE promoter. To stabilize the same three subunits in a class I and class 
II transcriptional activator, such as CAP, would require two activators binding to two tandem 
binding sites (Barnard, Wolfe and Busby, 2004).  The use of a tetramer as the active species 
could potentially provide ultrasensitivity, to concisely commit to lysogeny once the threshold 
CII concentration has been reached. Proteolytic degradation of CII disrupts the 
tetramerization interface of CII, providing 186 a means to rapidly remove CII and the ability to 
default to the lytic cycle or reenter the lytic cycle, in the case of prophage induction.  
Acknowledgments 
This work was supported by funding from the Australian Research Council (DP150103009 and 
DP160101450). We gratefully acknowledge Prof. Richard Gourse for providing the RNAP 
alpha-CTD alanine scanning library. We also acknowledge University of Adelaide Biochemistry 





Afonine, P. V. et al. (2012) ‘Towards automated crystallographic structure refinement with 
phenix.refine’, Acta Crystallographica Section D: Biological Crystallography, 68(4), pp. 352–
367. doi: 10.1107/S0907444912001308. 
Arndt, U. W., Crowther, R. A. and Mallett, J. F. W. (1968) ‘A computer-linked cathode-ray tube 
microdensitometer for X-ray crystallography’, Jorunal of Physics E: Scientific Instruments, 1(5), 
pp. 510–516. doi: 10.1088/0022-3735/1/5/303. 
Asayama, M. and Ohyama, T. (2007) ‘Curved DNA and Prokaryotic Promoters’, in DNA 
Conformation and Transcription, pp. 37–51. doi: 10.1007/0-387-29148-2_3. 
Bandyopadhyay, K. et al. (2011) ‘Studies on Escherichia coli HflKC suggest the presence of an 
unidentified factor that influences the lysis-lysogeny switch’, BMC Microbiology, 11. doi: 
10.1186/1471-2180-11-34. 
Banuett, F. et al. (1986) ‘hflB, a new Escherichia coli locus regulating lysogeny and the level of 
bacteriophage lambda cII protein’, Journal of Molecular Biology, 187(2), pp. 213–224. doi: 
10.1016/0022-2836(86)90229-9. 
Barnard, A., Wolfe, A. and Busby, S. (2004) ‘Regulation at complex bacterial promoters: How 
bacteria use different promoter organizations to produce different regulatory outcomes’, 
Current Opinion in Microbiology, 7(2), pp. 102–108. doi: 10.1016/j.mib.2004.02.011. 
Battye, T. G. G. et al. (2011) ‘iMOSFLM: A new graphical interface for diffraction-image 
processing with MOSFLM’, Acta Crystallographica Section D: Biological Crystallography, 67(4), 
pp. 271–281. doi: 10.1107/S0907444910048675. 
Benoff, B. et al. (2002) ‘Structural basis of transcription activation: The CAP-αCTD-DNA 
complex’, Science, 297(5586), pp. 1562–1566. doi: 10.1126/science.1076376. 
Browning, D. F. and Busby, S. J. W. (2004) ‘The regulation of bacterial transcription initiation’, 
Nature Reviews Microbiology, 2(1), pp. 57–65. doi: 10.1038/nrmicro787. 
Brünger, A. T. (1992) ‘Free R value: A novel statistical quantity for assessing the accuracy of 
crystal structures’, Nature, 355(6359), pp. 472–475. doi: 10.1038/355472a0. 
Brünger, A. T. et al. (1998) ‘Crystallography & NMR system: A new software suite for 
macromolecular structure determination’, Acta Crystallographica Section D: Biological 
Crystallography, 54(5), pp. 905–921. doi: 10.1107/S0907444998003254. 
Busby, S. and Ebright, R. H. (1999) ‘Transcription activation by catabolite activator protein 
(CAP)’, Journal of Molecular Biology, 293(2), pp. 199–213. doi: 10.1006/jmbi.1999.3161. 
Campbell, E. A. et al. (2002) ‘Structure of the bacterial RNA polymerase promoter specificity σ 
subunit’, Molecular Cell, 9(3), pp. 527–539. doi: 10.1016/S1097-2765(02)00470-7. 
Chen, V. B. et al. (2010) ‘MolProbity: All-atom structure validation for macromolecular 
crystallography’, Acta Crystallographica Section D: Biological Crystallography, 66(1), pp. 12–
21. doi: 10.1107/S0907444909042073. 
Collaborative Computational Project Number 4 (1994) ‘The CCP4 suite: Programs for protein 
crystallography’, Acta Crystallographica Section D: Biological Crystallography, 50(5), pp. 760–
763. doi: 10.1107/S0907444994003112. 
Cowtan, K. (2006) ‘The Buccaneer software for automated model building. 1. Tracing protein 
68 
chains’, Acta Crystallographica Section D: Biological Crystallography, 62(9), pp. 1002–1011. 
doi: 10.1107/S0907444906022116. 
Craig, T. A. et al. (1999) ‘Analysis of transcription complexes and effects of ligands by 
microelectrospray ionization mass spectrometry’, Nature Biotechnology, 17(12), pp. 1214–
1218. doi: 10.1038/70767. 
Crooks, M. (2006) Transcriptional Interference between the Switch Promoters of 186. 
University of Adelaide. 
Darnell, S. J., LeGault, L. and Mitchell, J. C. (2008) ‘KFC Server: interactive forecasting of protein 
interaction hot spots.’, Nucleic acids research, 36(Issue suppl_2), pp. W265–W269. doi: 
10.1093/nar/gkn346. 
Datsenko, K. A. and Wanner, B. L. (2000) ‘One-step inactivation of chromosomal genes in 
Escherichia coli K-12 using PCR products’, Proceedings of the National Academy of Sciences of 
the United States of America, 97(12), pp. 6640–6645. doi: 10.1073/pnas.120163297. 
DeLano, W. L. (2002) ‘The PyMOL molecular graphics system’. 
Diederichs, K. and Karplus, P. A. (1997) ‘Improved R-factors for diffraction data analysis in 
macromolecular crystallography’, Nature Structural Biology, 4(4), pp. 269–275. doi: 
10.1038/nsb0497-269. 
van Dijk, M. and Bonvin, A. M. J. J. (2009) ‘3D-DART: A DNA structure modelling server’, Nucleic 
Acids Research, 37(SUPPL. 2). doi: 10.1093/nar/gkp287. 
van Dijk, M. and Bonvin, A. M. J. J. (2010) ‘Pushing the limits of what is achievable in protein-
DNA docking: Benchmarking HADDOCK’s performance’, Nucleic Acids Research, 38(17), pp. 
5634–5647. doi: 10.1093/nar/gkq222. 
Dodd, I. B. et al. (2001) ‘Octamerization of λ CI repressor is needed for effective repression of 
PRM and efficient switching from lysogeny’, Genes and Development, 15(22), pp. 3013–3022. 
doi: 10.1101/gad.937301. 
Dodd, I. B. and Egan, J. B. (1990) ‘Improved detection of helix-turn-helix DNA-binding motifs 
in protein sequences’, Nucleic Acids Research, 18(17), pp. 5019–5026. doi: 
10.1093/nar/18.17.5019. 
Dove, S. L., Darst, S. A. and Hochschild, A. (2003) ‘Region 4 of σ as a target for transcription 
regulation’, Molecular Microbiology, 48(4), pp. 863–874. doi: 10.1046/j.1365-
2958.2003.03467.x. 
Emsley, P. et al. (2010) ‘Features and development of Coot’, Acta Crystallographica Section D: 
Biological Crystallography, 66(4), pp. 486–501. doi: 10.1107/S0907444910007493. 
Estrem, S. T. et al. (1998) ‘Identification of an UP element consensus sequence for bacterial 
promoters’, Proceedings of the National Academy of Sciences of the United States of America, 
95(17), pp. 9761–9766. doi: 10.1073/pnas.95.17.9761. 
Evans, G. and Bricogne, G. (2002) ‘Triiodide derivatization and combinatorial counter-ion 
replacement: Two methods for enhancing phasing signal using laboratory Cu Kα X-ray 
equipment’, Acta Crystallographica Section D: Biological Crystallography, 58(6 II), pp. 976–
991. doi: 10.1107/S0907444902005486. 
Evans, P. R. and Murshudov, G. N. (2013) ‘How good are my data and what is the resolution?’, 
69 
Acta Crystallographica Section D: Biological Crystallography, 69(7), pp. 1204–1214. doi: 
10.1107/S0907444913000061. 
Gaal, T. et al. (1994) ‘Localization of the intrinsically bent DNA region upstream of the E.coli 
rrnB P1 promoter’, Nucleic Acids Research, 22(12), pp. 2344–2350. doi: 
10.1093/nar/22.12.2344. 
Gaal, T. et al. (1996) ‘DNA-binding determinants of the α subunit of RNA polymerase: Novel 
DNA-binding domain architecture’, Genes and Development, 10(1), pp. 16–26. doi: 
10.1101/gad.10.1.16. 
Gourse, R. L., Ross, W. and Gaal, T. (2000) ‘UPs and downs in bacterial transcription initiation: 
The role of the alpha subunit of RNA polymerase in promoter recognition’, Molecular 
Microbiology, pp. 687–695. doi: 10.1046/j.1365-2958.2000.01972.x. 
Herman, C. et al. (1993) ‘Cell growth and λ phage development controlled by the same 
essential Escherichia coli gene, ftsH/hflB’, Proceedings of the National Academy of Sciences of 
the United States of America, 90(22), pp. 10861–10865. doi: 10.1073/pnas.90.22.10861. 
Hernández, H. and Robinson, C. V. (2007) ‘Determining the stoichiometry and interactions of 
macromolecular assemblies from mass spectrometry’, Nature Protocols, 2(3), pp. 715–726. 
doi: 10.1038/nprot.2007.73. 
Herskowitz, I. and Hagen, D. (1980) ‘The Lysis-Lysogeny Decision of Phage lambda: Explicit 
Programming and Responsiveness’, Annual Review of Genetics, 14(1), pp. 399–445. doi: 
10.1146/annurev.ge.14.120180.002151. 
Huddleston, V. (1970) Coliphage 186 control of the lysogenic response. University of Adelaide, 
Adelaide, Australia. 
Jain, D. et al. (2005) ‘Crystal structure of bacteriophage λcII and its DNA complex’, Molecular 
Cell, 19(2), pp. 259–269. doi: 10.1016/j.molcel.2005.06.006. 
Kabsch, W. (2010) ‘XDS’, Acta Crystallographica Section D Biological Crystallography, 66(2), 
pp. 125–132. doi: 10.1107/S0907444909047337. 
Kainz, M. and Gourse, R. L. (1998) ‘The C-terminal domain of the alpha subunit of Escherichia 
coli RNA polymerase is required for efficient rho-dependent transcription termination’, 
Journal of Molecular Biology, 284(5), pp. 1379–1390. doi: 10.1006/jmbi.1998.2272. 
Karplus, P. A. and Diederichs, K. (2012) ‘Linking crystallographic model and data quality’, 
Science, 336(6084), pp. 1030–1033. doi: 10.1126/science.1218231. 
Katayama, S. et al. (1999) ‘Promoter upstream bent DNA activates the transcription of the 
Clostridium perfringens phospholipase C gene in a low temperature-dependent manner’, 
EMBO Journal, 18(12), pp. 3442–3450. doi: 10.1093/emboj/18.12.3442. 
Kim, D. E., Chivian, D. and Baker, D. (2004) ‘Protein structure prediction and analysis using the 
Robetta server’, Nucleic Acids Research, 32(WEB SERVER ISS.), pp. 526–531. doi: 
10.1093/nar/gkh468. 
Kobiler, O., Rokney, A. and Oppenheim, A. B. (2007) ‘Phage lambda CIII: A protease inhibitor 
regulating the lysis-lysogeny decision’, PLoS ONE, 2(4). doi: 10.1371/journal.pone.0000363. 
Krissinel, E. and Henrick, K. (2007) ‘Inference of Macromolecular Assemblies from Crystalline 
State’, Journal of Molecular Biology, 372(3), pp. 774–797. doi: 10.1016/j.jmb.2007.05.022. 
70 
De La Fortelle, E. and Bricogne, G. (1997) ‘Maximum-likelihood heavy-atom parameter 
refinement for multiple isomorphous replacement and multiwavelength anomalous 
diffraction methods’, in Methods in Enzymology, pp. 472–494. doi: 10.1016/S0076-
6879(97)76073-7. 
Lamont, I. et al. (1993) ‘Genes for the establishment and maintenance of lysogeny by the 
temperate coliphage 186.’, Journal of bacteriology, 175(16), pp. 5286–5288. 
Lee, D. J., Minchin, S. D. and Busby, S. J. W. (2012) ‘Activating transcription in bacteria’, Annual 
Review of Microbiology, 66(1), pp. 125–152. doi: 10.1146/annurev-micro-092611-150012. 
Lonetto, M. A. et al. (1998) ‘Identification of a contact site for different transcription activators 
in region 4 of the Escherichia coli RNA polymerase σ70 subunit’, Journal of Molecular Biology, 
284(5), pp. 1353–1365. doi: 10.1006/jmbi.1998.2268. 
Lutz, R. and Bujard, H. (1997) ‘Independent and tight regulation of transcriptional units in 
escherichia coli via the LacR/O, the TetR/O and AraC/I1-I2 regulatory elements’, Nucleic Acids 
Research, 25(6), pp. 1203–1210. doi: 10.1093/nar/25.6.1203. 
McCoy, A. J. et al. (2007) ‘Phaser crystallographic software’, Journal of Applied 
Crystallography, 40(4), pp. 658–674. doi: 10.1107/S0021889807021206. 
Murakami, K., Fujita, N. and Ishihama, A. (1996) ‘Transcription factor recognition surface on 
the RNA polymerase α subunit is involved in contact with the DNA enhancer element’, EMBO 
Journal, 15(16), pp. 4358–4367. doi: 10.1002/j.1460-2075.1996.tb00809.x. 
Murchland, I. et al. (2014) ‘Promoter activation by CII, a potent transcriptional activator from 
bacteriophage 186’, Journal of Biological Chemistry, 289(46), pp. 32094–32108. 
Murchland, I. et al. (2021) ‘Instability of CII is needed for efficient switching between lytic and 
lysogenic development in bacteriophage 186’, Nucleic Acids Research, 48(21), pp. 12030–
12041. doi: 10.1093/nar/gkaa1065. 
Murshudov, G. N. et al. (2011) ‘REFMAC5 for the refinement of macromolecular crystal 
structures’, Acta Crystallographica Section D: Biological Crystallography, 67(4), pp. 355–367. 
doi: 10.1107/S0907444911001314. 
Neufing, P. J. et al. (1996) ‘The CII protein of bacteriophage 186 establishes lysogeny by 
activating a promoter upstream of the lysogenic promoter’, Molecular microbiology, 21(4), 
pp. 751–761. 
Neufing, P. J., Shearwin, K. E. and Egan, J. B. (2001) ‘Establishing Lysogenic Transcription in the 
Temperate Coliphage 186’, Journal of Bacteriology, 183(7), pp. 2376–2379. doi: 
10.1128/JB.183.7.2376-2379.2001. 
Oppenheim, A. B. et al. (2005) ‘Switches in bacteriophage lambda development’, Annual 
Review of Genetics, 39(1), pp. 409–429. doi: 10.1146/annurev.genet.39.073003.113656. 
Panjikar, S. et al. (2005) ‘Auto-Rickshaw: An automated crystal structure determination 
platform as an efficient tool for the validation of an X-ray diffraction experiment’, Acta 
Crystallographica Section D: Biological Crystallography, 61(4), pp. 449–457. doi: 
10.1107/S0907444905001307. 
Panjikar, S. et al. (2009) ‘On the combination of molecular replacement and single-wavelength 
anomalous diffraction phasing for automated structure determination’, Acta 
Crystallographica Section D: Biological Crystallography, 65(10), pp. 1089–1097. doi: 
71 
10.1107/S0907444909029643. 
Pannu, N. S. and Read, R. J. (2004) ‘The application of multivariate statistical techniques 
improves single-wavelength anomalous diffraction phasing’, Acta Crystallographica Section D: 
Biological Crystallography, 60(1), pp. 22–27. doi: 10.1107/S0907444903020808. 
Pettersen, E. F. et al. (2004) ‘UCSF Chimera—a visualization system for exploratory research 
and analysis’, Journal of computational chemistry, 25(13), pp. 1605–1612. 
Ponstingl, H., Henrick, K. and Thornton, J. M. (2000) ‘Discriminating between homodimeric 
and monomeric proteins in the crystalline state’, Proteins: Structure, Function, and Genetics. 
doi: 10.1002/1097-0134(20001001)41:1<47::aid-prot80>3.3.co;2-#. 
Powers, E. T. and Powers, D. L. (2003) ‘A Perspective on Mechanisms of Protein Tetramer 
Formation’, Biophysical Journal, 85(6), pp. 3587–3599. doi: 10.1016/S0006-3495(03)74777-8. 
Ptashne, M. (1986) ‘A genetic switch: Gene control and phage. lambda’, Blackwell Scientific 
Publications. 
Ross, W. et al. (2003) ‘An intersubunit contact stimulating transcription initiation by E. coli 
RNA polymerase: Interaction of the α C-terminal domain and σ region 4’, Genes and 
Development, 17(10), pp. 1293–1307. doi: 10.1101/gad.1079403. 
Satiaputra, J. et al. (2019) ‘Native mass spectrometry identifies an alternative DNA-binding 
pathway for BirA from Staphylococcus aureus’, Scientific Reports, 9(1). doi: 10.1038/s41598-
019-39398-6. 
Savery, N. J. et al. (1998) ‘Transcription activation at class II CRP-dependent promoters: 
Identification of determinants in the C-terminal domain of the RNA polymerase α subunit’, 
EMBO Journal, 17(12), pp. 3439–3447. doi: 10.1093/emboj/17.12.3439. 
Savery, N. J. et al. (2002) ‘Determinants of the C-terminal domain of the Escherichia coli RNA 
polymerase α subunit important for transcription at class I cyclic AMP receptor protein-
dependent promoters’, Journal of Bacteriology, 184(8), pp. 2273–2280. doi: 
10.1128/JB.184.8.2273-2280.2002. 
Schneider, T. R. and Sheldrick, G. M. (2002) ‘Substructure solution with SHELXD’, Acta 
Crystallographica Section D: Biological Crystallography, 58(10 I), pp. 1772–1779. doi: 
10.1107/S0907444902011678. 
Shearwin, K. E. and Egan, J. B. (2000) ‘Establishment of Lysogeny in Bacteriophage 186 DNA 
BINDING AND TRANSCRIPTIONAL ACTIVATION BY THE CII PROTEIN’, Journal of Biological 
Chemistry, 275(37), pp. 29113–29122. 
Shotland, Y. et al. (2000) ‘Proteolysis of bacteriophage λ CII by Escherichia coli FtsH (HflB)’, 
Journal of Bacteriology, 182(11), pp. 3111–3116. doi: 10.1128/JB.182.11.3111-3116.2000. 
Tang, H. et al. (1994) ‘Location, structure, and function of the target of a transcriptional 
activator protein’, Genes and Development, 8(24), pp. 3058–3067. doi: 
10.1101/gad.8.24.3058. 
Terwilliger, T. (2004) ‘SOLVE and RESOLVE: Automated structure solution, density 
modification, and model building’, Journal of Synchrotron Radiation, 11(1), pp. 49–52. doi: 
10.1107/S0909049503023938. 
Tina, K. G., Bhadra, R. and Srinivasan, N. (2007) ‘PIC: Protein Interactions Calculator’, Nucleic 
72 
Acids Research, 35(SUPPL.2). doi: 10.1093/nar/gkm423. 
Trusina, A. et al. (2005) ‘Functional alignment of regulatory networks: a study of temperate 
phages’, PLoS Computational Biology, 1(7), p. e74. 
Vagin, A. and Teplyakov, A. (1997) ‘MOLREP: An Automated Program for Molecular 
Replacement’, Journal of Applied Crystallography, 30(6), pp. 1022–1025. doi: 
10.1107/S0021889897006766. 
Vlahoviček, K., Kaján, L. and Pongor, S. (2003) ‘DNA analysis servers: Plot.it, bend.it, model.it 
and IS’, Nucleic Acids Research, 31(13), pp. 3686–3687. doi: 10.1093/nar/gkg559. 
De Vries, S. J., Van Dijk, M. and Bonvin, A. M. J. J. (2010) ‘The HADDOCK web server for data-
driven biomolecular docking’, Nature Protocols, 5(5), pp. 883–897. doi: 
10.1038/nprot.2010.32. 
Zuo, Y. and Steitz, T. A. (2015) ‘Crystal structures of the e.coli transcription initiation 

























































































































































































































































pE27 top ATGTTTGATTTTCAGGTTTCCAAACAT 
pE27 bottom ATGTTTGGAAACCTGAAAATCAAACAT 
pE31 top ACATGTTTGATTTTCAGGTTTCCAAACATCC 
pE31 bottom GGATGTTTGGAAACCTGAAAATCAAACATGT 
pE35 top CAACATGTTTGATTTTCAGGTTTCCAAACATCCCC 




Table S 2 - Strains for lacZ assay 
Reporter assay Strains used Notes 
Measuring activity of 
CII truncations 
IM26 + pZS45 CII CII variants and empty control expressed 
from pZS45 plasmid 
Measuring activity of 
CII tetramerization 
mutants 
IM26 + pZS45 CII CII variants and empty control expressed 
from pZS45 plasmid 
Alanine scanning 
mutagenesis of RNA 
polymerase α-CTD 
IM50 + pHTf1 rpoA 
IM50 + pREIIα rpoA 
RNA polymerase α subunit mutants 
expressed from pHTf1 or pREIIα plasmids 
 
CIIE46K expressed from pZS45 plasmid 
 
 
Table S 3– Growth media for lacZ assays 
Step Media 
Measuring activity of CII 
truncations 








50 µg mL-1 
spectinomycin and 50 
µg mL-1 kanamycin 
50 µg mL-1 
spectinomycin and 
50 µg mL-1 
kanamycin 
50 µg mL-1 
spectinomycin, 50 µg 
mL-1 kanamycin and 





50 µg mL-1 
spectinomycin and 50 
µg mL-1 kanamycin 
50 µg mL-1 
spectinomycin and 
50 µg mL-1 
kanamycin 
50 µg mL-1 
spectinomycin, 50 µg 
mL-1 kanamycin and 
100 µg mL-1 
ampicillin 
Inoculation of 
cultures for lacZ 
measurements 
50 µg mL-1 
spectinomycin, 50 µg 
mL-1 kanamycin and 80 
μM IPTG 
50 µg mL-1 
spectinomycin, 50 µg 
mL-1 kanamycin and 
100 μM IPTG 
50 µg mL-1 
spectinomycin, 50 µg 
mL-1 kanamycin, 100 
µg mL-1 ampicillin 




CII-DNA docking parameters used for HADDOCK 
DNA construction 
 1 TGCAACATGTTTGATTTTCAGGTTTCCAAACATCCCCAC  39 
40 GTGGGGATGTTTGGAAACCTGAAAATCAAACATGTTGCA  78 
DNA half sites are underlined. A global 40° angle bend was adopted by the DNA with 1° steps. 
Various DNA binding angles between 35°-45° were tested, with 40° found to be the optimal 
fit for CII145 structure 1.  
Docking parameters 
DNA active residues (DNA half sites): A7 T8 G9 T10 T11 T12 G13 C27 A28 A29 A30 C31 A32 T33 
A46 T47 G48 T49 T50 T51 G52 C66 A67 A68 A69 C70 A71 T72 
CII active residues: N32 Q37 T38 N41 K42 
CII passive residues: M25 A29 A32 G33 M34 V36 R40 L43 N44 P45 Q47 T52 P54 L58 
DNA segments between the half sites, center-to-center, were defined to be semi-flexible. This 
corresponds to the segments T7-A30 and A49-C69. 
79 
  
Figure S 1 - Stereoviews of composite omit 2mFo-dFc electron density map of CII145 
(condition 1), CII145 (condition 2) and CII135 are shown in (A), (B) and (C), respectively. The 
contour level was set at 1σ. 
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Figure S 2 – pE DNA (-67 to -29) was predicted to have an intrinsic bend of 21°. DNA was 
modelled using the bend.it server (Vlahoviček, Kaján and Pongor, 2003). DNA strand in red 
and yellow corresponds to 5’-TGCAACATGTTTGATTTTCAGGTTTCCAAACATCCCCAC-3’ and 5’-
GTGGGGATGTTTGGAAACCTGAAAATCAAACATGTTGCA-3’, respectively.   
CII135 can bind a single pE half site 
Native mass spectrometry was used to investigate DNA binding by CII135 in vitro. CII135 was 
mixed with a single pE half site and analysed by electrospray ionization mass-spectrometry 
(ESI-MS). However, the resulting spectra are noisy with many unassigned peaks, making it 
difficult to draw definitive conclusions. A low abundance peaks corresponding to CII135 in 
complex with one pE half site DNA could be identified (Figure S 3). This result provides an initial 
indication that a CII135 dimer can bind a single pE half site. A CII135 dimer being able to bind 
an oligonucleotide via a single pE half site would allow a CII145 tetramer to bind to two 
oligonucleotides via two pE half sites. This species was detected as a low abundance species 
in the mass-spectra of CII145 in the presence of pE DNA (Figure 6).  
The ability of CII135 to bind DNA is preserved in vivo. It displayed significantly reduced DNA 
binding activity relative to wild-type CII and CII145 in pCIIR lacZ assays (Murchland et al., 
2014). However, the activity is greater than a no-CII control. CII135 exhibits 97% less 
transcriptional activation than wild-type, but the activity is detectably measured above 
inactivated CII (HTH inactivation mutant) and no-CII controls. The loss of activation function is 
CII135 is likely due to reduced DNA binding and loss of activation epitopes for RNAP. CII135 
binding pE operators in vivo also presents potential regulatory effects, where inactive dimers 
could bind to pE half sites and occlude active CII from the promoter. It is uncertain how 
substantial this effect is, as CII tetramers have higher affinity to pE and should outcompete the 




Figure S 3 - Native ESI-MS spectra of CII135 (53 µM) as a mixture with 10 bp pE half site DNA 
(5 µM). A CII135 dimer was observed to form a complex with 1 piece of pE half site DNA. The 
2889 m/z peak was assigned as CII135 based on m/z assignments from an ESI-MS spectra of 
CII135 (Figure 9B). 
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3 STRUCTURAL STUDIES OF 186 CI USING X-RAY 
CRYSTALLOGRAPHY, SMALL ANGLE X-RAY 
SCATTERING AND MASS SPECTROMETRY 
3.1 Introduction 
In order for a phage to establish lysogeny, it must promptly shut down lytic gene expression 
after initial infection of the host bacterium and establish lysogenic gene expression, which is 
then maintained through subsequent cell generations. Chapter 1 reviewed the lytic-lysogenic 
decision in bacteriophage λ and 186, where the respective immunity repressors were 
highlighted as central to the maintenance of lysogeny. It is evident that cooperative interactions 
between the functional dimeric binding units of these repressors are essential to achieve 
efficient repression of lytic functions and exert positive and negative autoregulation on 
immunity repressor levels. This enables the lysogenic state to be stable, yet poised for escape. 
Higher order oligomerization of immunity repressor dimers has also been observed in other 
phages such as phage 434 in the presence of DNA (Ciubotaru and Koudelka, 2003), TP901-1 
(Pedersen et al., 2008) and phage P22 (De Anda et al., 1983). The key points from Chapter 1 will 
be summarized below.  
The immunity repressor of bacteriophage λ, λCI, uses cooperativity at multiple levels to maintain 
lysogeny.  λCI binds to operators at the OL and OR sites of the λ regulatory region. The relative 
intrinsic affinity of the operators favours the occupation by λ CI dimers of OL1 and OL2 at OL and 
OR1 and OR2 at OR, over the weaker affinity OL3 and OR3 operators. This binding represses the 
lytic pR and pL promoters. λ CI dimers occupying these adjacent operators can form tetramers. λ 
CI tetramers can subsequently loop the intervening DNA between OL and OR to form an 
octameric complex, to further enhance the repression of the lytic promoters (Dodd et al., 2001; 
Ptashne, 2004). λ CI also regulates its own expression. At lower λ CI levels, the N-terminal 
domain of the λ CI protein occupying OR2 contacts the σ70 subunit of RNA polymerase, to activate 
its own expression along with expression of other lysogenic genes from pRM (Jain et al., 2004; 
Nickels et al., 2002). However, at high levels of λ CI, the octameric complex that bridges OL and 
OR align OL3 and OR3, allowing a λ CI tetramer to occupy them.  Occupation of OL3 and OR3 
represses λ pRM to limit levels of λ CI in the cell (Dodd et al., 2004). This mechanism aids the 
responsiveness of prophage induction by allowing RecA to more rapidly reduce active λ CI levels 
following activation of the host SOS response. 
Like bacteriophage λ, a supramolecular immunity repressor-DNA complex is involved in 
transcriptional regulation in bacteriophage 186. The 186 CI repressor is thought to oligomerize 
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into a 14mer wheel-like quaternary structure (Pinkett et al., 2006; Wang et al., 2013). This 
current model of 186 regulation states that the 186 CI 14mer acts as a scaffold, where 186 
regulatory DNA can wrap on and off to regulate the lytic and lysogenic states (Pinkett et al., 
2006) (Figure 1-15). DNA encompassing the 186 lytic pR and lysogenic pL promoters can wrap 
onto the wheel to repress both promoters. This repression is mediated by contacts with CI 
operator sites between pR and pL. The operators at pR have stronger affinity and are better 
defined, relative to operators at pL.  The pL-pR region is flanked (~ 300 bp away) by CI operators 
FL and FR.  These flanking sites can loop onto the 186 CI wheel to compete with and push off the 
pL DNA, without disrupting the 186 CI-pR interactions. This wrapping and looping mechanism 
allows for 186 CI to repress 186 pR, whilst allowing lysogenic genes to be transcribed by pL. The 
pL promoter is further activated by relief of the transcriptional interference generated by the 
strong pR promoter. At high levels of 186 CI, the flanking sites FL and FR are thought to be 
sequestered by additional 186 CI wheels, to abolish pL derepression by FL/FR. This 
autoregulation limits 186 CI levels in vivo (Dodd and Egan, 2002). This is analogous to λ CI 
negative autoregulation, to prevent CI levels from becoming excessive and impeding prophage 
induction.  
Structural characterisation has been conducted on 186 CI. Pinkett et al. (2006) solved the crystal 
structures of two different variants of the 186 CI protein, a full length dimer (E146K mutant) 
and the C-terminal oligomerization domain, which was solved as a 14mer. Wang et al. (2013) 
observed 186 CI interacting with DNA as low resolution discs via atomic force microscopy. The 
186 CI 14mer complex is central to the current model of lytic-lysogenic transcriptional 
regulation in bacteriophage 186, yet no high resolution structure of the complex has been 
obtained. If we wish to use 186 as a counterpoint model to λ, it would be extremely useful to 
have an atomic resolution structure of the full-length wild type 186 CI wheel. Firstly, such a 
structure would validate our model of cooperative regulation in this phage system. Secondly, it 
would demonstrate how the N-terminal DNA binding domains are arranged when the protein 
exists as a wheel. This allows further refinement of model by showing how the operators are 
bound by the wheel and, in turn, explain the arrangement of operators on the prophage DNA. 
3.2 Expression of the 186 CI repressor 
The full length 186 CI protein was encoded under the control of the T7 promoter of the 
pET3aHis6 vector (Shearwin et al., 2002). The expressed protein contains a C-terminal thrombin 
cleavage sequence followed by a hexahistidine tag. This same affinity tag was previously used to 
purify 186 CI CTD. 186 CI-His6 was previously shown to be active in vitro (Shearwin et al., 2002). 
E. coli BL21(λDE3) pLysS was used as the host for the expression of the CI protein. Cells were 
grown at 37⁰C to an OD600 of 0.6 in 2 x 1 L LB medium containing 100 µg mL-1 ampicillin and 30 
µg mL-1 chloramphenicol. 186 CI production was induced upon addition of 200 µM IPTG and 
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cultivation overnight at 25⁰C. Cells were harvested by centrifugation, suspended in 
approximately 40 mL of lysis buffer (20 mM sodium phosphate, 500 mM NaCl, 20 mM imidazole, 
5 mM 2-mercaptoethanol, pH 7.4) and stored at -20⁰C. 
3.3 Purification 
All purification steps were performed at 4⁰C on a Bio-Rad NGC Chromatography system. Frozen 
E. coli cells were thawed and lysed using high pressure disruption (Microfluidics cell disruptor). 
The lysate was clarified using centrifugation at 40 000g for 1 hr at 4⁰C.  Protein for 
crystallization trials was produced as follows. The cell lysate was applied to 5 mL HisTrap FF 
column (GE Healthcare) pre-equilibrated with lysis buffer. Bound proteins were eluted using an 
imidazole gradient (20 mM – 500 mM). Fractions showing above baseline UV absorbance at 280 
nm were tested for purity using SDS-PAGE (Figure 3-1). Fractions containing the purified 
protein were pooled and dialysed against 50 mM Tris-Cl pH 7.5, 150 mM NaCl, 0.5 mM EDTA, 0.1 
mM DTT. The protein was concentrated to 7.7 mg mL-1 by ultracentrifugation on Amicon Ultra-
15 centrifugation units (Millipore) prior to crystallization trials.  
 
Figure 3-1 – SDS-PAGE analysis of fractions from Ni-NTA chromatography to purify 186 CI. Samples were run on 4-
12%NuPAGE BisTris Protein Gels (ThermoFisher Scientific) with NuPAGE MOPS buffer. Lane M: Novex Sharp Pre-
Stained Protein Standard (ThermoFisher Scientific, 2 µL), Lane 1: Crude E. coli lysate prior to purification. Lane 2-11: 
Various elution fractions that show UV absorbance above baseline.  
The 186 CI repressor protein could be purified to high purity in a single step using Ni2+ IMAC 
chromatography. SDS-PAGE analysis revealed a dominant band in the Ni2+ IMAC purification 
fractions around 20 kDa, consistent with the theoretical molecular weight of CI-His6 of 22.6 kDa. 
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Several minor higher molecular weight impurities were also observed but did not prevent 
subsequent crystallization of the protein. 
3.4 Crystallization  
Crystallization screening was conducted via sitting-drop vapour diffusion in 96 well Intelliplates 
(Art-Robbins) using a Phoenix robot (Art Robbins). The commercial screens used to screen for 
crystallization conditions were the PEG/ION, Natrix, Crystal screens from Hampton Research 
and the MCSG suite from Microlytic (https://production.moleculardimensions.com/
products/microlytic-screens). 1 µL of protein was mixed with an equal volume of reservoir 
solution and equilibrated over 75 µL reservoir solution. Three crystals were observed in the G10 
condition of the MCSG1 suite. This corresponded to reservoir solution containing 15% (w/v) 
PEG 3350 and 0.1 M magnesium formate. Crystals were cryoprotected prior to data collection by 
passing the crystal through mother liquor containing 13% (v/v) glycerol. Subsequent attempts 
to reproduce the crystals were not successful. 
3.5 X-ray data collection and processing 
Only one of the three crystals, shown in Figure 3-2, from the initial screen gave diffraction 
greater than 4 Å resolution. Data was collected from the single crystal at 100 K at the Australian 
Synchrotron on the MX1 beamline (Aragão et al., 2018; McPhillips et al., 2002). Diffraction data 
was processed and scaled using iMosflm and Scala (Battye et al., 2011; Evans and Murshudov, 
2013). The data processing statistics of the diffraction from this crystal are listed in Table 3-1. 
 
Figure 3-2 – 186 CI was successfully crystallized and diffraction data was collected from the crystal. A) Crystal of 186 
CI grown in MCSG1 G10. Crystal position is indicated by the red box. B) Representative image of the diffraction 
acquired from the crystal shown in A. 
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Table 3-1 - Data collection statistics for the native data. Values in parentheses are for the highest resolution shell. 
Synchrotron radiation source MX1, Australian Synchrotron, 
Melbourne 
Detector Quantum 210r (ADSC) 
Wavelength (Å) 0.9537 
Data collection temperature (K) 100 
Space-group P21 






Matthews coefficient VM 2.54 assuming 6 molecules in the ASU 
2.17 assuming 7 molecules in the ASU 
Solvent content (%) 51% assuming 6 molecules in the ASU 
43% assuming 7 molecules in the ASU 
Resolution range (Å) 54.41-2.30 
Total reflections 424697 (32888) 
Unique reflections 59330 (4575) 
Completeness (%) 99.9 (100) 
Redundancy 7.2 (7.2) 
<I/σ(I)> 16.5 (7.1) 
CC1/2 (%) 99.8 (98.3) 
Rmerge (%) 8.5 (24.5) 
Rpim (%) 3.7 (10.6) 
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The Matthews coefficient was used to estimate the number of monomers in the asymmetric unit. 
The Matthews coefficient, defined as  
𝑉𝑀 =
𝑣𝑜𝑙𝑢𝑚𝑒 𝑜𝑓 𝑢𝑛𝑖𝑡 𝑐𝑒𝑙𝑙
𝑍𝑋 ×  𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑎𝑟 𝑤𝑒𝑖𝑔ℎ𝑡 𝑜𝑓 𝑚𝑎𝑐𝑟𝑜𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑒
 
Z is the number of asymmetric units in the unit cell.  X is the number of molecules in the 
asymmetric unit and is initially not known. Empirically it has been found that VM typically falls 
between 2 and 3 Å3/Da. This suggests that there are six or seven monomers in the asymmetric 
unit, which give a VM of 2.54 Å3 Da-1 and 2.17 Å3 Da-1, respectively.  
3.6 Attempts to solve the phase problem 
3.6.1 Principles of molecular replacement 
To solve the 3-dimensional structure from the X-ray diffraction of its protein crystal, two 
parameters need to be determined for the structure factors; amplitude and phase. The 
amplitude can be measured directly from the diffraction image, but the phase cannot. One of the 
methods to obtain the phases is molecular replacement (Rossmann and Blow, 1962). In 
molecular replacement, the phases come from a previously solved or predicted model, called a 
probe or search model. 
For the molecular replacement method to provide phases, the probe needs to be positioned in 
the unit cell of the target crystal such that the theoretical diffraction from the probe resembles 
the experimental diffraction. Six spatial parameters are fitted to each probe (3 translational and 
3 rotational) to position it in the unit cell.   
Different molecular replacement algorithms are available to arrive at these six parameters. The 
molecular replacement program Phaser (McCoy et al., 2007), which employs a maximum 
likelihood algorithm, breaks up the search for the 6 parameters into two 3-dimensional 
searches. First, the three rotational parameters are fitted, followed by the three translational 
parameters. Some programs search for all six parameters simultaneously. The EPMR program 
performs a six-dimensional search by using evolutionary search algorithm to optimize the 
rotation and translation of the probe simultaneously (Kissinger et al., 1999).  
3.6.2 Attempt to solve phase problem  
Attempts to solve the phase problem using molecular replacement, using the programs Phaser 
(McCoy et al., 2007) and EPMR (Kissinger et al., 1999), failed to produce a correct solution. The 
search models used for molecular replacement were structures of previous 186 CI crystal 
structures solved by Pinkett (2006). Molecular replacement was attempted with the full CIE146K 
dimer, a CIE146K monomer, the CI N-terminal domain and the CI C-terminal domain, as a 
monomer and an oligomer with arrangements guided by the existing crystal structure.  
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3.6.3 Reasons that may contribute to molecular replacement failing 
The search models used for molecular replacement were either domains of CI or a single amino 
acid substitution mutant. However, even with these high similarity search models, molecular 
replacement was unable to solve the phase problem.  
Molecular replacement using a high similarity probe can fail when there have been 
conformational changes in the protein, such that the probe is no longer sufficiently structurally 
similar to the true crystal structure. The CI NTD and CI CTD are connected via a flexible linker 
and a movement of the CI NTD relative to the CTD may make the CIE146K search model an 
unsuitable probe. One possible way to tackle this is to use the NTD and CTD as separate search 
models, but this strategy has its own caveats. 
One factor that makes molecular replacement more difficult in this case is the presence of an 
estimated 6-7 molecules per asymmetric unit of the crystal. As the number of components in the 
asymmetric unit increases, the proportion of scattering that each component contributes to the 
total decreases. Thus, the low signal of each isolated component becomes harder for MR 
algorithms to find. Assuming six molecules in the asymmetric unit, the NTD and CTD contribute 
roughly 6% and 9%, respectively, of total protein scattering and may be missed by molecular 
replacement programs.   
With the roadblocks encountered with solving the crystal structure of wildtype 186 CI, the 
alternate biophysical techniques small angle X-ray scattering (SAXS) and electrospray ionization 
mass spectrometry (ESI-MS) were used to study the structure and oligomerization of 186 CI.  
3.7 SAXS 
SAXS is a solution-based technique. A collimated X-ray beam with defined wavelength is passed 
through a sample in solution and the intensity of scattered X-rays is measured on a detector 
(Figure 3-3). In solution, the sample can adopt all orientations. Solution scattering from all the 
orientations is averaged to give rise to radially symmetrical scattering collected at small angles 
to determine particle shape. In SAXS, the intensity of detected X-rays (I) is measured as a 
function of scattering angle. In most cases, scattering angle is expressed as momentum transfer q 
= (4πsinθ)/λ, where λ is the wavelength of incident X-ray and 2θ is the angle of the scattered X-
ray relative to the direct beam.  
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Figure 3-3. The basic setup for a SAXS experiment. A protein sample in solution is illuminated with a collimated, 
monochromatic X-ray beam. The solution scattering by the protein is measured using an X-ray detector. The intensity 
of scattered X-rays is measured as a one-dimensional function of momentum transfer q. Figure adapted from Skou et 
al. (Skou et al., 2014) and SAXIER (SAXIER, 2018). 
3.8 Preparation of 186 CI protein for SAXS 
Two variants of the 186 CI protein were overexpressed and purified for SAXS analysis. They 
were the wildtype 186 CI and the 186 CIE146K proteins, each with a C-terminal hexahistidine tag 
and intervening thrombin cleavage site. 186 CIE146K is a 186 CI cooperativity mutant that can 
form dimers, but is unable to form higher order oligomers (Pinkett et al., 2006).  Both proteins 
were overexpressed and purified as described in Section 3.3, with modifications described here. 
After Ni-IMAC purification, both proteins were dialysed into 50 mM Tris-HCl, 150 mM NaCl, 10 
mM EDTA, 5% glycerol, 5 mM TCEP, pH 7.5. The proteins were concentrated by 
ultracentrifugation using an Amicon Ultra-15 centrifugation unit (Millipore). The concentrated 
protein solutions were dialysed again into the same dialysis buffer. The final concentrations of 
186 CI and 186 CIE146K proteins as determined by UV absorbance were 8.7 mg/mL and 14.7 
mg/mL, respectively. The extinction coefficient of the proteins at 280 nm was calculated using 
ExPASy ProtParam webserver (Gasteiger et al., 2005) to be 23950 M-1 cm-1.  
3.9 SAXS data acquisition and processing 
SAXS data for 186 CI and 186 CIE146K was collected at the P12 EMBL BioSAXS beamline 
(Deutsches Elektronen-Synchrotron, Hamburg, Germany) on a Pilatus 2M photon-counting pixel 
detector, in collaboration with Dr. Haydyn Mertens. The sample-to-detector distance was set at 3 
m. The temperature of the cell was 15°C. The protein concentrations of the samples used for 
data collection were 7.4, 3.7, 1.85, 0.93 and 0.46 mg/mL for CIE146K and 8.7, 4.4, 2.2, 1.1 and 0.5 
mg/mL for CI. The protein was diluted with dialysis buffer. Dialysis buffer was also collected as a 
blank reading for subtraction of background scattering. Background subtracted scattering 
profiles are shown in Figure 3-4.  




Figure 3-4 – Normalized scattering profiles of 186 CI and 186 CIE146K. Scattering profiles are plotted as the logarithm 
of intensity of scattering against the momentum transfer q. Each plot has had background scattering subtracted and 
normalized to the protein concentration. Plots have been offset on the log scale. Grey lines represent the error bars on 
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All programs used to analyse and visualize SAXS data are available in the ATSAS package 
(Franke et al., 2017). SAXS data analysis was conducted with the help of Dr. Haydyn Mertens and 
Dr. Fiona Whelan. Kratky plots for CI and CIE146K at 8.4 mg/mL and 14.8 mg/mL, respectively, 
were drawn in SASplot (Franke et al., 2017). Guinier analysis was performed using the AutoRg 
function of Primus for each dataset (Konarev et al., 2003). The upper limit for data points 
selected for Guinier analysis was determined such that qRg ≤ 1.3. The lower limit was 
automatically selected by Primus. Pair distance-distribution functions P(r) were calculated by 
GNOM (Svergun, 1992). The intensity of zero angle scattering I(0) and radius of gyration Rg were 
extracted from Guinier and P(r) plots. The maximum linear dimension of the scattering 
molecules was also determined using P(r) plots.  
Several approaches were used to fit structural models to the scattering data of CIE146K. The 
simulated scattering curve of CIE146K crystal structures (PDB ID 2FJR) and CI-hybrid dimer 
(Chapter 4) was evaluated using CRYSOL (Svergun et al., 1995). Rigid body modelling of CIE146K 
was performed using CORAL (Petoukhov et al., 2012). CIE146K was treated as a multi-domain 
protein containing rigid domains, linked by dummy residues where the NTD and CTD domains 
could move relative to each other. The Advanced Ensemble Optimization Method (Tria et al., 
2015) was used to fit the CIE146K SAXS scattering curve with an ensemble of CIE146K conformers, 
based on the crystal structure. 
3.10 SAXS results 
3.10.1 Kratky analysis 
SAXS can be used as method for investigating unfolded and flexible proteins. A qualitative 
assessment of flexibility in a protein studied by SAXS can be made using a Kratky plot (Glatter 
and Kratky, 1982). A Kratky plot is a plot of q2.I(q) against q and has distinctive characteristics 
depending on the degree of protein folding (Figure 3-5) (Kikhney and Svergun, 2015). Well 
folded globular proteins display a peak at low q and return to near zero as q increases. In 
contrast, Kratky plots of completely unfolded proteins characteristically rise to high q2. I(q) at 
low q, but do not return to zero but feature a rising baseline at high q. Kratky plots for CI and 
CIE146K indicate the protein is partially folded. Partially folded proteins show a peak at low q, 
with an intermediate baseline. The X-ray crystal structure of CIE146K comprises two folded 
globular domains connected by a 15 residue linker. The Kratky plot indicates that in solution 
this linker is likely disordered.  In addition, the NTD of 186 CI has previously been suggested to 
require some conformational flexibility to allow it to bind to two distinct DNA half-sites. 
Comparison of λ CI and 186 CIE146K structures revealed that the NTD of 186 had a shorter helix 5, 
which may contribute to NTD flexibility by reducing structural constraints (Pinkett et al., 2006). 
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Figure 3-5 – Kratky plot for CI and CIE146K suggests that the protein is partially folded. (A) Characteristic Kratky plots 
(q2.I(q) vs q) for proteins displaying different proportions of foldedness. Well folded globular proteins display a bell-
shaped curve in a Kratky plot, returning to near zero values at higher q. Unfolded proteins and peptides have 
increasing q2.I(q) values that do not return to baseline at high q. Figure adapted from Rambo and Tainer (2011). (B) 
Kratky plots for CI and CIE146K show a peak at low q and an intermediate decrease in the mid to high q range, 
characteristic of a partially folded protein. 
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3.10.2 Guinier analysis 




3    (Equation 1) 
where I(0) is the scattering intensity at an angle of zero and Rg, the radius of gyration, is the root 
mean square distance of each contributing scatterer from the centre of the particle. For globular 
particles, the Guinier approximation works over a range where qRg < 1.3 (Guinier, 1939). 





𝑞2 + ln 𝐼(0)  (Equation 2) 
Thus, a Guinier plot (lnI(q) vs. q2) has a y-intercept of lnI(0) and a slope of -Rg2/3. Thus a Guinier 
approximation allows one to estimate I(0) and Rg, which provides structural parameters of the 
protein. Assuming a monodisperse solution, I(0) is directly proportional to the molecular mass 
of the complex in solution. Rg is dependent on the conformation of the protein, with more 
compact proteins giving smaller Rg values than extended conformations, when comparing two 
proteins of the same molecular weight (Kikhney and Svergun, 2015).   
Guinier plots were made for each dataset and used to determine I(0) and Rg for each of the 
proteins at different concentrations (Figure 3-6 and Figure 3-7). Visual assessment of the 
Guinier plots show linearity in this region for both proteins, which is indicative of  
monodispersity (Figure 3-6). However, subsequent analysis of the I(0) and Rg fits of the SAXS 
demonstrated polydispersity, which is possible if aggregation (such as oligomerization) and 
interparticle interference are subtle (Grant et al., 2015). In the low q data beyond the lower limit 
set for Guinier analysis, there was a slight deviation upwards from linear fit, also suggesting 
potential aggregation.  
186 CIE146K is a cooperativity mutant which forms dimers, but is unable to form higher order 
oligomers (Pinkett et al., 2006). This is reflected in its Rg and I(0) values, which are significantly 
smaller than for wildtype 186 CI. The slight increase in Rg and I(0) likely reflects the increase in 
dimeric species as concentration increases. The larger Rg and I(0) observed for wildtype CI is 
consistent with the higher order oligomeric species being formed by this protein. As protein 
concentration increases for the wild type species, Rg and I(0) also increase, reflecting a shift in 
the concentration-dependent equilibrium towards larger oligomeric species (Figure 3-7). 
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Figure 3-7 – Guiner plots were used to extract the radius of gyration Rg  (upper) and intensity of zero angle scattering 
I(0) (lower) for 186 CI and 186 CIE46K at different concentrations. The concentration dependent formation of higher 
order wild type CI oligomers is reflected in increasing I(0) and Rg.  
As zero angle scattering intensity I(0) is directly proportional to the molecular weight of the 
complex, I(0) can be used to measure the molecular weight of the complex. The absolute 
intensity of scattering is not directly measured, thus to convert to absolute units, secondary 
standards are used (Mylonas and Svergun, 2007). The standard used in this experiment was 






































  96 
 
of water was determined to be 5879 x 10-2 cm-1. To scale the I(0) of each protein sample into 




×  1.637 x 10−2 cm−1  (Equation 3) 
where I(0)Absolute is the scattering in absolute units and I(0)Relative is the experimentally measured 
scattering. The molecular mass of the scattering complexes can be calculated from I(0)Absolute 




2  (Equation 4) 
where NA = 6.023 x 1023 mol-1 is Avogadro’s number and ΔρM is the scattering contrasting of the 
sample. ΔρM is the product of the scattering length difference of the protein and the partial 
specific volume. The scattering length difference of the protein was calculated using the MULCh 
Constrast Module webserver (Whitten et al., 2008) to be 2.72 x 1010 cm-2 for both 186 CI and 186 
CIE146K. The partial specific volume was calculated using the NucProt webserver (Voss and 
Gerstein, 2005) to be 0.7432 mL/g. (ΔρM)2 was calculated to be 4.08 x  1020 g-2cm2. The estimated 
molecular masses for CI and CIE146K are shown in Figure 3-8. The molecular mass estimated for 
CIE146K and CI at the highest concentration are 40 kDa and 188 kDa, respectively. This was 
smaller than the expected molecular mass of 45.2 kDa for CIE146K and 316 kDa (14mer) for CI. 
  
















7.4 9752.6 0.027156 40047.61 1.77 
3.7 9011.41 0.025092 37004.02 1.64 
1.85 8756.36 0.024382 35956.69 1.59 
0.93 8015.75 0.02232 32915.49 1.46 
0.46 7497.2 0.020876 30786.14 1.36 
CI 
8.7 45865.2 0.127711 188338.6 8.34 
4.4 41519.5 0.115611 170493.7 7.55 
2.2 35096.4 0.097725 144118.2 6.37 
1.1 28260.8 0.078692 116048.8 5.13 
0.5 26155.5 0.07283 107403.7 4.75 
Figure 3-8 – Molecular weight determination of CI and CIE146K using Guinier analysis. Guinier plots were made for CI 
and CIE146K to estimate I(0) at each of the concentrations. I(0) was converted into absolute units using X-ray scattering 
by water as a calibrant. Absolute I(0) was used to calculate the molecular mass of the protein using the formula 𝑀𝑀 =
𝑁𝐴𝐼(0)𝐴𝑏𝑠𝑜𝑙𝑢𝑡𝑒
∆𝜌𝑀
2  where NA is Avogadro’s number and ΔρM is the scattering length difference. Errors in molecular mass 
were estimated at 10%, based on (2007). A table of calculated values during various steps of MW estimation using 
I(0) is provided.  
3.10.3 Pair distance-distribution function P(r) 
The pair distance-distribution function, also called the pair-density distribution function, pair 
distribution function or P(r) function, is the distribution of paired-sets of distances between all 
points within a scattering object weighted by their respective electron densities. In SAXS, the 
P(r) function describes the paired set of distances between all the electrons in a macromolecule 
or complex. The P(r) function is generated via a Fourier transform of the SAXS scattering profile 
I(q) (Putnam et al., 2007; Rambo, 2018). The P(r) distribution can provide structural details of 
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linear dimension in the scattering particle. In addition, the shape of the distribution is 
dependent on the structure of the macromolecule (Figure 3-9) and can be sometimes be used as 
an initial indication of overall shape. 
 
Figure 3-9 – Pair distance-distribution functions P(r) of different geometric bodies. Figure adapted from Svergun and 
Koch (2003). 
In addition, P(r) distributions can be used to calculate Rg and I(0) values for SAXS datasets with 
data that lies outside the Guinier approximation and can be used to cross-check Rg and I(0) 
values obtained from a Guinier plot. In practice, an indirect Fourier transform is used to 
generate P(r) based on a user-entered Dmax value. P(r) plots are generated through trial-and-
error, where the user selects different Dmax values and visually assesses the P(r) distribution, and 
the fit to the scattering data, to determine if the chosen Dmax is appropriate. P(r) distributions 
were generated for both CI and CIE146K using the GNOM program and the ATSAS package (Franke 
et al., 2017), and Rg and I(0) were extracted from the plots  (Figure 3-10). Rg and I(0) values 
obtained from P(r) distributions and Guinier analysis are very close, with a deviation of less than 
2% in all cases (Figure 3-11). This cross-check shows that the Guinier approximation used was 
appropriate.  
The Dmax of CIE146K at the concentrations tested were between 9 and 11 nm. However, the 
maximum linear dimension of the CIE146K dimer in the crystal structure is only 7 nm (Figure 
3-10B). This suggests that the dimer conformation of CI in solution may be less compact that the 
crystal structure due to the flexible linker between the NTD and CTD of CI allowing the NTD to 
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extend. Dmax, Rg and I(0) for CI increase with concentration, consistent with the idea that 
increasing higher order oligomers form with increasing concentration. 
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Figure 3-10 – Pair distance distribution functions of CI and CIE146K. (A) P(r) distributions for CI and CIE146K. Different 
Dmax values were used to generate P(r) distributions for CI and CIE146K using the GNOM program of the ATSAS package 
(Franke et al., 2017). The P(r) distributions that visually fit the data and the corresponding Dmax value are shown. (B) 
The dimensions of the CIE146K protein in the crystal structure are smaller than the Dmax values determined from P(r) 
distributions, with the largest atom to atom distance at 7 nm.  
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Figure 3-11 Guinier analysis and P(r) distribution analysis for 186 CI and 186 CIE146K give radius of gyration Rg and 
intensity of zero angle scattering I(0) values that are consistent with each other at all concentrations tested.  
3.10.4 Ensemble optimization method to examine flexibility in CIE146K 
Given a structural model, it is possible to generate the theoretical scattering pattern. This 
theoretical scattering pattern would account for orientation averaging effects in solution. 
However, for flexible systems, the theoretical scattering pattern would also need to account for 
conformational averaging. Each new conformation in the sample adds to the scattering pattern, 
such that the final observed scattering is a linear combination of scattering from its constituent 
conformations. Given K distinct conformations, the SAXS intensity is given by 𝐼(𝑞) =
 ∑ 𝑣𝑘𝐼𝑘(𝑠)
𝐾
𝑘=1 , where vk and Ik are the fractional proportion and scattering intensity of the kth 
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One method to account for this conformational flexibility is known as the Ensemble 
Optimization Method (EOM) (Bernadó et al., 2007; Tria et al., 2015). In EOM, a large pool of 
random conformers is generated to approximate conformational space. The scattering profile 
for each conformer is calculated and a genetic algorithm is used to select the conformations that 
best fit the experimental scattering. The algorithm aims to minimize discrepancy χ2 (Bernadó et 
al., 2007; Tria et al., 2015), given by 








 Equation 5 
where K is the number of conformations, Iexp(q) is the experimental scattering, µ is a scaling 
factor and σ are the standard deviations. Discrepancy (χ2) can also be used as a goodness of fit 
metric to compare the fits between different modelling methods. 
Several structural models were fitted to the CIE146K SAXS scattering curve (Figure 3-12). The 
theoretical scattering profiles for the CIE146K crystal structure (PDB ID 2FJR) and CI-hybrid 
crystal structure (Chapter 4) were generated and compared to the observed scattering curve of 
CIE146K. A significantly better fit was obtained by fitting a rigid body model of CIE146K, made by 
translating the NTD and CTD from the CIE146K crystal structure relative to each other, with 
linkers represented as interconnected dummy residues. The model that better fits the data, as 
judged by χ2, has a reoriented NTD (Figure 3-12A). In all these cases, the scattering profile 
assumes only one scattering species. EOM 2.0 was also employed to generate an ensemble of 
scattering conformers of CIE146K to fit the data. The final ensemble selected by the algorithm 
consists of five conformers (Figure 3-12B). The conformers differed in the position of the NTDs 
relative to the CTD dimer, demonstrating the flexibility of the linker.                           
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Figure 3-12 – Fitting structural models to CIE146K SAXS data. (A) A rigid body model of CIE146K, modelled to fit the 
CIE146K SAXS data. The flexible termini and linkers between the domains are represented by dummy atoms. The CIE146K 
crystal structure that was used as a template for rigid body modelling is superimposed and shown as a slightly 
transparent structure.   (B) Ensemble of CIE146K dimer conformers fitted to the SAXS scattering profile using the EOM 
2.0 algorithm. Each conformer is assigned a fractional contribution, which corresponds to the predicted fraction of 
CIE146K dimers that occupy this conformation at any point in time. (C) The theoretical scattering patterns of the 
structural models compared to the experimental scattering profile. χ2 is used as a goodness of fit metric, with lower 
values indicating a closer fit. The EOM structural models, followed by the rigid body model, provided the closest fit to 
the data.   
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3.11 Discussion of SAXS data 
SAXS was a useful tool for studying 186 CI. Crystallographic studies of the CI protein described 
in Pinkett et al. (2006) have provided atomic level structural detail on the domains of the 
protein and have suggested a possible 14-mer assembly that could be adopted by the protein. 
However, non-biologically relevant conformations and oligomers can form due to packing of 
proteins into a solid crystal. SAXS provides a complementary source of structural information on 
the CI protein in the solution state, avoiding the effects of crystal packing on the protein 
quaternary structure. SAXS is a lower resolution technique which can be used to derive global 
shape and conformation, which when combined with high resolution structural data can 
produce detailed structural models (Putnam et al., 2007). 
The adoption of a higher-order quaternary structure by 186 CI dimers is thought to be crucial to 
its ability to transcriptionally regulate lytic and lysogenic gene expression in the phage lifecycle 
(Dodd and Egan, 2002; Wang et al., 2013). The E146K mutation in CI abolishes higher order 
oligomer formation, as the X-ray structure of the protein revealed a dimeric structure. This is 
supported by SAXS data which shows that the apparent molecular weight and shape of CIE146K as 
indicated by the Guinier Rg and maximum linear dimension Dmax parameters, remain unchanged 
with increasing concentration. This reflects that CIE146K forms a dimer, which does not associate 
further. The estimated molecular mass was 40 ± 4 kDa, very close to the sequence calculated 
value of 45.2 kDa. In contrast, wild type CI shows an overall increase in global parameters 
correlated with increasing concentration, which may reflect the equilibrium shifting towards 
higher order oligomers as concentration increases. 
The molecular weight for CI at the highest concentration tested was estimated to be 188 ± 18 
kDa. This is smaller than the estimated molecular mass for the 14-mer complex at 316 kDa. As 
the high order oligomerization of CI is concentration dependent, it is possible that the 
concentrations tested were too low to observe the 14mer complex. There are several inherent 
uncertainties in the measurements and calculations that could also have caused this 
discrepancy.  The molecular weight calculation relies on protein concentration, partial specific 
volume derived from the primary structure and the experimentally determined I(0) value. 
Errors in these values would propagate into the mass determination. The concentration of 
protein was calculated from near UV-absorbance using native protein based on an extinction 
coefficient calculated from the primary sequence. This extinction coefficient implicitly assumes 
that the protein is denatured and its extinction coefficient is the linear combination of the major 
chromophores phenylalanine, tyrosine and tryptophan. In Appendix B, we experimentally 
determine the native extinction coefficient to be 3 ± 5% larger than the denatured extinction 
coefficient. The estimated molecular weight adjusted for concentration effects is 194 ± 30 kDa, 
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which still is not consistent with a 14mer. Mylonas and Svergun (2007) estimated the molecular 
mass of 13 proteins using I(0) and compared them to their true values. For molecular masses 
that were calculated using the partial specific volume derived from the primary sequence, the 
average deviation from the true value was 16.5%, with 5 of the 13 proteins having a deviation of 
greater than 20%. It was pointed out by the authors that particle specific volumes calculated 
from the primary sequence, as used in our calculations, are often significantly smaller than their 
experimentally measured values. Additionally, if we assume that wild type CI can form an 
oligomeric assembly and does so dynamically, as implied by the progressive increase in particle 
shape and size parameters, it is possible that the scattering particles present a weighted 
averaged MW for a range of different oligomeric states (Graziano et al., 2006). That the 
estimated molecular mass of the CI complex isn’t consistent with the 14mer is therefore 
unsurprising.  
The SAXS data has reaffirmed the flexibility of the CI protein. Kratky analysis of the data 
qualitatively indicates flexibility in both the CIE146K and wild type CI. EOM modelling of CIE146K 
can be used to model this flexibility, by modelling it as an ensemble of proteins in different 
flexed states. This model contained five constituent states with the NTD in various positions 
relative to the CTD.  The NTDs of the CIE146K protein in the crystal structure are positioned in the 
same plane as the CI wheel. For DNA to wrap around a CI wheel, each dimer’s NTDs need to be 
positioned roughly orthogonal to the wheel plane. In support of the CI wheel model, 
conformations iii—v of the EOM model position the NTDs in this CTD orthogonal position such 
that DNA would indeed be able to wrap around. Hypothetically, the mobility of the NTD defined 
by the ensemble may describe dynamic regulation of DNA binding, such that the predominant 
dimeric species have the NTD DNA binding interface ‘hidden’ by the CTD oligomeric domain, and 
wheel formation may switch the NTD to a DNA binding accessible state, as reflected in the 
relative percentage contribution (60%) of scattering by the ‘hidden’ NTD states i-ii in the CIE146K 
dimer (note that the dimer mutation is in the oligomeric interface of the CTD, not at the 
NTD/CTD interface). 
Neither SAXS nor the previous techniques employed to interrogate the CI complex  (AUC; 
(Shearwin et al., 2002); AFM, SEC-MALLS; (Wang et al., 2013)) are of sufficient resolution to 
definitively demonstrate the presence of a 14mer oligomeric complex that is central to the 
current model of 186 CI transcriptional regulation. To tackle this problem, native ion-mobility 
mass-spectrometry was used to directly measure the mass of the 186 CI complex with high 
resolution, to conclusively determine the true oligomeric state in vitro.     
3.12 Ion-mobility mass spectrometry 
Ion-mobility mass spectrometry (IM-MS) couples ion mobility separation (IM) with mass 
spectrometry (MS) to allow the masses and topology of protein complexes to be simultaneously 
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determined. An IM-MS instrument performs four functions – sample ionisation, IM separation, 
mass-to-charge separation and ion detection. To study 186 CI oligomeric state, IM-MS 
measurements on the protein were performed on the Synapt HDMS system (Waters, 
Manchester, UK) (Figure 3-13). The instrumentation has been described in detail elsewhere 
(Pringle et al., 2007), and its main functions will be described below.  
 
Figure 3-13 – Schematic diagram of the Waters Synapt HDMS system, displaying the sequential order of equipment 
required for ionization, ion selection, separation based on ion mobility and mass detection. Figure adapted from 
(Zhong et al., 2011). 
Sample ionisation 
The Synapt HDMS instruments ionises protein samples by electrospray ionisation (ESI) (Dole et 
al., 1968; Fenn et al., 1989). In this technique, the liquid sample is passed through a needle. An 
applied electric field results in the needle tip charging the surface of the liquid as it exits. 
Coulomb repulsion causes the liquid to disperse and a drying gas is applied to encourage 
evaporation. The net result is the production of gas phase ions (Fenn et al., 1989). By using 
volatile aqueous buffers (most commonly ammonium acetate) and physiological pHs, large non-
volatile biomolecules can be ionized with their native-like structures maintained.  
Ion-mobility separation 
Ion mobility separation involves passing ions through a chamber of neutral carrier gas at a 
controlled pressure in the presence of an external field. The mobility of the ion through the gas 
depends on the collisional cross-sectional area (CCS) and charge of the ion. Less compact ions 
collide more frequently with neutral gas molecules and hence take longer to travel through the 
chamber. Thus, ion mobility measurements provide information about protein shape. The drift 
time, the time it takes for the ions to traverse the chamber, is measured and can be converted to 
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CCS area using a standard curve of CCS area against drift time, made using calibrants of known 
CCS area (Ruotolo et al., 2008).  
Mass-to-charge separation 
The Synapt HDMS system uses the time of flight (ToF) analyser. When samples enter the mass 
analyser compartment, they are pushed by an electric potential from the pusher. The time t it 
takes for a sample ion to traverse the time-of-flight tube is given by 𝑡 = 𝑑√
𝑚
2𝑉𝑧
, where m is the 
mass of the ion, z is the charge of the ion, d is the distance traversed and V is the electric 
potential of the pusher. With both distance and electric potential constant, the time of flight of an 
ion to reach the detector can be used to determine its mass-to-charge ratio (Lane, 2005). For 
proteins and protein complexes, a series of multiply charged peaks is often observed for each 
species, allowing for deconvolution of the spectra to determine the molecular weights of the 
species.  
Computational calculation of CCS 
The CCS of a known or modelled structure can be computationally calculated. In our studies, CCS 
was computationally calculated from structural models using the Leeds method (Smith et al., 
2009). This method employs the Projection Approximation Algorithm. The ions cross-section is 
replaced with its projection (or shadow) which is averaged over all the possible orientations of 
the ion (Knapman et al., 2010). This approximates the ion as a sphere with this average 
projection. The collisions of this model sphere with buffer gas is simulated in silico to calculate 
the theoretical CCS.   
Mass selection and collision induced dissociation 
The Synapt HDMS instruments contains a quadrupole analyser and a collision cell. The 
quadrupole consists of four parallel rods. To select for ions with specific m/z, alternating 
radiofrequency (RF) potentials and fixed direct current (DC) are applied to these rods, creating 
an electric field, to oscillate the ions. With a defined RF potential and DC, only ions with one 
defined m/z will have a stable trajectory and pass through the quadrupole. All the other ions will 
be ejected from the quadrupole. In MS mode, no ion-selection is employed, and the quadrupole 
acts as an ion guide. In MS/MS mode, the quadrupole selects for ions of a particular m/z ratio. 
These ions can be activated in the collision cell. In the collision cell, the ions collide with an inert 
gas to excite the ions and cause collision induced dissociation (CID). 
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3.13 Mass spectrometry experimental procedures 
3.13.1 Preparation of samples for mass spectrometry 
The 186 CI was overexpressed in E. coli and purified as outlined in sections 3.2 and 3.3, 
respectively. The 186 CI C-terminal domain was overexpressed and purified as described by 
Pinkett et al. (2006). All proteins were exhaustively dialysed into 0.3 M ammonium acetate at 
4°C, flash frozen into liquid nitrogen and stored at -80°C.  
3.13.2 Mass-spectrometry examination of 186 CI-CTD and 186 CI 
Mass-spectrometry experiments were performed on a Synapt HDMS system (Waters, 
Manchester, UK). Ions were produced by electrospray ionisation (ESI) from sample introduced 
from gold-coated borosilicate capillaries prepared in-house (Hernández and Robinson, 2007). 
The instrument parameters were optimized to remove adducts while preserving noncovalent 
interactions and were typically as follows: capillary voltage, 1.5 kV; cone voltage, 50 V; trap 
collision energy, 10 V; source temperature, 20°C; and backing pressure, 6 mBar. 
Native mass spectrometry was performed on 186 CI-CTD, using exactly the same protein 
construct used for crystallography by Pinkett et al. (2006). The concentrations 13 μM and 34 μM 
were used  and the spectra are shown in Figure 3-14. At both concentrations, the major species 
detected were 10mer and 12mer species. There was no evidence for a 14mer species. To 
unequivocally assign these high molecular weight species, CID experiments were performed to 
fragment the 10mer and 12mer species. The mass of the fragmented ions can be determined 
from the MS/MS spectra and will sum up to give the mass of the parent ion.  CID of the 5689 m/z 
10mer species caused it monomer to be ejected from the ion to leave a 9mer, both of which were 
detected on the MS/MS spectra (Figure 3-15A).  CID of the 5963 and 6075 m/z 12mer species 
fragmented the ion into a 11mer and monomer, both of which were clearly observed on the 
MS/MS spectra (Figure 3-15B and C).  
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Figure 3-14 - ESI-TOF spectra of 186 CI-CTD at (A) 13 µM and (B) 34 µM was measured in aqueous ammonium 
acetate (0.3 M). Decamers (10mer) and dodecamers (12mer) of 186 CI-CTD were detected.  
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Figure 3-15 – Ionized species corresponding to decamers (10mer) and dodecamers (12mer) of 186 CI-CTD, detected 
via ESI-MS in Figure 3-14, were subjected to collision induced dissociation (CID) to confirm their oligomeric 
assignment. The MS/MS spectra of the CID of the 5689 and 5963 m/z ions are shown in (A) and (B), respectively. Both 
showed the presence of a nonamer and monomer, confirming the presence of a decamer in the native MS spectra. The 
MS/MS spectra of the collision induced dissociation of the 6075 m/z ions (C) showed the presence of an undecamer 
(11mer) and monomer, confirming the presence of a dodecamer in the native MS spectra. 
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Given the unexpected result of the dodecamer as the highest molecular weight oligomeric 
species observed for CI-CTD, rather than the 14-mer seen in the crystal structure, mass 
spectrometry was also used to investigate the oligomeric state of full length 186 CI. Mass 
spectrometry was conducted at 10 μM and 30 μM, with mass spectra shown in Figure 3-16. 
Dimer, tetramer, hexamer, octamer and 10mer species could be assigned at 10 μM. A very 
obvious 12mer species was detected at 30 μM. However, there is no evidence of a species above 
a 12mer in either spectrum. To validate this result, CID experiments were performed on the 
7632 m/z ion that was assigned to the 12mer (Figure 3-17). This ion fragmented into a 11mer 
and monomer to confirm the assignment was correct.  
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Figure 3-16 - ESI-TOF spectra of 186 CI at (A) 10 µM and (B) 20 µM was measured in aqueous ammonium acetate (0.3 
M). 186 CI forms dimers that sequentially oligomerize into a dodecamer (12mer) species. Dimers, tetramers, 
hexamers, octamers, decamers and dodecamers are detected. The proportion of dodecamers increases at the higher 
protein concentration. 
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Figure 3-17 – Ionized species corresponding to dodecamers (12mer) of 186 CI, detected via ESI-MS in Figure 3-16B, 
were subjected to collision induced dissociation (CID) to confirm their oligomeric assignment. The MS/MS spectra of 
the CID of the 7632 m/z ions showed the presence of undecamer (11mer) and monomer, confirming the presence of a 
dodecamer in the native MS spectra. 
3.14 Oligomerization of 186 CI 
Measuring the oligomerization state of 186 CI shows that the protein can form dimers, 
tetramers, hexamers, octamers, decamers and dodecamers. This oligomerization pattern 
suggests that the protein forms dimers that sequentially oligomerise until it reaches a final 
dodecamer state. This higher order oligomerization is mediated via the CTD, as the isolated CTD 
also forms decamers and dodecamers.  Taken together, it is likely that the true final oligomeric 
state of 186 CI, mediated by the 186 CI-CTD, is a dodecamer. In all the spectra, no 14mer species 
was observed. The 14mer complex observed in the crystal structure of the CI-CTD could be a 
crystal artefact and not reflective of its true quaternary structure. It could also be argued that CI 
concentrations are too low to observe a 14mer. However, the highest concentrations of CI (20 
μM) tested exceed the concentration found in a 186 lysogen, which is estimated around 1.1 μM 
(Dodd and Egan, 2002).  
3.14.1 Previous studies of 186 CI oligomeric state 
There have been several past experiments into CI oligomerization aside from X-ray 
crystallography. CI has been visualized directly through atomic force microscopy (AFM) 
experiments. The oligomeric state of CI has also been inferred from size exclusion 
chromatography combined with multi-angle laser light scattering (SEC-MALLS) and 
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sedimentation equilibrium experiments. In this section, this data is examined to see if it 
supports the 12-mer or 14-mer arrangement.  
Wang et al. (2013) performed AFM on 186 CI in the presence and absence of DNA. The 
resolution of the images was sufficient to observe 186 DNA interacting with CI oligomeric 
particles to form specific CI-DNA looped species. This supported the hypothesis that 186 CI 
exerts its transcriptional regulatory activity by wrapping of 186 DNA onto it. AFM also allowed 
the measurement of particle volume, which was used to infer the molecular weight of the 
particle using a calibration curve. The observed volume of 632 ± 152 nm3 encompasses both the 
12mer and 14mer arrangement (Figure 3-18). The 14mer deviates less from the standard curve 
and seems to fit the data better. However, it’s also difficult to judge the reliability of 
extrapolating the standard curve over 150 kDa past its largest calibrant. In the same publication, 
SEC-MALS was performed on 186 CI and 186 CI HTH-, measuring weighted average molecular 
weight peaks 280 ± 8 kDa and 274 ± 5 kDa, respectively. This corresponds to 12.4 ± 0.4 
monomers and 12.1 ± 0.2 monomers for 186 CI and 186 CI HTH-, respectively. Thus, the SEC-
MALS data supports 186 CI forming a 12mer over a 14mer. SAXS measurements of 186 CI 
obtained a highest average MW of 188 kDa, equivalent to 8.34 monomers, which is significantly 
smaller than both the 12mer (271 kDa) and 14mer (316 kDa). This discrepancy could be due to 
inaccuracies in the partial specific volume parameter used in the calculations, as explained in 
section 3.11. 
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Figure 3-18 – Volume calibration curve for AFM. The molecular weight of 186 CI can be inferred from its volume using 
a volume vs. molecular weight standard curve. Calibrant proteins (solid points) used from left to right are λ CI 
monomer (25 kDa), λ CI dimer (50 kDa), histone octamer (108 kDa) and the lac repressor tetramer (150 kDa). 186 CI 
(unfilled points) were measured to have a volume of 632 ± 152 nm3 and plotted with the theoretical molecular weight 
of a 12mer and 14mer. The chart was based on Figure S1 of Wang et al. (Wang et al., 2013).   
Sedimentation equilibrium was conducted on his-tagged 186 CI NTD (residues 1-82) and his-
tagged CI CTD (residues 83-192) (Pinkett, 2004; Shearwin et al., 2002). Both experiments 
suggested that 186 CI-CTD and full length 186 CI self-associated into a species 7 to 8-fold larger 
than the monomer. The self-association in solution was proposed to be through an equilibrium 
of monomers, dimers, tetramers and octamers (Shearwin et al., 2002). As pointed out by Pinkett 
et al. (Pinkett et al., 2006), the sedimentation equilibrium data could be fitted to higher order 
species but would require data to be collected at higher concentrations to justify their inclusion. 
In summary, native mass spectrometry, with its high mass resolution, has determined with high 
confidence that the 12mer is the largest oligomeric species formed by 186 CI. Results of previous 
experiments examining oligomerization of 186 CI, with the exception of the crystal structure of 
186 CI CTD, did not provide strong support for the 14mer over the 12mer complex.    
3.14.2 An alternative crystallography approach to study 186 CI-CTD oligomerization 
The possibility of a 186 CI 12mer complex presents some new questions. What could this 186 CI 
12mer look like and how might it achieve regulation? To investigate this, it would be useful to 
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an N-terminal DNA binding domain. The N-terminal domain may provide steric limitations to 
alter the oligomerization of the protein. However, previous endeavours (Pinkett, 2004) and our 
attempts to solve the structure of the full CI complex have failed (section 3.6). One of the 
possible issues with crystallizing the full length 186 CI as a complex is that the protein is very 
flexible, as revealed by Kratky analysis of SAXS data (section 3.10). This flexibility, likely arising 
from the flexible linker and the inherent flexibility in the NTD (Pinkett et al., 2006; Shearwin et 
al., 2002), would reduce crystallization propensity of the protein. One possible approach to 
improving crystallizability is to remove the long linker between the domains and replace the 
semi-flexible 186 CI NTD with a more rigid domain, which is attempted in the next chapter. 
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4 EXPRESSION, PURIFICATION, CRYSTALLIZATION 
AND STRUCTURE SOLUTION OF A HYBRID CI 
PROTEIN 
4.1 Introduction 
In the previous chapter, native mass spectrometry analysis of the full length 186 CI suggested that 
the protein forms a 12mer oligomeric complex, mediated by the C-terminal domain. This 
stoichiometry is inconsistent with the observation, from X-ray crystallography, that the C-terminal 
domain alone forms a 14mer complex. It would be ideal to structurally characterize the full-length CI 
complex in order to address this puzzle, and also to understand how DNA can interact with the CI to 
achieve its sophisticated transcriptional regulation. However, as described in Chapter 3, attempts to 
solve the crystal structure of the full-length 186 CI protein have been unsuccessful.  
In the absence of a full length 186 CI structure, a hybrid λ-186 CI repressor (henceforth referred to as 
the CI-hybrid or the hybrid protein) was investigated as a model to probe the oligomeric state and 
supramolecular assembly of 186 CI. The Shearwin lab constructed this hybrid protein (Pinkett et al., 
2006), which is a fusion of the λ CI NTD (residues 1-92) with the 186 CI CTD (residues 84-192). One 
potential advantage, from the structural biology perspective, of the hybrid protein is that its design 
reduces the length of the flexible linker found in wild type 186 CI (Shearwin et al., 2002). In addition, 
the use of the well characterised λ CI NTD, which has been successfully crystallised bound to lambda 
operator DNA (Beamer and Pabo, 1992), may also reduce the flexibility of the protein. Movements of 
NTD within the oligomeric protein would be further decreased by the dimerization of the λ CI NTD 
domain (Pabo and Lewis, 1982), a phenomenon not observed for 186 CI NTD (Shearwin et al., 2002). 
These reductions in flexibility may in turn aid protein crystallization (Derewenda, 2004). 
A case can also be made for the hybrid protein being a suitable model to investigate 186 CI. Both λ CI 
and 186 CI are two domain proteins, consisting of an N-terminal DNA binding domain and a C-
terminal oligomerization domain. The N-terminal domains from λ CI and 186 CI share significant 
structural similarity with both domains consisting of 5 alpha helices, with helices 2 and 3 forming a 
helix-turn-helix motif (Pinkett et al., 2006). Helix 5 is significantly shorter in 186 CI than λ CI, which is 
thought to provide some additional flexibility to 186 CI NTD. As the N-terminal DNA binding domains 
are structured similarly and are comparable in size, it is likely that the 186 CI CTD would be able to 
mediate the hybrid protein into the same overall oligomeric state. This hypothesis is further 
supported by size exclusion chromatography - multi-angle laser light scattering (SEC-MALLS) data 
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from our laboratory which measures the hybrid protein forming an oligomer with a molecular weight 
equivalent to approximately 12.9 monomers (Cui Lun, unpublished data).  
In their study, Pinkett et al. (2006) measured the activity of this hybrid protein in vivo against 
chromosomally integrated, synthetic reporter constructs (Figure 4-1A). The constructs utilized the 




Figure 4-1 - The λ-186 CI-hybrid protein, consisting of λ CI NTD (residues 1-92) fused to the 186 CI 
CTD (residues 84-192), functions as a repressor. (A) The λ-186 CI-hybrid protein is under the control 
of an IPTG-inducible plac promoter, with pUHA-1 supplying lac repressor. The λ-186 CI-hybrid protein 
can repress the pR promoter and activate the pRM promoter in the pR:lacZ and pRM:lacZ constructs 
shown. Error bars represent 95% confidence intervals. (B) Model proposing a mechanism for ability 
of the OL operators to increase pRM activation. The original model assumes the hybrid protein adopts 
a 14mer wheel, as a heptamer of dimers. OR1, OR2 and OR3 operators can bind the wheel to repress 
pR and pRM. The three OL operators can also bind the wheel. Figures are reproduced from Pinkett et 
al. (2006). 
In these constructs, the CI-hybrid protein can repress the λ pR promoter. This repression is aided by 
the presence of the OL binding sites, indicating that hybrid protein can simultaneously contact OL and 
OR (Figure 4-1A left construct). The regulation of λ pRM by the hybrid protein is different from λ CI. 
With three intact OR operators and in the absence of OL, the hybrid protein only slightly activates the 
pRM promoter (Figure 4-1A right construct ΔOLOR+). The 14mer wheel-centric model suggests that the 
hybrid protein can occupy all three OR operators. Similar to the mechanism with wild type lambda CI, 
when the hybrid protein occupies OR1-OR2, it can activate the pRM promoter by directly contacting 
RNAP bound at pRM (Jain et al., 2004; Nickels et al., 2002). However, the hybrid protein can more 
efficiently occupy OR3 than is the case in the lambda switch, and so can more efficiently compete 
with RNAP binding and thus reduce the level of pRM activation.  
Reducing the affinity of the hybrid protein for the OR3 operator, without affecting pRM strength, by 
introducing the OR3-r1 mutation (Dodd et al., 2001) increases the activation of pRM by over two fold 
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(Figure 4-1A right construct ΔOLOR-r1). This activation can be explained by the reduced occupation of 
OR3 by the CI-hybrid protein and thus reduced competition with RNAP binding at pRM. In contrast, λ 
CI activates pRM significantly more (regardless of the strength of OR3) due to weaker occupation of 
OR3 (Dodd et al., 2001).  
Introducing OL into the constructs improved the activation of pRM by the hybrid protein (Figure 4-1A 
right construct OL+OR+ and OL+OR-r1). Thus, OL appears to reduce the occupation of OR3. The proposed 
mechanism is that OL can compete with OR3 for binding sites on the hybrid CI wheel, to relieve 
repression on pRM. This activity is analogous to DNA looping to the 186 flanking FL/FR sites to relieve 
repression of pL in 186 CI model (Chapter 1). Thus, the presumed wheel formed by the CI-hybrid can 
show similar DNA binding and looping behaviour to 186 CI, making it a suitable alternative model to 
the 186 CI.  
In addition, the hybrid protein has successfully been used in a genetic screen, based on that originally 
used for lambda CI by Hochschild and Ptashne (1988), to select for cooperativity mutants in the 186 
CI-CTD (Pinkett et al., 2006). Many of these cooperativity mutants were positioned on the dimer-
dimer interface when mapped onto the crystal structure of the 186 CI-CTD wheel, which is perhaps 
the strongest evidence that the hybrid protein uses a similar oligomerisation mechanism to 186 CI.  
In this chapter, we successfully solved the X-ray crystal structure of the CI-hybrid protein bound to 
single DNA operators, and characterized its oligomerization using mass-spectrometry. 
4.2 Materials and Methods 
4.2.1 Overexpression of the hybrid protein 
The expression strain for the hybrid protein, CL1950, was provided by Cui Lun (Shearwin lab). CL1950 
is BL21(DE3) pLysS cells harbouring the hybrid protein expression vector pET3a λ-186 CI-hybrid His6. 
The vector contains the T7 promoter controlling the expression of the hybrid protein (λ CI residues 1-
92 fused to 186 CI residues 84-192) followed by a thrombin cleavage consensus sequence (LVPRGS) 
and a hexahistidine affinity tag.  
2 x 5 mL LB supplemented with 100 µg mL-1 ampicillin and 30 µg mL-1 chloramphenicol were 
inoculated with CL1950 glycerol stocks and grown overnight at 37°C. 2 mL of the overnight culture 
was used to inoculate 2 x 500 mL of the same selective LB media and cultured at 37°C to an OD600 of 
0.52. The cultures were induced with 200 µM IPTG and grown overnight at room temperature. Cells 
were harvested by centrifugation at 5000 g for 10 min and stored at -80°C until purification. Cell 
pellets were thawed and resuspended in 40 mL of lysis buffer (20 mM sodium phosphate, 500 mM 
NaCl, 20 mM imidazole, 5 mM 2-mercaptoethanol, pH 7.4) and sonicated on ice (4 x 30 s, 1 min rest 
between sonication cycles). The cell lysate was clarified by centrifugation (40 000 g, 40 min) and 
supernatant was sequentially passed through a 0.8 µm, 0.45 µm and 0.2 µm syringe filters to remove 
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remaining suspended solids. The clarified lysate was applied to a 5 mL HisTrap FF column (GE 
Healthcare) preequilibrated with lysis buffer. The column was washed with 10 CV of lysis buffer, 
followed by 2 CV of lysis buffer supplemented with 150 mM imidazole. Protein was eluted from the 
column with 2 CV of lysis buffer supplemented with 500 mM imidazole. Fractions showing UV 
absorbance A280 nm above baseline were pooled were tested for purity using SDS-PAGE (Figure 4-2). 
Fractions containing purified protein were dialysed against TEG150 (50 mM Tris-Cl, 0.1 mM EDTA, 
150 mM NaCl, 10% glycerol, pH 7.5, 0.5 mM DTT). The protein was concentrated to 8 mg/mL by 
centrifugation with Amicon Ultra-15 centrifugation units (Millipore). Protein was further purified by 
size-exclusion chromatography on an Enrich SEC 650 column (Bio-Rad), using TEG150 as the 




Figure 4-2 - SDS-PAGE analysis of fractions from Ni-NTA chromatography to purify CI-hybrid protein. 
Samples were run on 4-12% NuPAGE BisTris Protein Gels (ThermoFisher Scientific) with NuPAGE 
MOPS buffer. Lane M: Novex Sharp Pre-Stained Protein Standard (ThermoFisher Scientific, 2 µL), Pre: 
Pre-induction sample.  Post: Post-induction sample. FT: Flowthrough fraction. Elution fractions that 
show UV absorbance above baseline, corresponding to lanes 5-10, have been labelled on the gel 
image.  
4.2.2 Preparation for protein-DNA complex for crystallography 
Some of the published X-ray crystal structures of λ CI have the protein in complex with DNA (Beamer 
and Pabo, 1992; Jain et al., 2004; Stayrook et al., 2008). An attempt was made to crystallize the 
hybrid protein in complex with the same DNA (OL1) as described in Stayrook et al (2008). The 
oligonucleotide sequences are listed in Table 4-1. DNA oligonucleotides were commercially 
synthesized and purified with ion-exchange HPLC purification (Integrated DNA Technologies). Each 
oligonucleotide was dissolved in TE buffer (10 mM Tris-Cl, 0.1 mM EDTA, pH 8) to a concentration of 
3 mM. 50 µL of the two oligonucleotides were mixed, heated to 95°C and slowly cooled to room 
temperature to anneal the strands together.  100 µL of 8.6 mg/mL CI-hybrid protein was mixed with 
16.5 µL of 1.5 mM OL1 DNA and incubated on ice for 30 minutes. Crystallization screening was 
conducted via sitting drop vapour diffusion in 96 well Intelliplates (Art Robbins), set up using a 
Phoenix robot (Art Robbins). 1 µL of CI-hybrid/OL1 DNA mixture was mixed with 1 µL of reservoir 
solution and equilibrated over 75 µL reservoir solution at 16°C. Commercial screens were used to 
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provide crystallization conditions. The commercial screens used were NatrixHT, Index HT, Crystal 
Screen HT and PEG/ION HT (Hampton Research) (https://hamptonresearch.com/cat-1.html). A single 
crystal was observed in the NatrixHT screen condition F2 (0.08 M sodium chloride, 0.012 M 
potassium chloride, 0.04 sodium cacodylate trihydrate pH 8.0, 30% w/v (+/-)-2-methyl-2,4-pentadiol, 
0.012 M spermine tetrahydrochloride) after 3 months. The crystal was cryoprotected by passing it 
through a cryoprotection solution (7.5 µL mother liquor mixed with 1.5 µL of 80% glycerol) and flash 
freezing in liquid nitrogen.   
Table 4-1 - Oligonucleotide sequences for crystallography studies 
Oligonucleotide name Sequence 
OL1 top TATATCACCGCCAGTGGTAT 
OL1 bottom AATACCACTGCCGGTGATAT 
 
4.2.3 X-ray data collection, processing and structure solution 
Data was collected from a single crystal at 100 K at the Australian Synchrotron MX1 beamline using 
the ADSC Quantum 210r CCD detector (Aragão et al., 2018; McPhillips et al., 2002). 240 diffraction 
images were collected with 1° oscillation width, with crystal-to-detector distance set to 275 mm. 
Diffraction images were processed and scaled using XDS and Scala (Evans and Murshudov, 2013; 
Kabsch, 2010). The resolution limit was chosen such that the overall CC1/2 > 0.3. The data processing 
statistics are summarised in Table 4-2. The structure was solved by molecular replacement using 
Phaser MR (McCoy et al., 2007), positioning two search models in the asymmetric unit sequentially. 
The search models were a 186 CI-CTD dimer (PDB ID 2FKD chains A and B) and the λ CI in complex 
with OL1 DNA with the CTD removed from the model (PDB ID 3BDN with residues 93 to 236 removed 
from chains A and B). Each asymmetric unit contained a protein dimer in complex with one double 
stranded OL1 DNA. The model was iteratively refined and rebuilt using phenix.refine (Afonine et al., 
2012) and COOT (Emsley et al., 2010), respectively. Model validation was performed using 
Molprobity (Chen et al., 2010). Refinement statistics for the final model are summarized in Table 4-3. 
The final structure can be accessed from the Protein Data Bank with PDB accession ID 7JVT.  
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Table 4-2. Data processing statistics of CI-hybrid crystallography dataset. Statistics for the highest 
resolution shell are shown in parentheses. 
Wavelength (Å) 0.9537 
Total images 240 
Oscillation (°) 1.00 
Space group H32 






Resolution (Å)  44.34-3.16 
Mosaicity (°) 0.32 
Total reflections 165170 (29299) 
Unique reflections 11372 (2045) 
Redundancy 14.5 (14.3) 
Completeness (%) 99.8 (99.4) 
Average I/σ(I) 14.6 (3.1) 
Rmergea (%) 13.5 (73.8) 
Rmeasb (%) 14.0 (76.5) 
Rpimc 3.7 (0.200) 
CC1/2d 99.9 (91.0) 
a𝑅𝑚𝑒𝑟𝑔𝑒 = ∑ ∑ |𝐼𝑖(ℎ𝑘𝑙) − 〈𝐼(ℎ𝑘𝑙)〉|𝑖ℎ𝑘𝑙 ∑ ∑ 𝐼𝑖(ℎ𝑘𝑙)𝑖ℎ𝑘𝑙  (Arndt et al., 1968) 
b𝑅𝑚𝑒𝑎𝑠 = ∑ {𝑁(ℎ𝑘𝑙)/[𝑁(ℎ𝑘𝑙) − 1]}
1/2  × ∑ |𝐼𝑖(ℎ𝑘𝑙) − 〈𝐼(ℎ𝑘𝑙)〉|/ ∑ ∑ 𝐼𝑖(ℎ𝑘𝑙)𝑖ℎ𝑘𝑙𝑖ℎ𝑘𝑙  (Diederichs and 
Karplus, 1997) 
c𝑅𝑝𝑖𝑚 = ∑ {1/[𝑁(ℎ𝑘𝑙) − 1]}
1/2
ℎ𝑘𝑙  × ∑ |𝐼𝑖(ℎ𝑘𝑙) − 〈𝐼(ℎ𝑘𝑙)〉|/ ∑ ∑ 𝐼𝑖(ℎ𝑘𝑙)𝑖ℎ𝑘𝑙𝑖  (Weiss and Hilgenfeld, 
1997) 
dCC1/2 = ∑(𝑥 − 〈𝑥〉)(𝑦 − 〈𝑦〉)/[∑(𝑥 − 〈𝑥〉)2 (𝑦 − 〈𝑦〉)2]1/2 (Karplus and Diederichs, 2012) 
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Table 4-3 - Refinement statistics of CI-hybrid structure 
Reflections used in refinement 11352 (1121) 
Reflections used for R-free 1142 (115) 
R-worka 0.2271 (0.2917) 
R-freeb 0.2814 (0.3521) 
CC(work) 0.916 (0.588) 
CC(free) 0.933 (0.307) 
Number of non-hydrogen atoms 3882 
  macromolecules 3831 
  solvent 51 
Protein residues 397 
RMS(bonds) 0.002 
RMS(angles) 0.44 
Ramachandran favored (%) 96.44 
Ramachandran allowed (%) 3.31 
Ramachandran outliers (%) 0.25 
Rotamer outliers (%) 0.00 
Clashscore 6.92 
Average B-factor 84.99 
  macromolecules 85.37 
  solvent 56.47 
Number of TLS groups 11 
a 𝑅𝑤𝑜𝑟𝑘 = ∑ |𝐹𝑜 − 𝐹𝑐 |/ ∑ |𝐹𝑜| for all data with 𝐹𝑜 > 2𝜎 (𝐹𝑜), excluding data to calculate 𝑅𝑓𝑟𝑒𝑒  
b Rfree = ∑ |𝐹𝑜 − 𝐹𝑐 |/ ∑ |𝐹𝑜| for all data with 𝐹𝑜 > 2𝜎 (𝐹𝑜), calculated with 5% of reflections that are 
randomly chosen (Brünger, 1992). 
 
4.2.4 Analysis of structure 
Structures were visualized in UCSF Chimera (Pettersen et al., 2004) and PyMOL (DeLano, 2002). 
Surface area calculations were performed on the PDBePISA webserver (Krissinel and Henrick, 2007). 
Intramolecular residue-residue contacts between different protein chains were investigated with the 
Protein Interaction Calculator webserver (Tina et al., 2007), using the default distance constraints of 
the server. Protein-DNA contacts were analysed using NUCPLOT (Luscombe et al., 1997).  
4.2.5 Mass spectrometry characterisation of CI-hybrid protein 
The CI-hybrid protein was exhaustively dialysed into 0.3 M ammonium acetate at 4°C, flash frozen 
into liquid nitrogen and stored at -80°C. Mass-spectrometry experiments were performed on a 
Synapt HDMS system (Waters, Manchester, UK). Ions were produced by electrospray ionisation (ESI) 
from sample introduced from gold-coated borosilicate capillaries prepared in-house (Hernández and 
Robinson, 2007). The instrument parameters were optimized to remove adducts while preserving 
noncovalent interactions and were typically as follows: capillary voltage, 1.5 kV; cone voltage, 50 V; 





4.3.1 Structural analysis of the CI-hybrid protein 
The asymmetric unit contains a dimer of CI-hybrid in complex with one double stranded OL1 DNA 
(Figure 4-3A). Despite the different oligomerization C-terminal domains, the λ-derived CI NTDs in the 
hybrid structure contact the OL1 half sites in the same manner as λ CI in the crystal structure (3BDN) 
that was used as a search model (Figure 4-3B). Structural alignment of λ CI NTDs in complex with 
DNA from this structure to previously solved structures showed very little structural deviation as 
measured by all-atom RMSD, which lies between 0.56Å – 1.28Å (Figure 4-4A). The DNA provides 
strong steric constraints on the relative positions on the NTDs, which would be further restricted by 
the weak dimerization interface between helix 5 of the monomers (Pabo and Lewis, 1982; Sauer et 
al., 1990). The DNA present in the crystal structure of the hybrid is identical in sequence to previously 
solved structures of the λ CI dimer in complex with DNA (PDB ID: 3BDN) and λ CI NTD dimer in 
complex with DNA (PDB ID: 1LMB). An attempt was made to compare DNA-protein interactions 
across these structures (Figure 4-4B). However, the ability to accurately determine interactions 
between the CI-hybrid protein and DNA is hampered by the resolution (3.16 Å) of the model. At this 
resolution, many flexible side chains cannot be modelled from the electron density, which translates 
into many of the interactions between side chains and DNA being undetected. For this reason, there 
are several interactions detected in the highest resolution 1.8Å published structure (1LMB) that were 
not detected in the CI-hybrid structure. All of the DNA-protein interactions that were detected in the 
CI-hybrid structure were also found in the highest resolution model, with the exception of two 
interactions Asn58 and Asn61 of NTD 2 contacting the phosphates of guanine 13 and guanine 14, 
respectively. The Asn58 contact was also observed in the structure of the λ CI dimer complex with 
DNA (3BDN).  In the 1LMB model, N58 instead contacts the phosphate of the next base guanine 14. 
Thus, there is a local rearrangement of side chains in this area of the protein between the structures.  
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Figure 4-3. The CI-hybrid structure (PDB ID 7JVT) shows a high degree of structural similarity to the 
search models containing individual domains. (A) Asymmetric unit of the solved structure of the CI-
hybrid protein contains a dimer of CI-hybrid bound to OL1 DNA. The DNA binding and dimerization 
are mediated by the λ CI NTD and 186 CI CTD portions, respectively. The structure shares structural 
similarity to the previously solved structures of the domains in (B) λ CI (PDB ID: 3BDN) and (C) 186 CI 
CTD (PDB ID: 2FKD). The search models used in molecular replacement to solve the CI-hybrid 
structure have been approximated in red in (B) and (C).  
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Figure 4-4 – The CI-hybrid protein and λ CI share the same DNA-binding conformation. A) Structural 
superposition of λ CI NTDs (residues 1-92) in complex with DNA from the CI-hybrid protein (PDB ID 
7JVT) with previously solved structures of λ CI NTDs contacting DNA (PDB ID 1LMB, 1RIO) and  λ CI 
dimer binding DNA (PDB ID 3BDN). Minimal structural deviations were observed as indicated by the 
low all-atom RMSD values measured. B) Nucleotide-residue contact map summarising the 
interactions between λ CI NTDs and DNA in the CI-hybrid and previously solved structures 1LMB and 
3BDN reveals similar binding interactions. The protein chains to which the interacting residues 
belong are indicated by “NTD 1” and “NTD 2” on the right. Maps were generated using NUCPLOT 
(Luscombe et al., 1997). 
The C-terminal domain derived from 186 CI mediated the dimerization of the protein in a manner 
similar to the 186 CI-CTD 14mer structure (Figure 4-3C). Structural superposition of these C-terminal 
domains of the CI-hybrid protein against existing structures of the CI-CTD 14mer structure and the 
186 CIE146K dimer also shows minimal structural deviation, with all-atom RMSD measuring 0.537 Å 
and 0.525 Å, respectively.  
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Figure 4-5 – Superposition of a dimer of 186 CI CTD domains from the CI-hybrid protein (PDB ID 
7JVT), 186 CIE146K dimer (PDB ID 2FJR) and 186 CI-CTD 14mer wheel (PDB ID 2FKD). The 186 CI CTD in 
the CI-hybrid protein dimerises in the same manner as the CI-CTD and 186 CIE146K crystal structures.  
Having established that the dimers within CTD of the hybrid are essentially identical to the dimers 
within the isolated 186 CTD, the key question of the overall stoichiometry of the wheel assembly 
could be addressed.  The quaternary structure of the protein in the lattice is a dodecamer wheel, 
arranged as a hexamer of dimers (Figure 4-6). This is consistent with mass spectrometry experiments 
of the 186 CI-CTD and 186 CI proteins described in Chapter 3, which determined that the final higher 
order oligomer that formed from oligomerization of 186 CI-CTD dimers is a dodecamer. The 
arrangement of the DNA binding domains on the outside of the wheel would still allow DNA to wrap 
on and off the wheel. The protein binds OL1 DNA in the same plane as the wheel, as expected from 
this DNA wrapping model. Interestingly, the 186 CIE146K crystal structure has the DNA binding 
domains positioned relative to the CTD in a way where DNA would bind orthogonal to the plane of 
the wheel. However, it is clear from the structure of the hybrid protein that wild type 186 CI can bind 
DNA in a wheel-like manner, as the domains are connected by a flexible region which allows the DNA 
binding domains to rearrange into a conformation that facilitates wrapping of DNA onto the protein. 
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Figure 4-6 - CI-hybrid protein forms a dodecamer quaternary structure in the crystal lattice. Dimers of 
CI-hybrid oligomerize through the C-terminal domain to form a hexamer of dimers in a circular 
arrangement. 
4.3.2 Mass spectrometry analysis of the CI-hybrid protein 
To investigate the oligomeric state of the CI-hybrid protein outside a crystalline system, native mass 
spectrometry experiments were carried out on the CI-hybrid protein in the absence of DNA (Figure 
4-7). Dimers, tetramers, hexamers, octamers, decamers and dodecamers of the CI-hybrid protein 
were identified in the mass spectra of the CI-hybrid protein at concentrations 10 μM and 30 μM. The 
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same oligomeric states were also observed in the mass spectra of 186 CI (Chapter 3), suggesting that 
the same oligomerization pathway is followed by both proteins. The dimer and tetramer species 
were more abundant at 10 μM, compared to 30 μM. In contrast, the dodecamer species is more 
abundant at 30 μM. This is consistent with higher order oligomerisation being a concentration 
dependent process.   
Finally, collision induced dissociation (CID) was performed to provide additional evidence for the 
stoichiometry. CID of the 7950 m/z ions, assigned as a 12mer species, produced both 11mer and 
monomer fragment ions (Figure 4-8). This result provides a high level of confidence that the highest 




Figure 4-7 - ESI-TOF spectra of the CI-hybrid protein at (A) 10 µM and (B) 30 µM were measured in 
aqueous ammonium acetate (0.3 M). Dimers, tetramers, hexamers, octamers, decamers and 
dodecamers (12mer) are detected.  
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Figure 4-8 - The MS/MS spectra of the collision induced dissociation of the 7950 m/z species, 
assigned as a 12mer in Figure 4-7B, detected a undecamer (11mer) and monomer.  
4.4 Discussion 
4.4.1 Alternative wheels configurations mediated by 186 CI CTD 
The dodecamer wheel arrangement of the CI-hybrid crystal structure differs from the 14mer wheel 
observed in the 186 CI-CTD crystal structure, which was composed of a heptamer of dimers (Figure 
4-3C). Circular protein assemblies, like 186 CI, present a straightforward mechanism for forming 
alternative oligomeric states. A subunit can be added and subtracted from the circular ring, provided 
the physical constraints, such as the distance between protein-protein interfaces, are satisfied 
(Figure 4-9). For example, bacteriophage portal proteins exclusively form 12-mer rings within intact 
phage particles. However, isolated phage portal proteins have been observed to form other ring 
oligomers when purified following overexpression from plasmids. These oligomers range from 11mer 
to 14mer structures (Cardarelli et al., 2010; Cerritelli and Studier, 1996; Dube et al., 1993; Orlova et 
al., 2003). Other circular assemblies with alternative oligomeric states include the bacterial 
pneumolysin toxin (Tilley et al., 2005), the Salmonella typhimurium flagella motor (Young et al., 2003) 
and components of the S. typhimurium type III secretion system needle complex (Marlovits et al., 
2004). A similar mechanism may be explain the observation that the 186 CI and CI-hybrid crystal 
structures have adopted different oligomeric states.  
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Figure 4-9 – Mechanism of forming alternative ring assemblies. Proteins that oligomerize into rings 
can often form larger or smaller rings by adding and removing subunits from the circular assembly. 
The same protein-protein interfaces are utilized in the n and n+1 oligomers.  
Proteins have been found to form oligomeric structures in crystals that differ from their true state in 
solution. Crystallography uses protein concentrations many-fold more concentrated than found in 
nature, which may cause non-physiologically relevant oligomers to form. Conditions in 
crystallography are also optimised to promote protein-protein interactions to form a crystal lattice. 
The crystal lattice may stabilise non-physiologically relevant oligomers and complexes through crystal 
packing. Bahadur et al. (2004) studied structures present in the Protein Data Bank and found over 
100 non-physiologically relevant dimers, where proteins exist as monomers in solution. In addition, 
some oligomeric assemblies can prefer to crystallize in certain spacegroups as their oligomer 
symmetry can be incorporated into the symmetry of the crystal (Chruszcz et al., 2008). Proteins that 
form rings and wheels are often radially symmetric and the crystallization process may preferentially 
select for certain oligomeric rings.  
Another possibility is that the oligomeric state of 186 CI in the cellular context could be dependent 
upon whether it is bound to DNA. For example, if not interacting with DNA, 186 CI could in principle 
form dodecamers solely via CTD mediated oligomerisation. If bound to DNA, CI might favour a 
different oligomeric state through the influence of the DNA mediated protein-protein interactions 
between adjacent dimers. This would be somewhat similar to bacteriophage λ, where DNA looping 
mediates the formation of the λ CI octamer (Dodd et al., 2005), which is otherwise less favourable in 
the absence of DNA (Senear et al., 1993). In the lambda situation, DNA binding and looping simply 
assist a pre-existing oligomerisation, rather than drive the formation of a distinct oligomer (Cui et al., 
2013).  
Thus, further experiments that follow from this study of 186 CI should aim for structural 
characterisation of a 186 CI-DNA complex. While attempts at crystallisation of CI in the presence of 
short fragments of DNA have been unsuccessful, it may be possible with DNA designed to be long 
enough to wrap around the whole wheel. Alternatively, cryo-electron microscopy may be a more 
amenable approach for observation of the 186 CI protein-DNA complex than X-ray crystallography. 
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4.4.2 Dimer-dimer interface analysis 
The dimer-dimer interface of the 186 CI-CTD and CI-hybrid buries approximately 970 Å2 and 885 Å2 of 
solvent accessible surface area, respectively. This higher buried surface area is reflective of the closer 
packing of the domain in the 14mer wheel. 
Pinkett et al. (2006) conducted a genetic screen for cooperativity mutants in the 186 CI C-terminal 
domain using the CI-hybrid protein. The genetic screen was designed to isolate mutants that could 
still bind DNA but showed reduced cooperativity between the operator sites. The screen isolated 15 
mutations at 13 positions that reduced cooperativity between dimers. These mutations can be 
mapped onto both the 12mer and 14mer wheel structures. As expected, the mutations both cluster 
around the dimer-dimer interface in both cases (Figure 4-10).  
 
Figure 4-10 – The 186 C-terminal domain uses the same interface to form the dodecamer and 14mer. 
The CI-CTD cooperativity mutants isolated by Pinkett et al. (Pinkett et al., 2006) cluster in this 
oligomerization interface in both arrangements. The 14mer arrangement has the dimers packed 
closer together to accommodate an extra dimeric subunit.  
The cooperativity mutants were investigated for possible residue-residue interactions between 
adjacent dimers in a wheel configuration. The distances of these interactions in the 12-mer and 14-
mer configuration in the crystal structures were quantified (Table 4-4). It is important to note that 
the interaction distances of the 14mer were based upon 13 or more values, but the interaction 
distances of the 12mer were only based on 2 values. This is because the crystal structure of the 186 
CI CTD contains 14 subunits in the asymmetric unit, and each dimer interacts with an adjacent dimer 
slightly differently. However, in the case of the CI-hybrid structure, the asymmetric unit contained a 
CI-hybrid dimer. The 12mer arrangement is generated through symmetry operations based on the 
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spacegroup of the crystal. This results in only 2 unique bond interaction distances in the 
arrangement. Each residue interaction distance was observed 6 times in the arrangement.  
Out of the residue positions where 186 CI-CTD dimer cooperativity mutants were found, four 
residues were found to form plausible ionic interactions with residues from adjacent dimers. K156 
from one dimer can form an ionic interaction with either E96 or E146 on an adjacent dimer. 
Interaction with one glutamate side chain positions the lysine side away from interacting with the 
other. In the 14mer crystal structure, K156 preferentially interacts with E96. In the 12mer crystal 
structure, K156 was observed to interact with either E96 or E146, at the detriment of the other 
interaction. This choice between ionic interactions possibly contributes to seeing both 12mer and 
14mer oligomeric states in the crystal structures. The other ionic interaction between K168 and E153 
is closer in the 12-mer than 14-mer. 
Table 4-4 – Residue-residue interaction distances of 186 CI cooperativity mutants in the 12mer and 
14mer configuration based on crystal structures. 





in 12mer (Å) 
Contact distance in 
14mer (Å) * 




F110L none identified    




























P158S none identified    
L162P none identified    
H163R none identified    
















C173R none identified    
I178T none identified    
*Average of all the residue interaction distances in the crystal structure (n≥13). Error stated is the 
standard error.  
4.4.3 Model of transcription regulation using a dodecamer 
The previous model of transcriptional regulation of pL and pR by CI involved DNA from these 
promoters wrapping around a 14mer wheel (Pinkett et al., 2006). It is important to consider whether 
this model of transcriptional regulation by DNA looping remains valid with a 12mer wheel. A 
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schematic diagram of the regulation model with a 12mer and 14mer is shown in Figure 4-11. One of 
the assumptions of the 14mer model is that DNA strands in close proximity can sterically clash to 
occlude and diminish binding. FL and FR are proposed to use this steric clash property to push pL 
operators off the wheel to activate pL (Figure 4-11 species c). However, in the structure of the hybrid 
protein (Figure 4-6 bottom), the DNA does not lie strictly in the plane of the wheel due to flex in the 
positions of the NTDs. It may be possible for DNA strands to enter and exit the 186 CI wheel from 
above and below the plane, to mitigate clashing effects. Thus, it is important to discuss the possible 
roles of clashing in the 12mer and 14mer models.  
 
Figure 4-11 – Comparison of the dodecamer and tetradecamer wheel models of transcriptional 
regulation. 186 CI forms a wheel with the DNA binding HTH-containing domains facing outwards. 
DNA around the pR and pL promoters can wrap around the wheel to repress both the pR and pL 
promoters (species a). The pL promoter with weaker affinity operators can loop off the wheel 
scaffold to be replaced by a flanking site (species b and c). At higher concentrations, both FL and FR 
are both sequestered by another CI wheel (species d).  
There are two regulatory features of the 186 CI wheel model where DNA clashes can be considered, 
which are summarized in Figure 4-12. They are (i) corepression of the pL and pR promoters and (ii) pL 
derepression by competition off the wheel by FL and FR binding. 186 CI can corepress pR and pL (Dodd 
and Egan, 2002), which is proposed to be driven by six contiguous operators (including two poorly 
defined operators) between pR and pL all bound to the wheel (Figure 4-11 species a). The dodecamer 
complex has six dimers of CI, and thus should still be able to complex with the six CI operator sites 
between the pL and pR promoters. However, a strong steric clashing effect between DNA entering 
and exiting the wheel would prevent the operator pL from binding, preventing Figure 4-11 species a 
from forming and would not be consistent with pR-pL corepression. Thus, strong steric clashing 
effects are inconsistent with the 12mer model, but not the 14mer model. 
The flanking sites FL and FR can improve pL derepression by CI. This is proposed to be an effect of FL 
and FR binding to the wheel and sterically pushing off the operator at pL. In both the 12mer and 
14mer models, the presence of steric clashes would allow the pL DNA to be pushed off by flanking 
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sites. In a 12mer model with no steric clashes, pL can be activated by an FL or FR site binding to the 
wheel. As there are only 6 available binding positions on the wheel, the operator at pL may free due 
to a lack of binding positions. Thus, FL/FR assisted derepression of PL can be observed with a 12mer 
wheel even in the absence of DNA clashes. In a 14mer model with no steric clash effect, there are 
enough binding positions on the wheel to bind to all 6 operators between pL and pR and whilst 
allowing an FL or FR operator to bind. Thus, this model would require an extra binding site (or 
significant non-specific binding of DNA) adjacent to FL or FR to push off pL. In summary, the 14mer 
wheel model requires DNA clashes to explain the regulatory effects of FL and FR. 
 
 
Figure 4-12- The effect of DNA clashes on transcriptional regulation by a 12mer and 14mer CI wheel. 
A 12mer wheel would be consistent with the CI transcriptional regulation model in the absence of 
strong steric clashes between DNA entering and exiting the wheel. Strong DNA clashes would not 
allow both pR and pL to simultaneously occupy the wheel and is inconsistent with observed pR-pL 
corepression. The regulation model based around the 14mer would be inconsistent in the absence of 
strong steric clashes as pR, pL and FL (or FR) could simultaneously occupy the wheel. This simultaneous 
occupation would result in FL/FR not efficiently derepressing pL. 
When examining the CI-hybrid protein regulating λ pR and pRM, it was observed that OL reduces 
repression of pRM (Figure 4-1). This was attributed to a clashing effect whereby an OL operator pushes 
off pRM, which would be consistent in both a 12mer and 14mer model. However, without the 
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presence of clashes, both the 12mer and 14mer CI-hybrid wheels would have enough binding 
positions to allow binding. It is possible that the extent of DNA clashes differs between the 186 CI 
wheel and CI-hybrid wheel. The linker between the DNA binding domain and CTD of the 186 CI 
protein is significantly longer than the CI-hybrid protein. As will be explained below, this longer linker 
may allow for the DNA to sit even higher or lower than the plane of the wheel compared to the CI-
hybrid protein. This arrangement may eliminate DNA clashes that still exist in the CI-hybrid wheel.  
In 186 CI, if the NTDs sat above and below the plane of the wheel, the DNA could follow an 
“oscillatory” trajectory around the wheel, allowing even longer pieces of DNA wrapping around the 
wheel. This arrangement may be the method 186 CI uses to alleviate steric clashes between the 
entry and exits points of the DNA into the well (Figure 4-14). 186 CI can bind two distinct half sites 
and bind to operators with variable spacing, as explained in Chapter 1. The flexible positioning of the 
DNA binding domains in terms of distance from the centre of the wheel and its position above or 
below the plane of the wheel may contribute to its ability to bind different arrangements of 
operators.  
Changing the number of subunits in the wheel will alter the internal cavity diameter, the symmetry 
and curvature of the wheel. Changing the curvature of the wheel would affect the length of DNA that 
can wrap around the wheel. To estimate the amount of DNA that will wrap around a single wheel 
(Figure 4-11 species a), a structural model of the CI wheel was created based on the hybrid wheel 
structure and the crystal structure of the 186 CI dimer. A DNA molecule was traced around the wheel 
to approximately match the diameter (Figure 4-13A). This modelled DNA was 164 bp. The linker 
connecting the DNA binding domain to the oligomerization domain is flexible, thus the true diameter 
of the wheel could be marginally larger or smaller than the model. Wang et al. (Wang et al., 2013) 
measured by AFM an average of 180 bp wrapping around the wheel.  This could be the result of the 
NTD domains extending slightly further away from the wheel centre. The DNA modelled to wrap 
around the wheel lies fully in the plane of the wheel. This would create the aforementioned steric 
clashes when DNA enters and exits the wheel (Figure 4-13B). Modelling an oscillatory DNA trajectory, 
as depicted in Figure 4-14, to avoid DNA clashes would predict a longer piece of DNA would be 






Figure 4-13 – Model of DNA wrapping around a 186 CI wheel. (A) Model of dodecameric CI wheel 
constructed through superimposing the CI-NTD (PDB 2FJR) onto the hybrid wheel structure. 164 bp 
DNA was modelled to wrap around the wheel using GraphiteLiteExplorer (Hornus et al., 2013). (B) 
DNA was modelled in the plane of the wheel. The model predicts that binding in this manner would 




Figure 4-14 – DNA wrapping around the CI wheel could adopt an oscillatory conformation, resulting 
in more DNA wrapped than if the DNA wrapping was fully in the plane of the wheel. The 
conformation could also circumvent steric clashes between the DNA entry and exit points. DNA and 
CI wheel are depicted as a blue line and cylinder, respectively.  
4.5 Conclusions 
The immunity repressor CI from bacteriophage 186 presents a new mechanism of regulating lytic and 
lysogenic transcription in a temperate bacteriophage that shows differences to the conventionally 
studied bacteriophage λ. This mechanism utilises DNA looping onto a wheel scaffold and the relief of 
transcriptional interference to activate the lysogenic promoter. To validate this model, structural 
characterization of a CI-hybrid protein was conducted and strongly suggests that 186 CI adopts a 
dodecamer wheel in vitro, rather than the previously proposed tetradecamer wheel. This 
oligomerization complex does not contradict the DNA looping model of regulation proposed by 
Pinkett et al. (2006) and Wang et al. (2013). Further studies are required to determine the 
quaternary structure of 186 CI in the presence of DNA.  
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5 CONSTRUCTION OF TEMPERATURE SENSITIVE 
EXPRESSION SYSTEMS 
The following chapter describes the development of new temperature sensitive expression systems 
for E. coli. In this manuscript, we characterize temperature sensitive mutants of the 186 CI immunity 
repressor and CI-hybrid repressor. These proteins were structurally characterized in Chapter 3 and 
Chapter 4, respectively. Two new temperature sensitive expression systems were developed based 
around these repressors and temperature sensitive expression was successfully demonstrated. This 
manuscript was written with the intention to submit to Journal of Biological Engineering or ACS 
Synthetic Biology. I performed all the experiments described, analysed the data, prepared figures for 
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Abstract 
The λ cI857-pRM-pR system provides temperature-induced gene expression, relying on a temperature-
sensitive mutant of the λ cI protein. Two alternative temperature-sensitive transcriptional repressors 
are characterized in this study. The CI immunity repressor from bacteriophage 186 also has a 
thermolabile mutant CIG22R. A lacZ in vivo reporter gene assay showed that the protein tightly 
repressed its cognate promoters at 30°C, but lost activity at temperatures 37°C-40°C. A temperature-
sensitive chimeric repressor containing domains from both the λ and 186 CI proteins is also 
described. This protein, the hybridts, allows for temperature-controlled repression of the λ pR 
promoter and responds more rapidly to elevated temperatures than cI857. Two self-contained 
expression systems 186 CIG22R-pR-pL and hybridts-pRM-pR, analogous to the cI857 system, showed 
comparable temperature-induced gene expression to the cI857 system. At 37°C, both the CIG22R and 
hybridts systems display high promoter activity compared to λ cI857, which may be desirable for 
applications that wish to avoid initiation of the E. coli heat shock response.  
Introduction   
Inducible promoters have been extensively employed for regulated gene expression in bacteria for 
applications such as protein overexpression, synthetic gene circuits, and controlling metabolic 
pathways. Several temperature-sensitive expression systems have been developed that use elevated 
temperatures as the signal to induce gene expression (Hasan and Szybalski, 1995; Terpe, 2006). 
These expression systems avoid several of the major pitfalls of chemically inducible systems, which 
use an added ligand as the induction signal. Inducers such as IPTG (used in the lac repressor system 
(Gronenborn, 1976; Simons et al., 1987)) can be expensive which limits their application for large 
scale production. For the industrial production of therapeutic products, chemical inducers such as 
IPTG and antibiotics also present a potential biohazard and must be removed from the final product 
(Andrews et al., 1996; Lee and Keasling, 2008). In addition, thermo-regulated systems are scalable to 
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large fermenters as culture temperatures are externally adjustable, with an associated reduced risk 
of contamination from the addition of inducer solution. 
Many temperature inducible systems employ a thermolabile mutant of the λ immunity repressor cI 
called cI857 (Lieb, 1966; Valdez-Cruz et al., 2010). Applications of cI857-controlled gene expression 
include protein overexpression (Cheng et al., 1984; Yoakum et al., 1982), toggle switches (Gardner et 
al., 2000) and chromosomal integration of DNA (Haldimann and Wanner, 2001). The cI857 protein is 
active and effectively represses the λ pL and pR promoters at permissive temperatures around 28-
30⁰C. Raising the temperature to 40-42⁰C inactivates the protein, allowing pR and pL to exhibit strong 
promoter activity (Sussman and Jacob, 1962; Villaverde et al., 1993).  
A common implementation of λ cI857 in a inducible expression system is the λ cI857-pRM-pR 
expression system (Jechlinger et al., 2005), which utilizes the natural bacteriophage λ genomic 
architecture. The gene of interest is placed under the control of the λ pR promoter. The divergently 
orientated λ pRM promoter drives the expression of cI857. Between these promoters lie the OR1, OR2 
and OR3 operators, which regulate the activities of these two promoters (Meyer and Ptashne, 1980; 
Ptashne, 1986). A λ cI repressor tetramer binding to OR1 and OR2 represses pR and activates pRM 
through stabilizing contacts with RNA polymerase positioned at that promoter. When cI levels are 
high, the repressor binds to the low affinity OR3 to reduce repressor production (Meyer and Ptashne, 
1980; Ptashne et al., 1980). In this setup, cI857 positively and negatively autoregulates its own levels 
and is inactivated at high temperatures to allow expression of the gene of interest. 
λ cI857 systems has one main drawback for production-based applications. Effective inactivation of λ 
cI857 requires temperatures above 37°C which places undesirable physiological stresses on 
Escherichia coli-based systems. The heat stress can exacerbate protein misfolding during expression, 
leading to increased inclusion body formation and proteolysis (Georgiou et al., 1994; Schein, 1991). 
The bacterial heat shock response is also triggered, which can also negatively impact the quantity, 
quality and stability of protein produced. This response, under the control of the alternative signal 
factor σ32 (Grossman et al., 1984), imposes a metabolic burden by diverting resources towards the 
synthesis of molecular chaperones and heat shock proteins (Hoffmann and Rinas, 2001). For 
example, transferring cultures from 30°C to 42°C for 5 minutes resulted in the upregulation of five 
representative heat shock proteins (such as GroEL) to the point they constitute about 20% of 
intracellular protein (Yamamori et al., 1978). Upregulated protein synthesis under heat shock can 
deplete intracellular amino acid pool, upregulate protease activity, and trigger the stringent 
response. Depending on the protein, the upregulated proteases could be detrimental to obtaining an 
intact product. In the stringent response, translational machinery is downregulated to limit protein 
production capacity. Thus, it would be useful to have inducible expression systems that respond to 
lower temperatures, where the promoters are active at 37°C.  
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Additionally, many artificial gene circuits employ the same set of transcriptional regulators, namely, 
tetR, lacI, λ cI and araC (Brödel et al., 2016; Elowitz and Leibier, 2000; Gardner et al., 2000; Singh, 
2020; Stricker et al., 2008). cI857 cannot be utilized in such systems already expressing λ cI, as the 
non-temperature sensitive repressors would repress the promoters at the restrictive temperatures. 
Alternative temperature inducible systems that do not cross-react with these commonly used 
transcriptional regulators would expand the toolkit available for building increasingly complex gene 
circuits.   
Thus, a thermo-regulated inducible system, unrelated to the common set of transcriptional 
regulators, that can achieve high induction of gene expression without invoking heat stress 
responses would be valuable. We hypothesized that 186 CIG22R may be a suitable candidate repressor 
to use in such a system.  Originally isolated by Baldwin et al (1966), 186 CIG22R is a temperature 
sensitive mutant of the bacteriophage 186 immunity repressor, with a glycine 22 to arginine 
substitution, that represses its cognate 186 pR promoter at permissive temperatures (Dodd et al., 
1990; Lamont et al., 1993). It is further hypothesized that due to the highly cooperative nature with 
which 186 CI binds its operator DNA (Dodd and Egan, 1996), it may be more rapidly inactivated by 
temperature upshifts. 
λ cI and 186 CI both consist of two structurally independent domains, a N-terminal DNA binding 
helix-turn-helix (HTH) containing domain and a C-terminal oligomerization domain. Pinkett et al. 
(2006) has previously created a hybrid repressor protein by replacing the oligomerization domain of 
λ CI, which can form octamers, with the oligomerization domain of 186 CI, which can form even 
higher order structures. This chimeric repressor protein is proposed to cooperatively oligomerize like 
186 CI and yet remains able to repress the lambda pR promoter. Thus, replacing the oligomerization 
domain of λ cI857 with the 186 CI oligomerization domain may create a highly cooperative 
temperature sensitive repressor with a lower restrictive temperature, than λ cI857. 
In this study, we constructed two thermo-regulated systems based on these two repressors and 
demonstrate that they are practical alternatives to the λ cI857-pRM-pR system. These systems have 
different temperature response profiles, which could be beneficial when optimizing applications that 
utilize the λ cI857-pRM-pR inducible expression system. 
Results 
186 CIG22R gradually loses activity from 30°C to 40°C 
To characterize the activity of 186 CIG22R at different temperatures, a series of lacZ reporter assays 
were conducted. The CI repressor and its temperature sensitive variant were expressed from an IPTG 
inducible plac promoter on a low copy number plasmid. The ability of the 186CI protein variants to 
repress the 186 pR promoter were tested in the reporter strain KS980 (Figure 5-1A). This strain  
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contains the lacZ reporter gene under the control of the 186 pR promoter, without the FL and FR 
flanking sites that normally enhance the efficiency of CI repression on 186 pR (Dodd and Egan, 2002).  
A range of IPTG concentrations between 0-200 µM was used to produce a range of repressor levels in 
vivo. As expected, wildtype 186 CI repressor could efficiently repress 186 pR, reducing pR activity to 
1-2% of unrepressed promoter activity levels at the 200 µM IPTG at each of the tested temperatures. 
In contrast, a gradual loss of repression of pR by 186 CIG22R was observed as the temperature 
increased (Figure 5-1B). The slightly reduced promoter activity in the absence of IPTG is consistent 
with incomplete LacI repression of the plasmid plac (Penumetcha et al., 2010). At 30°C, CIG22R shows 
comparable activity to 186 CI, repressing pR to 14 lacZ units at 200 µM IPTG. At 37°C and 40°C, there 
is a substantial drop in the observed pR repression by CIG22R to 150 and 290 lacZ units, respectively, at 
200 µM IPTG. While these results confirm the temperature sensitive nature of the G22R mutation, 
some activity remains at 40°C. 
The effect of the G22R mutation on a C-terminally His6-tagged version of the 186 CI was also tested. 
This protein has a C-terminal thrombin cleavage tag followed by a hexahistidine tag and was 
previously studied by Pinkett et al (2006), where they solved the crystal structure of the protein. The 
G22R mutation also confers thermolability on the tagged protein (Figure 5-2B). The untagged protein 
displays increased repression activity over the tagged version, even at 30°C, suggesting the His6 tag 
partly impairs protein function or reduces protein levels in vivo.   
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Figure 5-1 – In vivo lacZ reporter assays demonstrate that 186 CIG22R is a thermolabile protein that gradually loses the ability 
to repress its cognate promoter 186 pR as temperature increases from 30°C to 40°C. A) pR:lacZ reporter strain used to 
measure activity of 186 CI protein variants, KS980 = NK7049 (λRS45lacZΔYA-pBC2-HincII–SnaBI FL−pR+pL+FR−) carries a 
chromosomally integrated single copy of the pR:lacZ fusion (Dodd and Egan, 2002). Diagram based on figure by Pinkett et al 
(2006). B) At 30°C, 37°C and 40°C, 186 CI represses pR FL- FR- efficiently. At 30°C (top), 186 CIG22R shows similar pR repression 
as wildtype CI. At 37°C (middle) and 40°C (bottom), 186 CIG22R markedly reduced repression of pR compared to wildtype CI, 




Figure 5-2 - The G22R amino acid substitution makes a His6-tagged 186 CI thermolabile, with reduced pR repression as 
temperature increases from 30°C to 40°C. A) pR:lacZ reporter strain used to measure activity of 186 CI protein variants, 
KS980 = NK7049 (λRS45lacZΔYA-pBC2-HincII–SnaBI FL−pR+pL+FR−) carries a chromosomally integrated single copy of the 
pR:lacZ fusion (Dodd and Egan, 2002). Diagram based on figure by Pinkett (2006). B) 186 CIG22R-His6 loses activity in the 
order of 30°C (top), 37°C (middle) and 40°C (Bottom). Data error bars are 95% confidence intervals. The sample sizes for 
empty vectors and CI variants were n ≥ 6 and n ≥ 8, respectively. 
The observed loss of function of CIG22R in vivo may arise from changes in CIG22R production or 
degradation in the cell in response to elevated temperatures. A reduction in the steady state levels of 
the CIG22R protein in the cell would lead to pR derepression. To investigate this possibility, the steady 
state levels of thermolabile and wildtype CI were quantified in vivo via western blotting (Figure 5-3). 
At all temperatures tested between 30°C-40°C, 186 CI and CIG22R can be observed on the blot. CIG22R 
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did not show reduced levels relative to wildtype as temperature increased. This result suggests that 
CIG22R inactivation is not based around proteolytic degradation.  
 
Figure 5-3 –Western blot analysis of 186 CI and 186 CIG22R steady state levels in pR FL- FR- reporter strains. A) Representative 
western blot image showing the level of expression of CI and CIG22R. B) Densitometric analysis showing the CI:CIG22R ratios at 
30°C, 37°C and 40°C. CIG22R levels do not preferentially decrease relative to wildtype at higher temperatures. Sample size was 
n=3 and error bars represent the 95% confidence interval. Changes in CI:CIG22R ratios between the temperatures were found 
to be not statistically significant. Significance was evaluated by a paired one-tailed Student’s t-test on the log10 transformed 
data. 
186 CIG22R-pR-pL system provides comparable temperature-inducible gene expression to λ 
cI857-pRM-pR system 
The natural genomic architecture of 186 was used as a model to design an inducible expression 
system equivalent to the λ cI857-pRM-pR system. In both bacteriophage λ and 186, the immunity 
repressor is expressed from the lysogenic promoter λ pRM and 186 pL, respectively. Both repressors 
act to repress transcription from a lytic promoter that drives transcription in the opposite direction 
as the lysogenic promoter. These promoters, λ pL and 186 pR, respectively, are situated close to the 
lysogenic promoter. A key difference between the two bacteriophages is that 186 uses a convergent 
promoter arrangement whilst λ uses divergent promoters.  
In this 186 CIG22R-pR-pL system, the expression of 186 CIG22R is driven by the 186 pL promoter. Raising 
the temperature of the system should inactivate 186 CIG22R and allow expression of the gene of 
interest from 186 pR. Furthermore, promoter activity from pR would reduce 186 pL activity due to 
transcriptional interference (Callen et al., 2004), further reducing 186 CIG22R gene activity. To test this 
proposed system, a genome-integrated reporter was constructed (Figure 5-4A). In this reporter, the 
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natural cI-pR-pL-apl layout of the 186 pR and pL promoters is retained, including the FL/FR flanking 
sites. FL and FR are CI operators ~300 bp either side of the 186 pR and pL promoters that aid 
repression of pR by CI, and increase the activity of pL. In this arrangement, 186 CIG22R is under the 
control of pL and a lacZ reporter gene is placed downstream of pR, following the apl gene mutated to 
inactivate its DNA binding function (aplHTH-), and avoid Apl repression of 186 pR and pL (Cutts et al., 
2020; Dodd et al., 1993). A control reporter carrying a cIHTH- mutant was also constructed.   
An analogous reporter construct was made to test λ cI857 in the same system (Figure 5-4B). The 
thermolability of λ cI857 arises from a single amino acid substitution A66T in the N-terminal domain 
of λ cI (Lieb, 1981). In the λ reporter construct, the natural λ cI-pRM-pR-cro layout is retained, with a 
lacZ reporter gene placed downstream of cro and thus under the control of the pR promoter (the λ 
tR1 terminator is removed). The cro gene, croHTH-, encodes a mutant λ cro protein defective in 
binding DNA, to prevent it from repressing pR and pRM  (Schubert et al., 2007). The lacZ reporter gene 
has the same ribosome binding site as the lacZ reporter gene in the 186 CIG22R construct to keep the 
constructs comparable. λ cI857 repressor is under the control of pRM. The OL operators, normally 2.3 
kb upstream of pR, were included to allow for λ CI positive and negative autoregulation via DNA 
looping (Dodd et al., 2004, 2001; Lewis et al., 2011).  
Both the 186 CIG22R-pR-pL and λ cI857-pRM-pR systems showed tight repression of the 186 and λ pR 
promoters at 30°C, and strong temperature induction in the in vivo reporter gene assays (Figure 5-4A 
and B). Maximal induction occurred at the highest temperature tested (40°C), with all constructs 
measuring >88% unrepressed promoter activity (Figure 5-4C). LacZ expression from λ pR was stronger 
than 186 pR at all the temperatures tested, possibly reflective of intrinsic differences in λ pR and 186 
pR promoter strengths. Both unrepressed promoter activities were observed to increase in activity 
with temperature. This effect was more pronounced with the 186 pR promoter, which increased from 




Figure 5-4 –186 CIG22R-pR-pL, λ cI857-pRM-pL, and hybridts-pRM-pR constructs display temperature inducible promoter 
expression as temperature increases from 30°C to 40°C.  
A) Top: 186 pR:lacZ reporter constructs was created to measure the temperature inducibility of a 186 CIG22R-pR-pL system. 
The natural arrangement of 186 pR-pL is retained, with CIG22R under the control of 186 pL. 186 CIHTH- (186 CIS37R/S38E) contains 
mutations in the HTH motif to abolish DNA binding, to allow measurement of unrepressed 186 pR activity. Bottom: 186 pR in 
the 186 CIG22R construct displays tight repression at 30°C (1.1 lacZ units), with promoter induction temperature increases to 
40°C.  
B) Top: λ pR:lacZ reporter constructs were created to measure the of temperature inducibility of λ cI857-pRM-pL and hybridts-
pRM-pR systems. These constructs use the natural arrangement of pRM-pL from λ. λ cI857HTH-(λ cI857Q34R/S34E) contains 
mutations in the HTH motif that abolish DNA binding, allowing measurement of unrepressed pR activity. Bottom: λ pR in the 
cI857 and hybridts construct shows temperature dependent derepression as temperature increases from 30°C to 40°C. At 
30°C, cI857 and hybridts constructs measured 1.2 and 3.8 lacZ units, respectively. The hybridts shows 2.3 fold greater 
derepression at 37°C than λ cI857.  
Error bars in (A) and (B) represent 95% confidence interval (n≥6 for unrepressed promoter measurements and n≥8 for the λ 
186 CIG22R, λ cI857 and hybridts measurements). Data points at 40°C with overlapping error bars have been staggered to 
improve readability.  
C) Ratio of promoter expression by CIG22R, λ cI857 and hybridts constructs to inactive repressor constructs. All three constructs 
are well repressed at 30°C and significantly derepressed at 40°C. At 37°C, the 186 CIG22R and hybridts constructs display 
substantially more derepression than the cI857 construct. Error bars represent 95% confidence intervals, calculated through 
the error propagation from measurements from (A) and (B). Statistical significance was evaluated by a paired one-tailed 
Student’s t-test on the log10 transformed data (*** denotes p<0.001). 
Importantly, the 186 CIG22R constructs produced significantly greater promoter activity at 37°C 
compared to the cI857 construct. This was true in terms of absolute units and relative to unrepressed 
promoter activity (Figure 5-4A and B). 
Hybridts protein provides temperature-controlled expression in pRM-pR systems 
The λ-186 CI-hybrid repressor described by Pinkett et al. (2006), is a fusion between the N-terminal 
DNA-binding domain of λ CI (amino acids 1-92) to the C-terminal oligomerization domain of 186 CI 
(amino acids 83-192). This protein was shown to repress λ pR and activate λ pRM, with both processes 
enhanced by OL (Pinkett et al., 2006). It was hypothesized that adding the cI857 amino acid 
substitution to the λ CI domain would confer temperature sensitivity to the CI-hybrid repressor. To 
test if this protein, named the hybridts repressor, could be used to provide temperature induced 
protein expression, the λ pR reporters were modified by replacing the λ cI857 gene with the hybridts 
gene (Figure 5-4B). 
Surprisingly, the hybridts repressor reporter behaved more similarly to the 186 CIG22R reporter in its 
temperature response than the λ cI857 repressor, whose mutation it carries, being more than 60% 
induced at 37°C (Figure 5-4C). Its fractional induction at 40°C was similar to the other repressors, 




New temperature inducible systems have practical applications 
The use of λ cI857 for temperature inducible expression has two main advantages. The first 
advantage is induction can easily be controlled. Increasing the temperature from 30°C to 42°C in an 
incubator or fermenter is sufficient to achieve maximal induction. This makes temperature induction 
scalable for large scale commercial applications. One caveat is that in large scale bioreactors, the rate 
of temperature change in the culture can be throttled by heat transfer limitations, as heating rate 
decreases as the fermenter size increases (Caspeta et al., 2009). Temperature inducible expression is 
particularly relevant for industrial and pharmaceutical applications as it does away with expensive 
and/or toxic inducer compounds. Furthermore, when fully derepressed, pR and pL act as strong 
promoters. The second advantage is that λ cI857 works in a wide variety of bacterial systems. Besides 
E. coli, λ cI857 has been tested and shown to work in many bacterial species including Bacillus 
subtilis, several species of Pseudomonas, Salmonella enterica, Klebsiella pneumoniae and Serratia 
rubidae (Breitling et al., 1990; Jawale et al., 2012; Winstanley et al., 1989).  
Different applications have different temperature requirements. This is an important consideration 
when deploying a temperature inducible system.  As an example, bacterial ghost vaccine candidates 
have been generated via λ cI857-based temperature inducible expression of the phiX174 lysin gene E 
in bacteria (Jawale et al., 2012; Jechlinger et al., 2005). However, this approach, when using the 
traditional λ cI857-pRM-pR requires growing cells below the permissible temperature of 30°C which 
may be suboptimal or not possible for organisms such as Helicobacter pylori. To address the needs of 
this application, Jechlinger et al. (2005) developed an altered pRM-pR promoters that could be 
extremely well repressed up to 37°C and 39°C. However, some applications have the opposite 
temperature requirement. Overexpression of protein in E. coli can often result in proteins 
sequestered into insoluble inclusion bodies. Higher induction temperatures can favor aggregation, 
with lower induction temperatures often promoting soluble protein expression (Kaur et al., 2018; 
Sørensen and Mortensen, 2005). Physiological responses from heat shock can also further 
compromise yield (Valdez-Cruz et al., 2010). Biosynthetic fermentations often benefit from growth at 
lower temperatures, as enzymes involved in the fermentation can have a shorter half-life at higher 
temperatures, causing decreased yields (Jiang et al., 2013).  Thus, in these cases, a higher degree of 
de-repression at lower temperatures and avoiding heat shock would be advantageous. To answer the 
needs of applications requiring lower restrictive temperatures, two alternative temperature sensitive 
repressors that may be inactivated at lower temperatures were investigated. These repressors were 
a mutant of the 186 immunity repressor, 186 CIG22R, and a hybridts repressor.  
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The activity of 186 CIG22R was measured in vivo via a lacZ reporter assay. The repressor expressed 
from a plasmid under the control of an IPTG inducible promoter. This protein is active at 30°C and 
gradually loses activity as temperature increases to 40°C. The dynamic range of the pR FL- FR- 
promoter (ratio of induced to uninduced promoter activity) in this setup is 20.3 ± 5.6.  
The activities of 186 CIG22R, hybridts and λ cI857 were tested in single integrant chromosomal reporter 
constructs. An advantage of these systems is that all the elements required for heat inducible 
expression were present on a single DNA construct, simplifying the molecular cloning required to 
apply these to applications.  The λ cI857 and hybridts constructs have identical λ pRM-pR promoter 
layouts and both proteins contain the λ cI NTD with the same temperature sensitive mutation, yet 
their temperature response differs. At 30°C, λ cI857 and the hybridts repressor keep the λ pR 
promoter well repressed at 0.8% and 2.5% of unrepressed pR levels, respectively. At 37°C, the 
hybridts repressor loses significantly more activity relative to λ cI857, at 68% unrepressed pR activity 
compared to 30% unrepressed pR activity, respectively. At 40°C, the pR promoter in the λ cI857 and 
hybridts constructs are close to maximum induction levels at 91% and 87% of unrepressed pR activity.  
The hybridts protein represses the same pR promoter and thus can substitute for λ cI857 in many λ pR-
based systems. This can potentially be utilized for the optimization of new and existing temperature 
inducible systems based around λ cI857. The higher induction levels at 37°C could be useful in 
systems described earlier that would benefit from avoiding heat shock stress.  
186 CIG22R also demonstrated characteristics of a practical temperature sensitive repressor. At its 
permissive temperature of 30°C, it keeps its cognate promoter 186 pR well repressed, to levels similar 
to wildtype protein (Figure 5-1A). It loses activity gradually as the temperature approaches 40°C. 
When implemented into a single DNA construct, the 186 CIG22R-pR-pL system displayed temperature 
inducible gene expression. Expression from 186 pR at 30°C is well repressed at 1.1 ± 0.4 lacZ units, 
comparable to λ cI857-pRM-pR at 1.2 ± 0.3 lacZ units. At 37°C, the 186 pR promoter has largely 
been derepressed and displays 1.5 fold more promoter activity than the λ cI857 system. At 
40°C, the 186 pR promoter is almost completely unrepressed.  
186 CIG22R presents a practical alternative to λ cI857 systems. One advantage is that it acts on 
186 lytic promoters and can be used in many of the biological systems that already employ λ cI 
repressor with the λ pL, pR and pRM promoters, where λ cI857 could not be used. The 186 CIG22R-
pR-pL system, like the hybridts system, has the same improvement over the λ cI857 system 
where it can achieve higher levels of induction at 37°C. Both 186 CIG22R and the hybridts proteins 
contain the 186 CI oligomerization domain that mediates the formation of a 12mer wheel, as a 
hexamer of dimers  (unpublished data). This increased rate of loss of activity with increasing 
temperature in 186 CIG22R and the hybridts repressor may be due to differences in oligomerization of 




Figure 5-5 – The oligomeric organization of λ cI, 186 CI and λ-186 CI-hybrid repressor. A) λ cI dimers binds to the stronger 
OL1, OL2, OR1, OR2 sites on the DNA. Tetramers form at these sites, and can further form an octamer, mediated by DNA 
looping. B) 186 CI and the λ-186 CI-hybrid oligomerize via the 186 CI oligomerization domain. These proteins form dimers, 
followed by subsequent oligomerization into a wheel-like arrangement, proposed to be a hexamer of dimers.   
Insights into the mechanisms of temperature sensitivity 
This study also provides some insight into the mechanism of thermolabile DNA binding 
repressor proteins. The N-terminal domain (NTD) and C-terminal domain (CTD) of λ cI thermally 
unfold independently from each other, with melting temperatures at 54°C and around 73°C, 
respectively (Pabo et al., 1979; Sauer et al., 1990). The λ cI NTD consists of 5 helices, with 
helices 2 and 3 forming the DNA-binding HTH motif. The A66T mutation in the N-terminal 
domain helix 4 (Figure 5-6) lowers the melting temperature of the NTD to 42°C (Hecht et al., 
1984). It is believed that the mutation partially disrupts the hydrophobic core of the NTD to 
increase the thermolability of the domain (Hecht et al., 1984; Sauer et al., 1990). The A66T 
mutation sits at the end of helix 4 in the DNA binding domain, close to helix 5. Helix 5 -helix 5 
contacts are involved in the weak dimerization of the NTD, with the CTD mediating strong 
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dimerization and subsequent high order oligomerization of the protein (Sauer et al., 1990). 
Thus, conformational changes of the N-terminal domain with the A66T mutation at high 
temperatures may also impair proper alignment of the HTH motifs for operator binding.  
The temperature sensitivity of both the λ cI857 and the hybrid-ts repressors is most consistent 
with the N-terminal domain unfolding or a loss of correct NTD alignment for binding the λ 
operators. It seems unlikely that the same mutation acts by causing dissociation of the λ CI CTD 
and the 186 CI CTD. One possible explanation for the hybrid-ts protein losing activity at lower 
temperatures than λ cI857 is that λ cI multimerization to tetramers and octamers is facilitated 
by DNA binding (Dodd et al., 2001; Lewis et al., 2011; Senear et al., 1993). The DNA should 
select for active dimers from the pool of λ cI857, and may thus effectively select for active DNA -
bound tetramers and octamers. Therefore, repression of pR may be able to remain strong in the 
presence of inactive CI monomers. In contrast, atomic force microscopy of 186 CI suggests that 
wheel oligomers may form prior to binding DNA (Wang et al., 2013). Thus, it could be possible 
that incorporation of a smaller proportion of monomers with inactive DNA binding domains 
would compromise the highly cooperative DNA binding ability of a large proportion of the 
wheels. 
The 186 CI G22 residue lies just after the first helix of the NTD. It is not known why the G22R 
mutation causes temperature sensitivity, though a reduced melting temperature or impaired 
NTD dimerization seem likely. Dimerization of the NTD appears weak, as the NTDs were not 
dimerized in the crystal structure of the full length CI dimer (Pinkett et al., 2006), and NTD 
association constant was measured to be at least 104 weaker than the full length protein 
(Shearwin et al., 2002). The 186 CI NTD shares structural similarity to the NTD of λ cI. The 186 CI 
NTD also consists of five helices. Helices 2 and 3, like λ cI, form the HTH motif (Pinkett et al., 
2006). Interestingly, the λ cI protein also has a temperature sensitive mutation T22H (Hecht et 
al., 1984), near the end of the first helix like G22R from the temperature-sensitive mutant of 
186 CI (Figure 5-6). These mutations to positively charged amino acids in this area of the domain 
may moderately disrupt the hydrophobic core of the domain to decrease melting temperatures. 
If the CIG22R NTD unfolds at 40°C, it does not change the in vivo steady state levels of CI, 
suggesting that the NTD unfolding does not encourage proteolysis.  
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Figure 5-6 – Temperature sensitive mutations mapped onto the structure of the 186 CI NTD (PDB ID: 2FJR; (Pinkett et al., 
2006)) and  λ cI NTD (PDB ID: 3BDN; (Stayrook et al., 2008))   Mutation sites are shown in black. Structures were visualized In 
PyMOL (Schrödinger, LLC, 2010). 
Despite the knowledge that thermolability can arise from amino acid substitutions that disrupt 
the hydrophobic core of a protein (Varadarajan et al., 1996), rational design of thermolabile 
proteins is not always straightforward. TSpred is an online server that uses hydrophobic 
moment and residue depth into the protein core to predict residues that when mutated may 
confer temperature sensitivity (Tan et al., 2014). In this study, two buried hydrophobic residues 
(V148 and V185) in the CTD of 186 CI were chosen by TSpred and reporters carrying mutations 
at these positions created. However, the resulting 186 CI repressors were functional and were 
not temperature sensitive (data not shown). 
Concluding remarks 
Many applications such as overexpression of protein, reprogramming of metabolic pathways 
and synthetic gene circuits require controllable promoters and the optimization of growth 
conditions such as temperature. This work has expanded the tunable promoter expression 
systems available for biologists, allowing for greater fine tuning of promoter activity across the 
30-42°C temperature range.  
Methods and Materials 
Plasmids and bacterial strains 
Bacterial strains used in this study are summarized in Table 5-1. Plasmids used in this study are 
summarized in Table 5-2.  
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Table 5-1 – E. coli strains used in this study.  
Strain Genotype Notes Reference 
E4300 NK7049 (ΔlacIZYA)X74 
galOP308 StrR Su−] 
Strain used for lacZ assays with IPTG 
inducible repressors 
Simons et al. (1987) 
KS980 E4300(λ∆YA pBC2 
HincII-SnaB1) FL- FR- pR 
lacZ pUHA-1 
Reporter strain with lacZ reporter 
gene under the control of pR without 
186 flanking sites. pUHA-1 plasmid 
constitutively provides lac repressor 
for inducible expression of repressor 
proteins 
Dodd and Egan 
(2002) 
E4643 MG1655 rph+ ΔlacIZYA Self-contained temperature-sensitive 
modules were integrated into the 
bacterial chromosome of this strain 




Strain to test temperature-sensitive λ 
cI857-pR-pRM system 
Self-contained temperature sensitive 







Strain to test temperature-sensitive 
hybridts-pR-pRM system 
Self-contained temperature sensitive 






Control strain with inactive λcI857 
λcI857 gene has mutations in the HTH 
motif to inactivate DNA binding 
 
Control module is integrated into the 




pL apl- lacZ] 
 
Strain to test temperature-sensitive 
CIG22R-pR-pL system 
Self-contained temperature sensitive 





Control strain with inactive 186 cI 
186 cI gene has mutations in the HTH 
This work 
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pR pL apl- lacZ] motif to inactivate DNA binding 
Control module is integrated into the 
lambda attachment site 
 
Table 5-2 – Plasmids used in this study 






Low copy vector to allow 
IPTG-inducible expression of 
various CII and CII-derivatives 
from the plac promoter 
Amino acid mutations are 
written in superscript 
His6 indicates a C-terminal 
hexahistidine tag was present 
on the protein 






and this work 
pZS35-empty Low copy vector used as no 
CI control in lacZ assays 






pUHA-1 Used to constitutively supply 
lacI from plac promoter in lacZ 
assays 
p15a ori; kanamycin 
resistance; wildtype lacI 
















λ CI(HTH-) and 186 CI(HTH-) 
are repressors that have 
mutations in the DNA binding 




resistance; can be 






pR pL apl- lacZ 
pIT3_CL_186CI(HTH-) 
pR pL apl- lacZ 
 
Characterisation of 186 CIG22R 
A series of lacZ assays were performed to determine how the repressor activity of 186 CIG22R changes 
with temperature. Escherichia coli strain used for lacZ assays was KS980 (Table 5-1). This reporter 
strain provided a pR FL- FR- promoter to test the activity of the 186 CIG22R protein at different 
temperatures.  The CI and 186CIG22R expression plasmids were constructed using the modular pZ 
system (Lutz and Bujard, 1997). Strains not expressing CI possessed an empty vector. Vectors pZS*35 
186 CI, pZS*35 186CIG22R and pZS*35 empty were used to allow inducible expression of 186 CI, 186 
CI-His6, 186 CIG22R, 186 CIG22R-His6 and no CI under the control of the IPTG inducible plac promoter.  
Western blots of CIG22R 
KS981 cells habouring pZS*35 empty, pZS*35 CI-His6, pZS*35 CIG22R-His6 were grown in LB 
supplemented with 30 µg/mL chloramphenicol, 50 µg/mL kanamycin and 100 µM IPTG at 30°C, 37°C 
and 40°C to mid-log phase. Cells were lysed using BPER (ThermoScientific) and Benzonase (2.5 
units/µL) (Novagen) and cell extracts run on a Bio-Rad Any kDa Criterion TGX gel in Tris-glycine 
running buffer. Protein bands were transferred to a PVDF membrane using a TransBlot Turbo 
Transfer system (Bio-Rad) and TransBlot Turbo Transfer Pack PVDF (Bio-Rad). Membranes were 
blocked using 5% BSA. 186 CI primary detection was with rabbit polyclonal antibody raised against 
purified 186 CI. Secondary antibody used to probe for 186 CI antibody was goat anti-rabbit IgG Cy5-
labelled ECL plex secondary antibody (GE Healthcare). Dried membranes were scanned using the 
Chemidoc imaging system (Bio-Rad) and images analysed by ImageJ. (Breitling et al., 1990) 
Single copy integrants for self-contained temperature based expression system 
All constructs were integrated in single copy in the chromosome of E4643  (MG1655 rph+ ΔlacIZYA) 
(Cui et al., 2013), at the λ attB site using the method described in Priest et al (2014).   
The self-contained 186 CIG22R temperature-based expression module was a pIT3_CL_186_CIG22R pR pL 
apl- lacZ reporter. The plasmid contained the 186 cI-pR-pL-apl-cII region with a lacZ reporter gene as 
a translational fusion to the first amino acid of CII. The apl gene has been mutated to introduce the 
E28R, R29E, R33Q mutations into the helix-turn-helix region of Apl to inactivate its DNA binding 
activity. To measure the unrepressed pR promoter activity of the self-contained module at different 
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temperatures, 186 CI was substituted with an inactive mutant of 186 CI. This CI mutant CIS37R/S38E had 
amino acid substitutions in the helix-turn-helix DNA binding motif .  
An equivalent temperature-based module was constructed for λ cI857. This was constructed by 
Gibson assembly of two synthesized G-blocks (IDT) into a BamHI/XmaI-digested 
pIT3_CL_lacZtrimfuse. One fragment contains the _OL_UP_timm_cI857 sequence, with the natural λ 
architecture. The other fragment contains cro_pR_pRM_cI-NTD. Additional details are provided in 
Supplementary Methods.  
A temperature sensitive chimeric repressor was designed based on the λ-186 chimeric repressor 
described by Pinkett et al (2006). The temperature sensitive chimeric repressor is a translational 
fusion between the λcI857 NTD (amino acids 1-92) and the 186 CI CTD (amino acids 83-192). The 
amino acid substitutions responsible for the temperature sensitive characteristic of cI857, A66T, is 
also present in this chimeric repressor. For the measurement of the unrepressed λ pR promoter in 
these constructs, cI857 was substituted with cI857Q34R/S35E, which has amino acid substitutions in the 
helix-turn-helix DNA binding motif.  
Kinetic lacZ assays 
Kinetic lacZ assays were performed in 96 well microtitre plates as previously described (Dodd et al., 
2001), with modifications described here. Growth media conditions for different lacZ experiments 
are summarized in Table 5-3. The reporter strains were restreaked from glycerol stocks onto 
selective LB agar media and incubated overnight. Fresh colonies from the restreak plates were used 
to inoculate 100 µL of selective LB broth in a well of a 96 well microtitre plate and incubated 
overnight at 30°C with shaking. After overnight incubation, cells were diluted to OD600 0.003 in 100 
µL fresh selective LB media in a microtitre plate. Plates were sealed and grown at one of three 
temperatures - 30°C, 37°C and 40°C. When culture OD600 reached 0.6-0.9, cultures were assayed for 
lacZ activity as described by Dodd et al (2001). 
 
 
Table 5-3 – Growth media and growth conditions for lacZ assays 
Step Media 
LacZ assays for pZS*35 CI system 
Restreak from glycerol stock LB agar supplemented with 30 µg/mL chloramphenicol and 50 
µg/mL kanamycin 
Inoculation of cultures from 
restreak plate 
LB broth supplemented with 30 µg/mL chloramphenicol and 50 
µg/mL kanamycin 
Inoculation of cultures for lacZ 
measurements 
LB broth supplemented with 30 µg/mL chloramphenicol, 50 
µg/mL kanamycin and 0-200 μM IPTG 
LacZ assays for pIT3 integrant constructs 
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Restreak from glycerol stock LB agar supplemented with 30 µg/mL chloramphenicol  
Inoculation of cultures from 
restreak plate 
LB broth supplemented with 20 µg/mL chloramphenicol  
Inoculation of cultures for lacZ 
measurements 
LB broth supplemented with 20 µg/mL chloramphenicol 
 
Construction of pZS*35 CI, pZS*35 CIG22R and pZS*35 empty 
The His6-tag was removed from the CI-His6 gene in via a 2-fragment Gibson assembly reaction. Two 
PCR reactions using pZS*35 186 CI-His6 as a template were performed using two different pairs of 
primers 1399 & 1342 and 1400 & 1331 (Table S 1). Primer 1399 was designed to anneal to the CI 
protein sequence and the vector to loop out the his-tag DNA. Primer 1400 was designed to overlap 
with 1399 to allow for Gibson assembly. Purified PCR products were assembled into a circular 
plasmid using Gibson isothermal assembly to create pZS*35 186CI.  
pZS*35 186 CIG22R and pZS*35 186 CIG22R-His6 was made by a two-fragment Gibson assembly reaction.  
pZS*35 186 CIG22R and pZS*35 186 CIG22R-His6 minipreps was used as PCR template, respectively. Two 
PCR reactions using the template were performed using two different pairs of primers 1340 & 1342 
and 1329 & 1331 (Table S 1). Primer 1329 contained the mutation to generate the G22R amino acid 
substitution.  Purified PCR products were assembled into a circular plasmids using Gibson isothermal 
assembly. 
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Figure S 1 – Plasmid map of pIT3-CL-186CIG22R pR pL apl- lacZ plasmid. (A) Temperature sensitive module was incorporated 
into the pIT3-CL-lacZtrimfuse plasmid (Priest et al., 2014). The DNA that makes up the temperature sensitive model, defined 
by the grey box, is annotated in (B). The temperature sensitive mutation in 186 CIG22R is shown in blue. The HTH- mutations 
present in the pIT3-CL-186CIHTH- pR pL apl- lacZ control plasmid is shown in purple. HTH mutations that abolish DNA binding 
by apl are shown in green. 
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Figure S 2 – Plasmid map of pIT3-CL-pL-OL-UP-λpRλpRM-hybridCIts cro- lacZ plasmid. (A) Temperature sensitive module was 
incorporated into the pIT3-CL-lacZtrimfuse plasmid (Priest et al., 2014). The DNA that makes up the temperature sensitive 
model, defined by the grey box, is annotated in (B). The temperature sensitive mutation in hybridts is shown in red. HTH 
mutations that abolish DNA binding by cro is shown in green. Mutations that abolish pL promoter activity are shown in pink. 
178 
 
Figure S 3 – Plasmid map of pIT3-CL-pL-OL-UP-λpRλpRM-λCI857 cro- lacZ plasmid. (A) Temperature sensitive module was 
incorporated into the pIT3-CL-lacZtrimfuse plasmid (Priest et al., 2014). The DNA that makes up the temperature sensitive 
model, defined by the grey box, is annotated in (B). The temperature sensitive mutation in cI857 is shown in red.  The HTH- 
mutations present in the pIT3-CL-pL-OL-UP-λpRλpRM-λCI(HTH-) cro- lacZ control plasmid is shown in purple.  HTH mutations 
that abolish DNA binding by cro is shown in green. Mutations that abolish pL promoter activity are shown in pink. 
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6 NOVEL METHOD TO DERIVATIZE CRYSTALS DURING 
INITIAL CRYSTALLOGRAPHY SCREENING TRIALS 
The following chapter presents two publications detailing a novel method to efficiently generate 
derivatized protein crystals by combining random microseeding matrix screening with derivatization 
with a heavy atom molecule I3C (5-amino-2,4,6-triiodoisophthalic acid). We demonstrate the efficacy 
of this technique with two test cases. Two protein crystal structures, the Orf11 N-terminal domain 
from bacteriophage P68 and hen egg white lysozyme, were successfully solved using this technique, 
solely using the anomalous signal from I3C. I performed all the experiments detailed in these 
publications, analysed the data, prepared figures for publication, deposited data into the Protein Data 
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Two commonly encountered bottlenecks in the structure determination of a
protein by X-ray crystallography are screening for conditions that give high-
quality crystals and, in the case of novel structures, finding derivatization
conditions for experimental phasing. In this study, the phasing molecule
5-amino-2,4,6-triiodoisophthalic acid (I3C) was added to a random microseed
matrix screen to generate high-quality crystals derivatized with I3C in a single
optimization experiment. I3C, often referred to as the magic triangle, contains
an aromatic ring scaffold with three bound I atoms. This approach was applied to
efficiently phase the structures of hen egg-white lysozyme and the N-terminal
domain of the Orf11 protein from Staphylococcus phage P68 (Orf11 NTD) using
SAD phasing. The structure of Orf11 NTD suggests that it may play a role as a
virion-associated lysin or endolysin.
1. Introduction
X-ray crystallography is commonly used to determine the
three-dimensional structures of proteins, with over 148 000
structures deposited in the Protein Data Bank (PDB) as of
February 2019 (Burley et al., 2019). However, there are many
bottlenecks in successful structure determination. For a
protein for which no X-ray crystal structure exists, the
conditions that will give rise to crystals are not known a priori.
Many crystallization conditions are screened to find one that
provides diffracting crystals. However, the large number of
factors that affect crystallization, including protein concen-
tration, precipitant, buffer, salt concentrations and tempera-
ture, make an exhaustive screening expensive and laborious
(Jancarik & Kim, 1991). Sparse-matrix screens are often used
to efficiently find crystallization conditions (Jancarik & Kim,
1991). Sparse matrix is a data-mining approach that chooses
crystallization conditions based on known and published
crystallization conditions. It can be generalized or tailored to
the macromolecule, for example membrane proteins or DNA-
binding proteins. Many sparse-matrix screens are readily
available commercially. Ireton & Stoddard (2004) pioneered
the microseed matrix screening (MMS) technique of trans-
ferring crystal seeds from existing crystals to new crystal-
lization conditions to create new conditions in which crystals
can grow. D’Arcy et al. (2007) further developed the technique
for use with random crystallization screens, such as the sparse-
matrix screens already described. This approach was named
random microseed matrix screening (rMMS) and was found
ISSN 2059-7983
to be an effective method for increasing the number of hit
crystallization conditions. In many cases, improved diffraction-
quality crystals could be obtained.
A protein structure can only be obtained using X-ray
crystallography if the phase problem can be solved. This
presents another bottleneck. If a suitable search model is
available through a homologous structure, the phase problem
can be solved by molecular replacement (MR; Rossmann,
1990; McCoy et al., 2007; Bibby et al., 2012). However, many
protein targets being studied do not have a suitable template
and require experimental phasing.
Several experimental phasing techniques have been devel-
oped. The traditional phasing method is isomorphous
replacement, which involves soaking crystals in solutions
containing heavy atoms such as lead, mercury or uranium.
Another phasing technique is anomalous dispersion at a single
wavelength (SAD; Wang, 1985) or multiple wavelengths
(MAD; Hendrickson, 1991). The anomalous dispersion tech-
nique requires atoms to be incorporated into the crystal lattice
that scatter anomalously at the wavelengths available at the
X-ray source. These can be incorporated through soaks or co-
crystallization with heavy-atom solutions, chemical modifica-
tion (for example selenium modification of nucleic acids) or
labeling during protein expression (selenomethonine and
selenocysteine). The theories of isomorphous replacement
and anomalous dispersion are described in Taylor (2010).
Suitable compounds and conditions for heavy-atom derivati-
zation are found empirically by screening. This process can be
very laborious, although some rational approaches have been
devised to guide the screening process (Lu & Sun, 2014).
Beck et al. (2008, 2010) synthesized the ‘magic triangle’
(I3C) and ‘MAD triangle’ (B3C) compounds specifically for
phasing, showing that they could phase several model proteins
(Fig. 1). Currently, there are 19 structures in the Protein Data
Bank that have been solved using I3C. The triangular
arrangement of anomalous scatterers can easily be identified
in the substructure. The two carboxylate groups and one
amino group can interact with the protein through hydrogen
bonding to either the protein backbone or to side chains to
facilitate more specific binding.
In this study, we incorporated I3C into an rMMS screen to
increase the chance of obtaining diffraction-quality crystals
while simultaneously incorporating heavy atoms into the
crystal for experimental phase determination. This method
aims to overcome the two identified bottlenecks in structure
determination of novel targets in one step. We demonstrated
this technique using hen egg-white lysozyme (HEWL) and the
N-terminal domain of Orf11 from Staphylococcus bacterio-
phage P68 (Orf11 NTD). Orf11 NTD is a good example of a
target that does not have a suitable template in the PDB to use
for MR and that did not produce sufficient hit conditions in an
initial screen. Our devised method very quickly gave diffrac-
tion-quality crystals that were already derivatized with a
heavy-atom compound and allowed the structure to be solved.
2. Methods
2.1. Crystallization of HEWL
HEWL was commercially acquired from Sigma–Aldrich
(catalog No. L6876) as a lyophilized powder. The powder was
dissolved in TBS (50 mM Tris–HCl pH 7.6, 150 mM NaCl) to a
final concentration of 30 mg ml1 as determined using UV
absorbance at 280 nm.
Lysozyme crystals were grown via hanging-drop vapor
diffusion. 1 ml protein solution was mixed with 1 ml reservoir
solution [0.2 M ammonium tartrate dibasic pH 7.0, 20%(w/v)
polyethylene glycol 3350] and equilibrated against 500 ml
reservoir solution. The crystals obtained were crushed to
generate an rMMS seed stock as described by D’Arcy et al.
(2007).
Sitting-drop vapor-diffusion crystallization screening of
HEWL was performed in 96-well Intelli-Plates (Art Robbins)
using the commercial Index HT screen (Hampton Research).
Four crystallization screens were carried out corresponding to
lysozyme without seeds or I3C, lysozyme with seeds, lysozyme
with I3C, and lysozyme with seeds and I3C.
For screens containing I3C, 1 M I3C stock was directly
added to the protein to give a final concentration of 20 mM
I3C. Sitting-drop vapor-diffusion trays were set up with the
I3C-containing protein stock. 1 ml protein solution was added
to 1 ml reservoir solution and 0.1 ml seed stock and equili-
brated over 75 ml reservoir solution.
A seeded crystal from condition C6 of Index HT grown in
the presence of I3C showed suitable diffraction. These crystals
appeared after three days and reached their maximum size
within two weeks. The size of the crystals was estimated to be
150 mm. Crystals were mounted on cryoloops (Hampton
Research), passed through Paratone (Hampton Research) for
cryoprotection and flash-cooled in liquid nitrogen for data
collection (Teng, 1990).
2.2. Data collection, structure solution and refinement of
HEWL
A 1.87 Å resolution SAD data set was collected at a
wavelength of 1.459 Å using an ADSC Quantum 210r CCD
detector on the macromolecular beamline MX1 at the
Australian Synchrotron (McPhillips et al., 2002). This wave-
length allows iodine to have a large anomalous signal (f 00 =
6.3 e and f 0 = 0.13 e). 360 diffraction images with 1 oscil-
lation width were collected at a crystal-to-detector distance of
120 mm. The diffraction data from two crystals were processed
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Figure 1
Chemical structures of I3C (5-amino-2,4,6-triiodoisophthalic acid) and
B3C (5-amino-2,4,6-tribromoisophthalic acid).
using XDS (Kabsch, 2010) and combined and scaled using
AIMLESS (Evans & Murshudov, 2013) (Table 1).
The structure was solved using the SAD protocol of Auto-
Rickshaw, the EMBL Hamburg automated crystal structure-
determination platform (Panjikar et al., 2005). The diffraction
data processed using AIMLESS (Evans & Murshudov, 2013)
were used as input. FA values were calculated using SHELXC
(Sheldrick, 2015). Based on an initial analysis of the data, the
maximum resolution for substructure determination and
initial phase calculation was set to 1.8 Å. 17 potential heavy-
atom sites out of the maximum number of 20 heavy atoms
requested were found using SHELXD (Schneider & Shel-
drick, 2002). The correct hand for the substructure was
determined using ABS (Hao, 2004) and SHELXE (Sheldrick,
2002). Initial phases were calculated after density modification
using SHELXE (Sheldrick, 2002). 89.48% of the model was
built using ARP/wARP (Perrakis et al., 1999; Morris et al.,
2004).
The resulting structure was used as a starting model in the
MRSAD module (Panjikar et al., 2009) of Auto-Rickshaw in
space group P43212 for further phase improvement, model
completion and refinement. The molecular-replacement step
of the pipeline was skipped. Refinement of the structure was
carried out using CNS (Brünger et al., 1998), REFMAC5
(Murshudov et al., 2011) and phenix.refine (Afonine et al.,
2012) within Auto-Rickshaw. A search for and refinement of
heavy atoms were conducted using Phaser (McCoy et al., 2007)
and MLPHARE (Winn et al., 2011), which identified 13 sites.
Nine sites were subsequently determined to correspond to the
three I atoms from each of three I3C ligands, and four sites
corresponded to the S atoms of two methionine and two
cysteine residues in the structure. Density modification was
performed in Pirate (Cowtan, 2000). Model building was
conducted using SHELXE (Sheldrick, 2002), RESOLVE
(Terwilliger, 1999, 2000) and Buccaneer (Cowtan, 2006), which
collectively built 128 out of 129 residues that were correctly
docked in the electron density. REFMAC5 and phenix.refine
were used to further refine the structure, which resulted in an
R and Rfree of 31.48% and 34.53%, respectively. The structure
was then iteratively rebuilt and refined using Coot (Emsley &
Cowtan, 2004) and phenix.refine to an R and Rfree of 19.67%
and 24.04%, respectively. Structure-solution statistics are
summarized in Table 2.
2.3. Expression of Orf11 NTD
Staphylococcus phage P68 Orf11 N-terminal domain (resi-
dues 2–200) was expressed in Escherichia coli BL21(DE3)
cells carrying the pLysS and pET-15b Orf11 NTD plasmids
(strain JT438). JT438 cells were grown overnight in 5 ml LB
medium supplemented with 100 mg ml1 ampicillin. The cells
were diluted 1:200 into fresh prewarmed LB medium
supplemented with 100 mg ml1 ampicillin. The culture was
grown at 37C with shaking until an OD600 of 0.6 was reached
and were then induced overnight at 16C using isopropyl
-d-1-thiogalactopyranoside (IPTG) at a final concentration
of 200 mM. The cells were harvested by centrifugation at 5000g
for 20 min. The cell pellets were stored at 80C.
2.4. Purification of Orf11 NTD
The cell pellets were thawed and resuspended in START
buffer [20 mM Tris pH 7.6, 500 mM NaCl, 20 mM imidazole,
5 mM -mercaptoethanol (BME) pH 7.2]. Cell resuspensions
were lysed by sonication on ice (5  30 s, 50% duty cycle,
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Table 1
Data-collection and processing statistics.
Values in parentheses are for the highest resolution shell.
Protein HEWL Orf11 NTD




Wavelength (Å) 1.459 1.459
Temperature (K) 100 100




Rotation range per image () 1 1
Total rotation range () 360 360
Space group P43212 P3121
a, b, c (Å) 77.16, 77.16, 38.20 61.397, 61.397, 101.606
, ,  () 90, 90, 90 90, 90, 120
Resolution range (Å) 38.20–1.87 (1.92–1.87) 36.73–2.08 (2.13–2.08)
Total No. of reflections 428577 (7041) 267451 (14604)
No. of unique reflections 9810 (475) 13689 (853)
Completeness (%) 98.4 (76.4) 98.3 (80.0)
Multiplicity 43.7 (14.8) 19.5 (17.1)
hI/(I)i 23.0 (1.8) 22.2 (3.5)
Wilson B factor (Å2) 17.501 42.71
Rp.i.m. 0.019 (0.198) 0.013 (0.134)
Rmeas 0.127 (0.850) 0.060 (0.578)
Ranom 0.0777 (0.171) 0.0528 (0.160)
CCanom 0.452 (0.120) 0.291 (0.038)
CC1/2 0.999 (0.938) 1 (0.983)
Table 2
Structure-solution statistics.
Values in parentheses are for the highest resolution shell.
Protein HEWL Orf11 NTD
Molecular mass (kDa) 14.3 22.8
Reflections used in refinement 9547 (921) 13296 (1219)
Reflections used for Rfree 913 (97) 893 (94)
Rwork 0.1967 (0.3442) 0.1792 (0.2498)
Rfree 0.2404 (0.3874) 0.2245 (0.3030)
CCwork 0.948 (0.887) 0.966 (0.910)
CCfree 0.923 (0.778) 0.938 (0.866)





No. of protein residues 129 199
R.m.s.d., bonds (Å) 0.003 0.003
R.m.s.d., angles () 0.54 0.50
Ramachandran favored (%) 99.21 96.95
Ramachandran allowed (%) 0.79 3.05
Ramachandran outliers (%) 0.00 0.00
Rotamer outliers (%) 0.00 2.00
Clashscore 5.39 3.32





No. of TLS groups 5 5
Sonifier Cell Disruptor B-30). The lysate was clarified by
centrifugation at 40 000g for 1 h and subsequent filtration
through 0.45 and 0.2 mm syringe filters (Sartorius Minisart)
using a disposable syringe. The supernatant was subjected to
Ni2+–IMAC chromatography on a 5 ml HisTrap FF column
(GE Healthcare) using an NGC FPLC system (Bio-Rad). The
column was washed with ten column volumes of START
buffer. The protein was eluted from the column with START
buffer with an imidazole gradient from 70 to 220 mM over
eight column volumes, followed by an imidazole gradient from
220 to 500 mM over two column volumes. Fractions showing
UV absorbance A280 above baseline were tested for purity
using SDS–PAGE. Fractions containing the purified protein
were pooled and dialysed against 25 mM Tris pH 7.5, 150 mM
NaCl, 10% glycerol, 5 mM BME. The protein was concen-
trated to 50 mg ml1 using Amicon Ultra-15 centrifugation
units (Millipore) and was stored at 80C.
2.5. Crystallization of Orf11 NTD using the rMMS protocol
in the presence of I3C
Crystallization screening for the Orf11 NTD protein was
conducted at 16C by the sitting-drop vapor-diffusion method
in 96-well Intelli-Plates (Art Robbins) using the commercial
PEG/Ion HT screen (Hampton Research). The stored protein
was diluted to 30 mg ml1 in 25 mM Tris pH 7.5, 150 mM
NaCl, 10% glycerol, 5 mM BME for crystallization. 1 ml
protein solution was added to 1 ml reservoir solution and
equilibrated over 75 ml reservoir solution. Crystals from
condition G12 of PEG/Ion HT were used to generate an
rMMS seed stock, as described by D’Arcy et al. (2007). A 1 M
stock of lithium I3C solution was prepared as described in
Beck et al. (2008). The protein stock was diluted to 30 mg ml1
using heavy-atom buffer (25 mM Tris pH 7.5, 150 mM NaCl,
10% glycerol, 5 mM BME, 50 mM I3C). The protein stock
contained I3C at a final concentration of 20 mM. Sitting-drop
vapor-diffusion trays were set up with the I3C-containing
protein stock. 1 ml protein solution was added to 1 ml reservoir
solution and 0.1 ml seed stock and was equilibrated over 75 ml
reservoir solution. For crystallization screens without I3C, I3C
was omitted from the buffer used to dilute the protein. The
sizes of the crystals used for data acquisition were estimated to
be between 50 and 75 mm. Crystals appeared after one day and
reached their maximum size within a week. If too many
crystals were observed in the drop, the seed stock was diluted
with PEG/Ion HT condition G12 reservoir solution in subse-
quent optimization steps.
Crystals were mounted on cryoloops (Hampton Research),
passed through Paratone (Hampton Research) for cryopro-
tection and flash-cooled in liquid nitrogen for data collection
(Teng, 1990).
2.6. Data collection, structure solution and refinement of
Orf11 NTD
A seeded crystal from condition H3 of PEG/Ion HT grown
in the presence of I3C showed suitable diffraction. A 2.0 Å
resolution SAD data set was collected at a wavelength of
1.459 Å using an ADSC Quantum 210r CCD detector on the
macromolecular beamline MX1 at the Australian Synchrotron
(McPhillips et al., 2002). At this wavelength, iodine has an f 00
and f 0 of 6.3 and 0.13 e, respectively. 360 diffraction images
with 1 oscillation width were collected at a crystal-to-detector
distance of 120 mm. The diffraction data were processed using
XDS (Kabsch, 2010) and scaled with AIMLESS (Evans &
Murshudov, 2013) (Table 1).
The structure was solved using the SAD protocol of Auto-
Rickshaw (Panjikar et al., 2005). The input diffraction data
were prepared and converted for use in Auto-Rickshaw using
programs from the CCP4 suite (Winn et al., 2011). FA values
were calculated using SHELXC (Sheldrick, 2015). Based on
an initial analysis of the data, the maximum resolution for
substructure determination and initial phase calculation was
set to 3.4 Å. Five heavy atoms out of the maximum number of
nine heavy atoms requested were found using SHELXD
(Schneider & Sheldrick, 2002). The correct hand for the
substructure was determined using ABS (Hao, 2004) and
SHELXE (Sheldrick, 2002). Based on the analysis of the hand
of the substructure, the space group of the data was changed
from P3221 to P3121. Initial phases were calculated after
density modification using SHELXE (Sheldrick, 2002).
84.54% of the model was built using ARP/wARP (Perrakis et
al., 1999; Morris et al., 2004).
The resulting structure was used as a starting model in the
MRSAD module (Panjikar et al., 2009) of Auto-Rickshaw in
space group P3121 for further phase improvement, model
completion and refinement. Refinement of the structure was
carried out using CNS (Brünger et al., 1998), REFMAC5
(Murshudov et al., 2011) and phenix.refine (Afonine et al.,
2012) within Auto-Rickshaw. A search for and refinement of
heavy atoms were conducted using Phaser (McCoy et al., 2007)
and MLPHARE (Winn et al., 2011), which identified four sites.
Three sites were subsequently determined to correspond to
the three I atoms from a single I3C, and one site corresponded
to the S atom of a methionine. Density modification was
performed in Pirate (Cowtan, 2000). Model building was
conducted using SHELXE (Sheldrick, 2002), RESOLVE
(Terwilliger, 1999, 2000) and Buccaneer (Cowtan, 2006), which
collectively built 194 out of 207 residues that were correctly
docked in the electron density. REFMAC5 and phenix.refine
were used to further refine the structure, which resulted in an
R and Rfree of 26.75% and 32.27%, respectively. The structure
was then iteratively rebuilt and refined using Coot (Emsley &
Cowtan, 2004) and phenix.refine to an R and Rfree of 17.34%
and 22.64%, respectively. Structure-solution statistics are
summarized in Table 2.
2.7. PDB codes
The coordinates and structure factors for Orf11 NTD and
HEWL have been deposited in the Protein Data Bank as
entries 6o43 and 6pbb, respectively.
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3. Results
3.1. I3C can be added to a random microseed matrix screen
and still give rise to more crystals than unseeded protein
The effect of adding I3C to an rMMS optimization screen
was tested using HEWL as a model crystallization protein.
rMMS optimization has previously been successfully applied
to lysozyme to increase the number of conditions supporting
crystal growth in the JCSG, PACT and Morpheus screens (Till
et al., 2013). Consistent with previous studies, we observe that
rMMS increases the number of conditions in which lysozyme
can crystallize in the Index HT screen (Hampton Research).
The rMMS screen generated 35 more conditions that
supported crystal growth [Fig. 2(a)]. Adding I3C without
seeding to the screen did not notably increase the number of
crystallization conditions found. Eight conditions no longer
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Figure 2
rMMS can generate new conditions that support the crystal growth of HEWL in the presence of I3C. (a) Crystallization conditions supporting the crystal
growth of HEWL in the Index HT screen are shaded in red. Seed stock was made from lysozyme crystals grown in 0.2 M ammonium tartrate dibasic pH
7.0, 20%(w/v) polyethylene glycol 3350. (b) Representative photographs showing crystals that formed with and without seeding both in the presence and
absence of I3C. (c) Dilution of seed stock was used to reduce the number of seeds to influence the crystal size. Seed stock was diluted 1:10 to give fewer
and larger crystals in condition B12 of Index HT.
supported crystal growth and three new conditions were found
in the presence of I3C. Adding I3C to the lysozyme rMMS
optimization screen generated substantially more conditions
than screens without seeding with and without I3C [Fig. 2(a)].
Having used HEWL as a test case, we tested this technique
with a protein with significantly lower crystallizability, Orf11
NTD.
Only one hit condition was obtained from the initial screen
with Orf11 NTD using the PEG/Ion HT screen (Hampton
Research). This condition generated a shower of microcrystals
that were too small to mount for X-ray diffraction. Adding
I3C to the screen resulted in the same hit condition but gave
no new conditions. The crystalline material from the unseeded
screen was used to make a seed stock for an rMMS screen
using PEG/Ion HT with and without I3C added. Five and six
new crystallization hits were identified in these optimization
screens, respectively [Fig. 3(a)].
The new hit condition H3 from PEG/Ion found by adding
undiluted seed stock produced too many crystals and was
optimized for crystal number by the dilution of seed stock as
detailed in Fig. 2. The growth of fewer crystals resulted in
larger crystals [Fig. 3(c)]. These two screens using HEWL and
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Figure 3
rMMS was used to find new hit conditions that support the crystal growth of Orf11 NTD in the presence of I3C. (a) Crystallization conditions supporting
crystal growth of Orf11 NTD in the PEG/Ion HT screen are colored. The crystallization condition used for seed stock is shown in blue. (b)
Representative photographs showing Orf11 NTD crystals that formed without and with seeding. (c) Dilution of seed stock can reduce excess nucleation
to give larger crystals. Seed stock was diluted 1:10 to give fewer but larger crystals in condition H3 of PEG/Ion HT.
Orf11 NTD provide a proof of concept
that I3C-derivatized crystals can be
grown and optimized using seeding
from a nonderivatized crystal.
To confirm that I3C was incorporated
into the crystals, crystals from the I3C
rMMS screen were harvested and the
crystal structures of the two proteins
were solved using the anomalous signal
without any external template informa-
tion.
3.2. Structure of HEWL
The structure of HEWL was solved
by SAD phasing using diffraction data
from a crystal grown using condition C6
of Index HT [Fig. 4(a)]. The structure
showed four I3C molecules bound to a
single HEWL monomer in the asym-
metric unit, with occupancies of 57, 54,
32 and 26% [Fig. 4(c)]. A structural
superposition of the structure with a
previously solved structure of HEWL
from a crystal co-crystallized with I3C
(PDB entry 3e3d; Beck et al., 2008)
showed that two of the four I3C mole-
cules bind to the same positions in the
protein [Fig. 4(d)].
3.3. Structure of Orf11 NTD
The structure of Orf11 NTD was
obtained by SAD phasing using
diffraction data from a crystal grown
using condition H3 of PEG/Ion HT
[Fig. 3(c)] in an rMMS screen in the
presence of I3C. This structure is shown
in Fig. 5(a), with representative electron
density shown in Fig. 5(b). One I3C
molecule was bound to the protein with
an occupancy of 53% and provided
sufficient signal to phase the structure.
An intrinsic S atom from Met138
provided a fourth anomalous scattering
atom. All scattering atoms displayed
clear density in the anomalous differ-
ence map [Figs. 5(c) and 5(d)].
4. Discussion
4.1. The I3C–rMMS method shows
promise
Molecular-replacement (MR) phasing
is the most popular method for solving
protein structures; however, in many
cases the protein target lacks a suitable
homology or ab initio model for
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Figure 4
Structure solution of HEWL. (a) The crystal structure of HEWL. (b) Stereoview of a composite
OMIT 2mFo  DFc electron-density map of HEWL. The contour level was set to 1. (c)
Substructure density of each I3C molecule. The anomalous difference map is contoured at 5. The
map was generated using phenix.maps. (d) The crystal structure of HEWL (PDB entry 6pbb) was
superimposed onto a previously solved structure of lysozyme soaked with I3C (PDB entry 3e3d)
and shows that two I3C molecules are bound in the same position.
successful MR phasing. In such cases, experimental phasing is
the method of choice for solving the phase problem. For
proteins that do not intrinsically possess scattering atoms,
external anomalous scatterers can be incorporated into the
crystal by soaking or co-crystallizing the protein with heavy
atoms. If heavy-atom ions or small molecules are incorporated
into a crystal via co-crystallization, it usually results in higher
occupancy. Another benefit of co-crystallization over soaking
is that it reduces manual crystal-manipulation steps that may
damage the crystal.
However, soaking is often preferred over co-crystallization
to derivatize crystals. Co-crystallization requires the set up of
additional screens. In addition, attempting to co-crystallize a
heavy-atom ligand in the same condition that yields
underivatized crystals can fail to yield crystals. This observa-
tion is unsurprising as the ligand can change the equilibrium of
the crystallization condition or the crystal contacts (Garman &
Murray, 2003; McPherson & Cudney, 2014). In this study, we
present an efficient method for screening for crystallization
conditions that co-crystallize a phasing compound into a
protein crystal.
rMMS often substantially increases the number of hit
conditions and produces improved diffraction-quality crystals
in new crystallization conditions (D’Arcy et al., 2007; Obmo-
lova et al., 2010). I3C has previously been demonstrated to
bind to proteins within a protein crystal, often via multiple
functional groups. The amino group and carboxyl groups of
I3C can form hydrogen bonds directly to the protein backbone
and side chains or via water bridges to
the protein. The benzene ring and
iodine allow – interactions and
halogen bonds, respectively. The ability
to form multiple interactions results in
I3C binding with high specificity and
occupancy in a protein crystal (Beck et
al., 2008).
It is possible that I3C can also stabi-
lize a lattice and/or generate new crystal
contacts, resulting in a protein crystal
with improved mechanical and diffrac-
tion properties. In the HEWL crystal,
three of the four I3C molecules interact
with three different protein monomers
[Fig. 6(a)]. In the Orf11 NTD crystal,
I3C was found at the interface between
three Orf11 NTD molecules and makes
interactions with all three protein
molecules [Fig. 6(b)]. Such contacts
between the protein molecules bridged
by I3C may explain why this crystal-
lization condition was only found when
rMMS was combined with I3C and not
with rMMS alone. We are aware of one
published case in which protein crystals
would only form in the presence of I3C
and would fail without it (Leverrier et
al., 2011). Thus, it seems likely that I3C
can increase the number of hits found
by rMMS by creating new crystal
contacts. In this study, a small increase
in the number of hits was found by
adding I3C to rMMS over a standard
rMMS screen. However, this is not a
clear positive effect as some hit condi-
tions were lost upon adding I3C.
By adding I3C to the protein solution
and using rMMS, we are efficiently
searching for crystallization conditions
in which I3C can bind the protein.
rMMS increases the likelihood of
obtaining crystals, and any such protein
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Figure 5
Structure solution of Orf11 NTD. (a) The crystal structure of Orf11 NTD. (b) Stereoview of a
composite OMIT 2mFoDFc electron-density map of Orf11 NTD. The contour level was set to 1.
Substructure density of I3C and the intrinsic S atom are shown in (c) and (d), respectively. The
anomalous difference map is contoured at 5. The map was generated using phenix.maps.
crystals obtained are likely to have I3C
incorporated, ready for SAD phasing.
This approach has successfully been
applied to both the HEWL and Orf11
NTD proteins. In both cases, an increase
in the number of hit conditions was
identified in the rMMS with I3C screens
compared with the unseeded screens
with and without I3C. For both HEWL
and Orf11 NTD, one of these new
conditions was confirmed to produce
I3C-derivatized crystals that allowed
solution of the protein structure.
There are several benefits to the use
of I3C with rMMS screening compared
with many of the compounds that are
commonly used for derivatization.
Firstly, I3C is inexpensive and readily
available. Secondly, many of the
commonly used heavy-metal salts such
as uranyl acetate and platinum potas-
sium chloride are incompatible with our
rMMS approach. Many of these metal
ions will form insoluble compounds
when mixed with sulfate and phosphate
buffers. Citrate and acetate in certain
crystallization conditions can also
chelate divalent metal ions to reduce
their effective concentration (Pike et al.,
2016). Sulfate, phosphate, citrate and
acetate are all commonly used in
crystallization conditions and would
preclude many heavy metals from our
rMMS approach. Finally, some heavy
atoms, but not I3C, react with HEPES
and Tris and/or bind to DTT and
-mercaptoethanol, which are used in
many protein preparations (Pike et al.,
2016).
I3C intrinsically provides two benefits
when solving structures. Each I3C
molecule provides three heavy scat-
tering atoms, providing a significant
anomalous signal for phasing. The
heavy atoms are arranged in an equi-
lateral triangle with sides of 6 Å. This
arrangement allows the presence of I3C
to be confirmed in the substructure-
determination stage. If a triangle with
these dimensions is found, it indicates a
correct substructure. The specificity of
I3C binding also makes it preferable to
halide or alkali metal ions, which bind to
many positions on the protein. This lack
of specificity can result in many poorly
occupied sites, making substructure
determination difficult.
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Figure 6
I3C can mediate contacts between protein molecules in a crystal. One I3C molecule from (a) the
HEWL crystal and (b) the Orf11 NTD crystal are shown. The same I3C molecule from the Orf11
NTD crystal is displayed in two different orientations for clarity. I3C–protein interactions include
hydrogen bonding, – stacking interactions, salt bridges, water bridges and halogen bonding. In
both cases, each I3C molecule forms interactions with three different protein molecules (each
shown in a different color), which could assist in lattice packing. Protein–ligand interaction analysis
was conducted using the PLIP web server (Salentin et al., 2015).
Figure 7
Orf11 is predicted to have a GyH domain and a CHAP domain, connected via a linker containing
three -helices. This predicted domain architecture of Orf11 is similar to that of the endolysin
protein PlyCA from Streptococcus phage C1. The PlyCA domain architecture was defined using the
crystal structure of the protein (PDB entry 4f88; McGowan et al., 2012). The domain architecture of
Orf11 was assigned using multiple bioinformatics tools. The GyH domain was identified using the
FFAS-3D homology-detection server (Xu et al., 2014). The CHAP domain was determined using
the Pfam protein-domain database (Finn et al., 2016). The -helical content within the linker region
was defined using the JPred4 secondary-structure prediction server (Drozdetskiy et al., 2015). The
residue numbers for the domain boundaries are annotated above the diagrams.
Another benefit of using iodine is that it provides a large
anomalous signal (f 00 = 6.9 e) at the Cu K wavelength used by
many home-source X-ray generators (and can also be used on
home sources for isomorphous replacement). This property
would allow the collection of anomalous data for phasing
without the need to wait for synchrotron beamtime.
This screening approach can be applied to identify new co-
crystallization conditions using other heavy-atom molecules.
One possibility is the MAD triangle (Beck et al., 2010), which
has a similar molecular structure with iodine substituted by
bromine. This phasing molecule has the benefit of allowing
MAD phasing as the Br K edge is accessible at many
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Figure 8
Orf11 shows limited sequence similarity and high structural similarity to the PlyCA protein from Streptococcus phage C1. (a) Sequences of the PlyCA
GyH domain (residues 1–213) and the Orf11 NTD domain (residues 1–201) were aligned using T-Coffee (Armougom et al., 2006), with an identity of
22% and a sequence similarity of 40%. Alignments were displayed using ESPript (Gouet et al., 1999) and similarity was calculated using the Risler matrix
(Risler et al., 1988). (b) A superposition of the PlyCA GyH domain and Orf11 NTD structures shows that the proteins adopt similar tertiary folds. The
two proteins were superimposed with PyMOL (DeLano, 2002) using C positions, with an r.m.s.d. of 3.5 Å over 127 atoms. (c) The conserved catalytic
residues of the glucosaminidase domain of GyH are Glu78, Tyr74 and Asn87. The equivalent residues Glu71, Tyr67 and Asn81 in Orf11 NTD appear in
similar positions. The residues appear in an electronegative cleft in the protein. The electrostatic potentials of Orf11 NTD were calculated using the
APBS plugin in PyMOL.
synchrotron beamlines. It would also be of interest to test
the tantalum bromide cluster (Knäblein et al., 1997), which
provides an extremely large amount of phasing power, espe-
cially for large proteins or protein–protein/DNA complexes.
4.2. Orf11 is likely to be a lysin
Bacteriophage P68 Orf11 was identified as a putative
endolysin using a bioinformatics approach. Endolysins are
enzymes that degrade the peptidoglycan structure in bacterial
cell walls and, along with holins that form pores in the inner
membrane, form the escape system for bacteriophages to exit
their host via lysis (Young, 2014). A homology search using
the FFAS (Xu et al., 2014) and Pfam (Finn et al., 2016) web
servers identified two putative domains in the Orf11 protein:
an N-terminal glycosyl hydrolase (GyH) domain and a
C-terminal cysteine, histidine-dependent aminohydrolase/
peptidase (CHAP) domain (Fig. 7). Both domains commonly
appear in endolysin proteins (Oliveira et al., 2013). Another
possibility is that Orf11 corresponds to a virion-associated
lysin protein (VAL). Some phages, particularly those that
infect Gram-positive bacteria, use glycosyl hydrolases asso-
ciated with the virion to degrade the peptidoglycan layer
(Fernandes & São-José, 2018). This process clears a path to
enable the phage to find the cell membrane and allows the
phage machinery to inject DNA into the cell.
The structure of Orf11 NTD is very similar to that of the
GyH domain of PlyC. PlyC is an endolysin protein from
Streptococcus phage C1 and is the most potent endolysin
protein discovered to date (McGowan et al., 2012; Riley et al.,
2015). PlyC consists of one PlyCA polypeptide mounted on
a PlyCB octamer. A structural superposition of the GyH
domain of PlyCA (PDB entry 4f88; McGowan et al., 2012)
with Orf11 NTD reveals similar overall folds, despite a low
sequence identity between the domains of 22% [Figs. 8(a) and
8(b)]. However, attempts to solve the data set via molecular
replacement using the PlyC GyH domain as a model failed to
yield a solution. Small deviations from the true structure in the
template may have prevented the algorithm from finding an
initial solution. The glycosyl hydrolase domain of PlyCA has
three key catalytic residues, Glu78, Tyr74 and Asn87, thought
to form the catalytic center. In the structure of Orf11 NTD
these same residues appeared at similar spatial positions
within an electronegative cleft in the protein [Fig. 8(c)]. From
this, it is possible that the Orf11 NTD is a glycosyl hydrolase.
A secondary-structure prediction of Orf11 shows that a
region containing three -helices lies between the two
domains (Fig. 7). This topology is similar to that of PlyCA,
which has a helical docking domain consisting of three
-helices that anchors it to the cell-wall-binding protein PlyCB.
All of this, taken together, suggests that Orf11 is a lysin
protein that perhaps requires an additional protein to direct it
to its bacterial target.
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Bioinformatics, 15, 305–308.
research papers
680 Truong et al.  Combining rMMS and the magic triangle Acta Cryst. (2019). D75, 670–681
Hao, Q. (2004). J. Appl. Cryst. 37, 498–499.
Hendrickson, W. A. (1991). Science, 254, 51–58.
Ireton, G. C. & Stoddard, B. L. (2004). Acta Cryst. D60, 601–605.
Jancarik, J. & Kim, S.-H. (1991). J. Appl. Cryst. 24, 409–411.
Kabsch, W. (2010). Acta Cryst. D66, 125–132.
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Protein structure elucidation using X-ray crystallography requires both high quality
diffracting crystals and computational solution of the diffraction phase problem.
Novel structures that lack a suitable homology model are often derivatized with
heavy atoms to provide experimental phase information. The presented protocol
efficiently generates derivatized protein crystals by combining random microseeding
matrix screening with derivatization with a heavy atom molecule I3C (5-amino-2,4,6-
triiodoisophthalic acid). By incorporating I3C into the crystal lattice, the diffraction
phase problem can be efficiently solved using single wavelength anomalous
dispersion (SAD) phasing. The equilateral triangle arrangement of iodine atoms in
I3C allows for rapid validation of a correct anomalous substructure. This protocol
will be useful to structural biologists who solve macromolecular structures using
crystallography-based techniques with interest in experimental phasing.
Introduction
In the field of structural biology, X-ray crystallography is
regarded as the gold standard technique to determine
the atomic-resolution structures of macromolecules. It has
been utilized extensively to understand the molecular
basis of diseases, guide rational drug design projects and
elucidate the catalytic mechanism of enzymes1,2 . Although
structural data provides a wealth of knowledge, the process
of protein expression and purification, crystallization and
structure determination can be extremely laborious. Several
bottlenecks are commonly encountered that hinder the
progress of these projects and this must be addressed
to efficiently streamline the crystal structure determination
pipeline.
Following recombinant expression and purification,
preliminary conditions that are conducive to crystallization
must be identified which is often an arduous and time-
consuming aspect of X-ray crystallography. Commercial
sparse matrix screens that consolidate known and published
conditions have been developed to ease this bottleneck3,4 .
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However, it is common to generate few hits from these initial
screens despite using highly pure and concentrated protein
samples. Observing clear drops indicates that the protein
may not be reaching the levels of supersaturation required
to nucleate a crystal. To encourage crystal nucleation and
growth, seeds produced from pre-existing crystals can be
added to the conditions and this allows for increased
sampling of the crystallization space. Ireton and Stoddard first
introduced the microseed matrix screening method5 . Poor
quality crystals were crushed to make a seed stock and then
added systematically to crystallization conditions containing
different salts to generate new diffraction-quality crystals that
would not have otherwise formed. This technique was further
improved by D'Arcy et al. who developed random microseed
matrix screening (rMMS) in which seeds were introduced into
a spare matrix crystallization screen6,7 . This improved the
quality of crystals and increased the number of crystallization
hits on average by a factor of 7.
After crystals are successfully produced and an X-ray
diffraction pattern is obtained, another bottleneck in the form
of solving the 'phase problem' is encountered. During the data
acquisition process, the intensity of diffraction (proportional
to the square of the amplitude) is recorded but the phase
information is lost, giving rise to the phase problem that
halts immediate structure determination8 . If the target protein
shares high sequence identity to a protein with a previously
determined structure, molecular replacement can be used
to estimate the phase information9,10 ,11 ,12 . Although this
method is fast and inexpensive, model structures may not be
available or suitable. The success of the homology model-
based molecular replacement method drops significantly as
sequence identity falls below 35%13 . In the absence of
a suitable homology model, ab initio methods, such as
ARCIMBOLDO14,15  and AMPLE16 , can be tested. These
methods use computationally predicted models or fragments
as starting points for molecular replacement. AMPLE, which
uses predicted decoy models as starting points, struggles
to solve structures of large (>100 residues) proteins and
proteins containing predominately β-sheets. ARCIMBOLDO,
which attempts to fit small fragments to extend into a larger
structure, is limited to high resolution data (≤2 Å) and by
the ability of algorithms to expand the fragments into a full
structure.
If molecular replacement methods fails, direct methods such
as isomorphous replacement17,18  and anomalous scattering
at a single wavelength (SAD19 ) or multiple wavelengths
(MAD20 ) must be used. This is often the case for truly
novel structures, where the crystal must be formed or
derivatized with a heavy atom. This can be achieved by
soaking or co-crystallizing with a heavy atom compound,
chemical modification (such as 5-bromouracil incorporation in
RNA) or labelled protein expression (such as incorporating
selenomethionine or selenocysteine amino acids into
the primary structure)21,22 . This further complicates the
crystallization process and requires additional screening and
optimization.
A new class of phasing compounds, including I3C (5-
amino-2,4,6-triiodoisophthalic acid) and B3C (5-amino-2,4,6-
tribromoisophthalic acid), offer exciting advantages over
pre-existing phasing compounds23,24 ,25 . Both I3C and
B3C feature an aromatic ring scaffold with an alternating
arrangement of anomalous scatters required for direct
phasing methods and amino or carboxylate functional
groups that interact specifically with the protein and provide
binding site specificity. The subsequent equilateral triangular
arrangement of heavy metal groups allows for simplified
validation of the phasing substructure. At the time of writing,
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there are 26 I3C-bound structures in the Protein Data Bank
(PDB), of which 20 were solved using SAD phasing26 .
This protocol improves the efficacy of the structure
determination pipeline by combining the methods of heavy
metal derivatization and rMMS screening to simultaneously
increase the number of crystallization hits and simplify
the crystal derivatization process. We demonstrated this
method was extremely effective with hen egg white lysozyme
and a domain of a novel lysin protein from bacteriophage
P6827 . Structure solution using the highly automated Auto-
Rickshaw structure determination pipeline is described,
specifically tailored for the I3C phasing compound. There
exists other automated pipelines that can be used such as
AutoSol28 , ELVES29  and CRANK230 . Non-fully automated
packages such as SHELXC/D/E can also be used31,32 ,33 .
This method is particularly beneficial to researchers who
are studying proteins lacking homologous models in the
PDB, by significantly reducing the number of screening and
optimization steps. A prerequisite for this method is protein
crystals or a crystalline precipitate of the target protein,
obtained from previous crystallization trials.
Protocol
1. Experimental planning and considerations
1. Use pre-existing crystals of the protein of
interest, preferably generated through vapor diffusion
crystallization. For a generalized protocol of vapor
diffusion crystallization, see Benvenuti and Mangani34 .
Other methods of crystallization such as microbatch
under oil and free interface diffusion will require
harvesting the crystals prior to crushing to generate
microseeds.
2. In the preparation of a seed stock, use the highest
quality crystals that can be sacrificed. The highest quality
crystal can be judged visually based on morphology
or the best diffracting crystal can be selected, if such
data is available. It is very likely that even better quality
crystals are obtained after optimization through seeding.
In the case where no crystals are available, crystalline
precipitate such as spherulites and needles can be used.
3. Identify salt crystals. Salt crystals can grow in
crystallization screens and can look like protein crystals.
Using salt crystals in rMMS will provide no benefit and
will waste precious sample, so it is important to eliminate
salt false positives.
1. Salt crystals are loud when they are crushed.
Crystals must be crushed to generate a seed stock,
so this strategy is particularly relevant. If an audible
crack sound is heard when crushing up the crystals,
the crystal is likely to be salt.
2. If the protein contains tryptophan and tyrosine
residues, use ultraviolet fluorescence microscopy to
identify protein crystals which fluoresce under these
lighting conditions.
3. Use Izit dye (methylene blue) to stain protein crystals
to differentiate them to salt crystals which remain
relatively unstained. However, this procedure is
more destructive and is only recommended if one
has crystals to spare from replicates of the same
drop.
 
NOTE: Although the aforementioned tests may
give promising results, salt crystals may still be
mistaken for protein crystals. In this case, diffraction
experiments can be used to definitively discern
between a protein and salt crystal.
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2. Preparation of lithium I3C stock
1. Measure out 120 mg of I3C (5-amino-2,4,6-
triiodoisophthalic acid) into a 1.5 mL microcentrifuge
tube.
2. Dissolve I3C in 200 µL of 2 M lithium hydroxide. The
solution can be gently heated using a heat block at 40-60
°C to encourage dissolution. The resulting lithium I3C
solution should be brown and has a concentration of 1 M.
 
CAUTION: Lithium hydroxide is corrosive. Safety
glasses, gloves and a lab coat should be worn.
3. Measure the pH of the solution. If necessary, add
small amounts of 1 M hydrochloric acid or 2 M lithium
hydroxide to adjust the pH to between 7 and 8. Add milliQ
water to make the final solution volume to 400 µL. The
concentration of the I3C stock solution is 0.5 M.
 
NOTE: Step 2.3 is optional. The pH of the solution should
be between pH 7-8 prior to any pH adjustment. This step
should be performed if the protein of interest is strongly
affected by pH. The protocol can be paused here. Lithium
I3C can be kept in the dark at 4 °C for at least two
weeks35 .
3. Addition of I3C to the protein stock
1. Method 1
1. Add stock lithium I3C to a 150 µL aliquot of the target
protein. The final concentration should be between
5-40 mM lithium I3C.
2. Method 2 (gentler method)
1. Prepare a protein dilution buffer that matches the
buffer of the target protein. To this dilution buffer, add
stock lithium I3C to give a concentration of lithium
I3C between 10-80 mM.
2. Dilute the protein 1:1 with protein dilution buffer to
give a final concentration of lithium I3C between 5-40
mM.
 
NOTE: Some proteins will precipitate upon coming
into contact with high concentrations of lithium
I3C in method 1, while other proteins can
tolerate it. Method 2 reduces the likelihood of
precipitation. However, this method halves the
protein concentration. For proteins that do not
have an established crystallization protocol, a
protein concentration of 10 mg/mL is generally
recommended for initial crystallization screening.
An initial molar ratio of I3C to protein of 8 is
recommended. Protein concentration and molar
ratio of I3C to protein can be optimized after the initial
screen.
4. Making a seed stock
1. Make a rounded probe for crushing crystals.
1. With a Bunsen burner on the blue flame, heat a
Pasteur pipette towards its middle. Using a tweezer,
pull the end of the Pasteur pipette to draw it out into
a thin diameter of less than 0.3 mm.
2. Once the midsection is thin enough, hold that
segment in the flame to separate the pipette at this
point and round the end of the pipette to finish the
glass probe.
 
NOTE: Rounded probe crystal crushers are sold
by third party vendors. These are an alternative to
making rounded probes.
2. Place five 1.5 mL microcentrifuge tubes on ice.
3. Under a light microscope, examine the crystallization tray
for a suitable condition to generate microcrystals. Ideally,
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good morphology large crystals are selected. However,
this technique also works with poor morphology crystals,
needles, plates, microcrystals and spherulites.
4. Open up the crystallization tray well. For 96 well
crystallization trays sealed with plastic, use a scalpel to
cut the plastic sealing the well. For hanging drop trays
sealed with grease, the coverslip can be removed using
tweezers and inverted onto an even surface.
5. Transfer 70 µL of reservoir solution to a microcentrifuge
tube and chill it on ice. To the other microcentrifuge tubes,
add 90 µL of reservoir solution and return to ice to chill.
 
NOTE: If the reservoir does not have enough volume
or does not exist (in the case of microbatch under oil),
create crystallization reservoir by mixing the appropriate
reagents.
6. Agitate the crystal in the drop using the crystal probe
to thoroughly crush it up. The crystal needs to be
completely crushed up which can be monitored under the
microscope.
7. Remove all the liquid from the drop and transfer it
to the microcentrifuge tube with the reservoir solution.
Mix and subsequently take 2 µL of mixture from the
microcentrifuge tube and add it back to the well. Rinse the
well with the solution and transfer it to the microcentrifuge
tube. Repeat this rinse step once more. From this point
on, keep the microcentrifuge tube cold to avoid melting
the microseeds in the mixture.
8. Vortex the tube at maximum speed at 4 °C for 3 min,
stopping regularly to chill the tube on ice to prevent
overheating.
 
NOTE: Some microseeding protocols add a
polytetrafluoroethylene seed bead to the microcentrifuge
tube to aid crystal crushing7,36 . We have employed the
technique without the use of a seed bead with success,
but see no problems with utilizing a seed bead to crush
up crystals.
9. Make a 1 in 10 serial dilution of the seed stock by
sequentially transferring 10 µL between the chilled
reservoir solutions.
10. Store seed stocks that will not be used immediately at
-80 °C.
5. Setting up an rMMS screen
1. Setting up a 96 well screening plate using a liquid
dispensing robot. In the absence of a robot, a
multichannel pipette may also be used.
1. Transfer 75 µL from a deep well block to a 96 well
crystallization tray. Add 1 µL to the crystallization
drop and 74 µL to the reservoir.
2. Transfer 1 µL of protein supplemented with lithium
I3C, made in step 2, to the crystallization drop.
3. Transfer 0.1 µL of seed stock to the crystallization
drop.
4. Seal the plate with clear sealing tape and incubate
the plate at a constant temperature to allow crystal
growth.
2. Setting up a hanging drop screens
1. Grease the edges of the hanging drop wells (hanging
drop crystallization trays can be found in 24 and 48
well formats).
2. Transfer 500 µL crystallization solution into
reservoir.
3. Near the center of a glass cover slide, place a 1 µL
drop of protein supplemented with lithium I3C, made
in step 2.
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4. Add 1 µL of the crystallization solution to the drop.
5. Transfer 0.1 µL of seed stock to the crystallization
drop.
6. Invert the cover slide and seal the crystallization well
by pushing the cover slide into the grease.
7. Incubate the plate at a constant temperature to allow
crystal growth.
 
NOTE: With new and untested seed stocks, it
is recommended to use the most concentrated
seed stock to maximize the chances of getting
crystallization hits. Subsequent conditions can be
set up with reduced seed concentration to optimize
the number of crystals.
3. Inspect crystal trays under a microscope regularly for
crystal growth. If crystals are of sufficient quality, they
can be harvested for data collection. Crystals can also
be used to generate new seed stocks and new rMMS
screens to allow for iterative optimization.
6. Data collection
1. Harvest crystals using cryoloops, cryoprotect the crystals
and flash cool them in liquid nitrogen. For additional
information on flash cooling crystals, refer to Teng37  and
Garman and Mitchell38 .
1. During the cryoprotection stage, if the crystal is
passed through a new aqueous solution, I3C can
be lost from the crystal due to it leeching into
the cryoprotection solution. Use lithium I3C in
the cryoprotection solution at a concentration that
matches the crystallization condition to mitigate this.
2. Crystals grown using this protocol have successfully
been cryoprotected using Parabar 10312 oil based
cryoprotectant (Hampton Research).
 
NOTE: The protocol can be paused here while
crystals are stored in liquid nitrogen.
 
CAUTION: Liquid nitrogen can cause cold burns.
Liquid nitrogen can also cause asphyxiation if used
in enclosed spaces.
2. Mount the crystal on the X-ray source goniometer and
collect diffraction data using the protocol specific for the
X-ray source.
3. This technique relies on anomalous signal from iodine
atoms in I3C. Thus, select the energy of the X-ray to
maximize this signal.
1. Set synchrotron X-ray sources with tunable energies
as low as possible. For many macromolecular
crystallography beamlines, the lowest configurable
energy is 8000 to 8500 eV.
2. Rotating anode X-ray sources cannot be tuned.
Commonly used anode sources with copper have
the Kα edge at 8046 eV, which provides a good
anomalous signal for iodine (f" = 6.9 e). Anode
sources with chromium have a Kα edge at 5415 eV,
which provides a large anomalous signal for iodine
(f" = 12.6 e).
4. Radiation damage is a significant problem during data
collection as it will degrade the anomalous signal39 .
Select the exposure time and attenuation of the beam
to achieve the best diffraction while minimizing radiation
dose.
 
NOTE: In a similar phasing compound with the iodine
atoms replaced with bromine atoms, radiation damage
has been shown to cause the radiolysis of the carbon
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bromine bond and a reduction in the occupancy of the
bromine atoms24 .
1. Use inverse beam SAD data collection as a
collection strategy. The data is collected in wedges,
with opposite wedges collected after each other.
This allows Friedel pairs to be collected with
an equivalent dose, resulting in an improved
measurement of anomalous signal less affected by
radiation damage. For example, an eight wedge
strategy to collect 360° would involve collecting
the data in the order of wedge 1 (0°-45°),
wedge 2 (180°-225°), wedge 3 (46°-90°), wedge
4 (225°-270°), wedge 5 (90°-135°), wedge 6
(270°-315°), wedge 7 (135°-180°) and wedge 8
(315°-360°).
 
NOTE: Continuous rotation is an alternative
collection strategy to that of inverse beam data
collection. For a recent comparison of the collection
strategies, see Garcie-Bonte & Katona40 .
7. Data processing and structure solution
1. Perform data reduction on the diffraction data using
XDS41 , with the aim of maximizing the anomalous signal.
Data reduction input parameters are specific to the
dataset and may require some trial and error. Here are
some recommendations to start.
1. Set FRIEDEL'S LAW=FALSE. Execute CORRECT
twice, setting STRICT_ABSORPTION_CORRECT
= TRUE and STRICT_ABSORPTION_CORRECT
= FALSE. One run can have a higher anomalous
signal than the other. Compare the anomalous
signals between the runs using the 'Anomal Corr'
and 'SigAno' disciplines in the output. This provides
an indicator of data quality.
2. Run SHELXC on the XDS_ASCII.HKL file for a
more accurate indication of anomalous signal. The
'Ranom' discipline will give an indication of the
anomalous signal at different resolutions.
2. Run POINTLESS42  and AIMLESS43  to scale the data.
In AIMLESS, set the parameter ANOMALOUS ON. If
the GUI is used, select the option Separate anomalous
pairs for outlier rejection and merging statistics.
Testing different resolution cutoffs may be required to
maximize anomalous signal.
3. Solve the protein structure using Auto-Rickshaw
automated crystal structure determination pipeline44 .
Auto-Rickshaw will attempt to solve the phase problem
and build the crystal structure of the protein automatically
with protein modelling and refinement software.
1. For proteins without a homology model template,
run the SAD protocol of Auto-Rickshaw in Advanced
Mode. Enter the required parameters.
1. Select PROTEIN as the molecule type.
2. Enter the data collection wavelength in
angstroms (Å).
3. Select "I" as substructure element to indicate
iodine atoms was used.
4. Select "i3c" as substructure type to indicate I3C
was the phasing molecule.
5. Select "sub_direct" as the substructure
determination method. This method employs
SHELXD32  to search for the substructure.
6. Select "3" as the number of expected
substructure per monomer.
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7. Enter "1" as the resolution cutoff of
substructure search. This allows Auto-
Rickshaw to automatically determine a suitable
resolution cutoff.
8. Enter the number of residues in a single
monomer, spacegroup of the dataset, and
number of molecules in the asymmetric unit
based on the Matthews coefficient.
9. Select the appropriate dissemination level of
X-ray data that suits the needs. Selecting
"AutoRickshaw developers" will allow Auto-
Rickshaw developers to troubleshoot the run if
problems arise.
10. Input the anomalous data as an mtz file.
11. Input the protein sequence as a seq, pir or
txt file. A seq file can be generated in a text
editor (such as Notepad++9  on Windows or
nano in Linux). Create a new file, enter the
primary sequence of the protein as one long line
or separated by line breaks. Save the file with
the .seq file extension.
12. Enter an institutional email address.
4. Results are delivered via a web-link sent to the email
address provided.
 
NOTE: AutoRickshaw is an automated pipeline
that invokes various crystallography software
packages to solve an X-ray crystal
structure32,33 ,45 ,46 ,47 ,48 ,49 ,50 ,51 ,52 ,53 ,54 ,55 ,56 ,57 ,58 .
If the Auto-Rickshaw run fails to solve the structure,
other Auto-Rickshaw settings can be tested. The
structure determination method can be changed to
"sub_phassade" to use Phaser59  instead of SHELXD32 .
The number of expected substructure per monomer can
be also increased or decreased.
5. During the experimental phasing of the crystal structure,
Auto-Rickshaw will attempt to position heavy atoms in the
unit cell, creating a substructure. The equilateral triangle
arrangement of iodine atoms in I3C presents an efficient
way of validating the substructure. If step 6.3 fails,
validating the substructure could aid in troubleshooting
structure solution.
1. Download the list of heavy atom sites from the Auto-
Rickshaw results page. It is a hyperlink called "heavy
atom sites". This will download a text file with the
heavy atom sites.
2. Change the file extension of the file from .txt to .pdb.
3. Open the PDB file in Coot60 . Turn on symmetry to
see other heavy atoms from neighboring asymmetric
units.
4. Measure the distances between the heavy atoms,
including across asymmetric units. I3C will appear
as an equilateral triangle with a side length of 6
angstroms. The presence of a triangle with these
dimensions indicates the placements of those heavy
atoms are correct.
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Representative Results
Incorporating I3C into rMMS can generate new conditions
supporting derivatized crystal growth
 
The efficacy of simultaneous rMMS screening and I3C
derivatization was demonstrated in two proteins, hen egg
white lysozyme (HEWL, obtained as a lyophilized powder)
and the putative Orf11 lysin N-terminal domain (Orf11
NTD) from bacteriophage P68. Each protein was screened
against PEG/ION HT under four different conditions including:
unseeded, seeded, unseeded with I3C and seeded with
I3C (Figure 1). For both proteins, the sole addition of I3C
did not increase the number of conditions conducive to
crystallization. In the case of Orf11 NTD, only one suitable
condition was identified with and without I3C (Figure 1B).
When I3C was added to the HEWL screens, the number
of hits was reduced from 31 to 26, highlighting the added
complexities of crystallisation when introducing phasing
compounds (Figure 1A). Consistent with other studies,
adding seed to commercial sparse matrix screens to generate
an rMMS screen significantly increased the number of
possible crystallization conditions for both proteins, resulting
in a 2.1 and 6 fold increase for HEWL and Orf11 NTD,
respectively6,61  (Figure 1). Most importantly, simultaneous
addition of I3C and seed increased the number of hits relative
to an unseeded screen, demonstrating a 2.3 and 7 fold
increase for HEWL and Orf11 NTD, respectively. Many of the
crystals from rMMS in the presence of I3C show excellent
crystal morphology (Figure 2).
Seeding allows careful control of crystal number in I3C rMMS
screens
 
In microseeding experiments, the number of seeds
introduced into a crystallization trial can be controlled by
dilution of the seed stock and this allows for precise control of
nucleation in the drop7,36 . This often allows larger crystals to
form since there is reduced competition of protein molecules
at nucleation sites. This advantage also extends to the I3C-
rMMS method and has been demonstrated successfully in
both HEWL and Orf11 NTD. Recreation of a crystallization
condition identified from the I3C-rMMS screen with a diluted
seed stock yielded fewer but larger crystals (Figure 3).
SAD phasing can be used to solve the structures from crystals
derived from rMMS I3C screen
 
Crystals grown using the diluted seed stock shown in Figure
3 were used to solve the structure of the proteins using SAD
phasing using diffraction data from a single crystal (Figure
4). Data was collected on the Australian Synchrotron MX1
beamline62 . Detailed data collection and structure solution
details are described elsewhere27 .
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Figure 1 - rMMS was used to generate new conditions for crystal growth in the presence of I3C for two test proteins.
96 well vapor diffusion crystallization screens were carried out using commercial sparse matrix screens. (A) Hen egg
white lysozyme was tested with the Index HT screen. Trays were seeded with HEWL crystals grown in 0.2 M ammonium
tartrate dibasic pH 7.0, 20% (w/v) polyethylene glycol 3350. (B) Orf11 NTD from bacteriophage P68 was tested with the
PEG/ION screen. Orf11 NTD trays were seeded from crystals from condition G12 from the unseeded screen, shown in
blue. Conditions supporting crystal growth are shown in red. rMMS seeding in the presence and absence of I3C both gave
significantly more crystal hits than unseeded trays. Figure adapted from Truong et al.27 . Please click here to view a larger
version of this figure.
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Figure 2 - Representative images of crystals grown from the vapor diffusion trials shown in Figure 1 (a) and (b).
Figure adapted from Truong et al.27 . Please click here to view a larger version of this figure.
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Figure 3 - Dilution of the seed stock is an effective way to reduce nucleation in a crystallization condition found
using the I3C-rMMS method, to control the number of crystals that form. Reducing nucleation within a drop often results
in crystals growing to larger dimensions. Figure adapted from Truong et al.27 . Please click here to view a larger version of
this figure.
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Figure 4 - Orf11 NTD (PDB ID 6O43) and HEWL (PDB ID 6PBB) were crystallized using the I3C-rMMS method and
solved using Auto-Rickshaw SAD phasing. (A) Ribbon structures of HEWL and Orf11 NTD solved through experimental
phasing. (B) I3C molecule bound to HEWL and Orf11 NTD. (C) Anomalous iodine atoms in I3C are arranged in an
equilateral triangle of 6 Å. Thus the presence of this triangle in the phasing substructure indicates that there is an I3C
molecule in that position. Please click here to view a larger version of this figure.
Discussion
Structure determination of a novel protein in the absence of a
suitable homology model for molecular replacement requires
experimental phasing. These methods require incorporation
of heavy atoms into the protein crystal which adds a level
of complexity to the structure determination pipeline and
can introduce numerous obstacles that must be addressed.
Heavy atoms can be incorporated directly into the protein
through labelled expression using selenomethionine and
selenocysteine. As this method is costly, laborious and
can result in lower protein yields, labelled protein is often
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expressed after crystallization conditions has been found and
optimized with unlabeled protein. Alternatively, crystals can
be derivatized by soaking in a solution containing heavy
atoms22,63 ,64 . This method often uses high quality crystals
and is therefore performed after a robust crystallization
method has already been developed. Successfully obtaining
a derivatized crystal using this method requires further
optimization of soaking procedures and screening of different
phasing compounds, therefore adding more time to an
already laborious process.
Co-crystallization of the protein with the heavy atom can
be performed at the screening stage, thus efficiently
streamlining the process and reducing crystal manipulation
steps that can cause damage. However, there still exists
the potential scenario of obtaining few initial crystallization
hits and the problem of choosing a compatible heavy atom
compound. Many currently available phasing compounds
are incompatible with precipitants, buffers and additives
commonly found in crystallization conditions. They may be
insoluble in sulphate and phosphate buffers, chelate to citrate
and acetate, react unfavorably with HEPES and Tris buffers
or become sequestered by DTT and β-mercaptoethanol21 .
As the I3C phasing compound does not suffer from these
incompatibilities, it is a robust phasing compound that could
be amenable to many different conditions.
In this study, a streamlined method of producing derivatized
crystals ready for SAD phasing through simultaneous co-
crystallization of the I3C phasing compound and rMMS is
presented. The combination of both techniques increases the
number of crystallization hits, with many of the conditions
having improved morphology and diffraction characteristics.
In both Orf11 NTD and HEWL test cases, new conditions
in the I3C-rMMS screen were identified that were absent
when I3C was not present. Potentially, I3C may bind favorably
to the protein, facilitating the formation and stabilization of
crystal contacts27 . In turn, this may induce crystallization
and possibly improve diffraction characteristics. Besides
being a compound compatible with sparse matrix screens,
I3C is also an attractive phasing compound due to its
intrinsic properties. The functional groups that alternate with
iodine on the aromatic ring scaffold allow specific binding
to proteins. This leads to greater occupancy and potentially
reduces background signal23 . Furthermore, the arrangement
of anomalous scatterers in an equilateral triangle is obvious in
the substructure and can be used to rapidly validate binding of
I3C (Figure 4B and 4C). Finally, it can produce an anomalous
signal with tunable synchrotron radiation as well as chromium
and copper rotating anode X-ray sources. Thus, it can be
applied to many different workflows. As I3C is widely available
and inexpensive to purchase, this approach is within reach for
most structural biology laboratories.
There are several experimental considerations that must be
addressed when using the I3C-rMMS method. This method
cannot be applied if initial crystalline material of the protein
cannot be obtained. In difficult cases, crystalline material
from a homologous protein can also be used to generate
seed stock. This cross-seeding approach to rMMS has shown
some promising results7 . Optimizing crystal number through
dilution of the seed stock is a crucial step, which should not be
overlooked, to maximize the chance of producing high quality
large crystals and acquiring suitable diffraction data. If there
are few I3C sites identified in the asymmetric unit, conditions
conducive to crystallization should be further optimized with
an increased concentration of I3C. This may increase the
occupancy of I3C to maximize the anomalous signal and aid
crystal derivatization.
Copyright © 2020  JoVE Journal of Visualized Experiments jove.com December 2020 •  •  e61894 • Page 15 of 19
There can be cases where this technique may not be
the optimal method to derivatize protein crystals. As the
size of a protein or protein-complex increases, the limited
number of I3C sites on the protein surface may not provide
sufficient phasing power to solve the structure. In these
scenarios where protein size is suspected to be impeding
phasing, selenomethionine labelling of the protein may be
a more viable approach to phasing the protein. If the
protein has adequate numbers of methionine residues in
the protein (recommended having at least one methionine
per 100 residues65 ) and high efficiency selenomethionine
incorporation into a protein can be achieved (such as in
bacterial expression systems66 ), multiple high occupancy
selenium atoms will be present in the crystals to phase the
structure.
In addition, some proteins may inherently be unsuited for
derivatization with I3C. I3C binding sites on proteins are
dependent on protein structure. There may exist proteins
that naturally have few exposed patches compatible with
I3C binding. Thus, it is not unforeseeable that there may be
difficulties in co-crystallizing some target proteins with I3C.
Disclosures
The authors have nothing to disclose.
Acknowledgments
This research was undertaken on the MX1 beamline at the
Australian Synchrotron, part of ANSTO. The authors would
like to acknowledge members of the Shearwin and Bruning
laboratories for discussions on this work. The authors would
also like to acknowledge Dr. Santosh Panjikar and Dr. Linda
Whyatt-Shearwin who contributed to the original work that
pioneered this protocol.
The following funding is acknowledged: Australian Research
Council (grant Nos. DP150103009 and DP160101450 to
Keith E. Shearwin); University of Adelaide (Australian
Government Research Training Program stipend scholarship
to Jia Quyen Truong and Stephanie Nguyen).
References
1. Zheng, H., Hou, J., Zimmerman, M.D., Wlodawer, A.,
Minor, W. The future of crystallography in drug discovery.
Expert Opinion on Drug Discovery. 9 (2), 125-137 (2014).
2. Oakley, A.J., Wilce, M.C.J. Macromolecular
crystallography as a tool for investigating drug, enzyme
and receptor interactions. Clinical and Experimental
Pharmacology and Physiology. 27 (3), 145-151 (2000).
3. Jancarik, J., Kim, S.H. Sparse matrix sampling. A
screening method for crystallization of proteins. Journal
of Applied Crystallography. 24 (pt 4), 409-411 (1991).
4. Newman, J. et al. Towards rationalization of
crystallization screening for small- To medium-sized
academic laboratories: The PACT/JCSG+ strategy. Acta
Crystallographica Section D: Biological Crystallography.
61 (10), 1426-1431 (2005).
5. Ireton, G.C., Stoddard, B.L. Microseed matrix screening
to improve crystals of yeast cytosine deaminase. Acta
Crystallographica Section D: Biological Crystallography.
60 (3), 601-605 (2004).
6. D’Arcy, A., Villard, F., Marsh, M. An automated
microseed matrix-screening method for protein
crystallization. Acta Crystallographica Section D:
Biological Crystallography. 63 (4), 550-554 (2007).
7. D’Arcy, A., Bergfors, T., Cowan-Jacob, S.W., Marsh,
M. Microseed matrix screening for optimization
in protein crystallization: What have we learned?
Copyright © 2020  JoVE Journal of Visualized Experiments jove.com December 2020 •  •  e61894 • Page 16 of 19
Acta Crystallographica Section:F Structural Biology
Communications. 70 (9), 1117-1126 (2014).
8. Taylor, G. The phase problem. Acta Crystallographica -
Section D Biological Crystallography. 59 (11), 1881-1890
(2003).
9. Rossmann, M.G. The molecular replacement method.
Acta Crystallographica Section A. 46 (2), 73-82 (1990).
10. McCoy, A.J., Grosse-Kunstleve, R.W., Adams,
P.D., Winn, M.D., Storoni, L.C., Read, R.J.
Phaser crystallographic software. Journal of Applied
Crystallography. 40 (4), 658-674 (2007).
11. Millán, C., Jiménez, E., Schuster, A., Diederichs, K.,
Usón, I. ALIXE: a phase-combination tool for fragment-
based molecular replacement. Acta Crystallographica
Section D. 76 (3), 209-220 (2020).
12. Liebschner, D. et al. Macromolecular structure
determination using X-rays, neutrons and electrons:
Recent developments in Phenix. Acta Crystallographica
Section D: Structural Biology. 75, 861-877 (2019).
13. Abergel, C. Molecular replacement: Tricks and
treats. Acta Crystallographica Section D: Biological
Crystallography. 69 (11), 2167-2173 (2013).
14. Pröpper, K. et al. Structure solution of DNA-
binding proteins and complexes with ARCIMBOLDO
libraries. Acta Crystallographica Section D: Biological
Crystallography. 70 (6), 1743-1757 (2014).
15. Rodríguez, D.D. et al. Crystallographic ab initio protein
structure solution below atomic resolution. Nature
Methods. 6 (9), 651-653 (2009).
16. Bibby, J., Keegan, R.M., Mayans, O., Winn, M.D.,
Rigden, D.J. AMPLE: A cluster-and-truncate approach
to solve the crystal structures of small proteins
using rapidly computed ab initio models. Acta
Crystallographica Section D: Biological Crystallography.
68 (12), 1622-1631 (2012).
17. Green, D.W., Ingram, V.M., Perutz, M.F. The structure
of haemoglobin - IV. Sign determination by the
isomorphous replacement method. Proceedings of the
Royal Society of London. Series A. Mathematical and
Physical Sciences. 225 (1162), 287-307 (1954).
18. Blow, D.M., Rossmann, M.G. The single isomorphous
replacement method. Acta Crystallographica. 14 (11),
1195-1202 (1961).
19. Wang, B.C. Resolution of phase ambiguity
in macromolecular crystallography. Methods in
Enzymology. 115 (C), 90-112 (1985).
20. Hendrickson, W.A. Determination of macromolecular
structures from anomalous diffraction of synchrotron
radiation. Science. 254 (5028), 51-58 (1991).
21. Pike, A.C.W., Garman, E.F., Krojer, T., Von Delft,
F., Carpenter, E.P. An overview of heavy-atom
derivatization of protein crystals. Acta Crystallographica
Section D: Structural Biology. 72 (3), 303-318 (2016).
22. Dauter, Z., Dauter, M., Rajashankar, K.R. Novel
approach to phasing proteins: Derivatization by short
cryo-soaking with halides. Acta Crystallographica
Section D: Biological Crystallography. 56 (2), 232-237
(2000).
23. Beck, T., Krasauskas, A., Gruene, T., Sheldrick,
G.M. A magic triangle for experimental phasing of
macromolecules. Acta Crystallographica Section D:
Biological Crystallography. 64 (11), 1179-1182 (2008).
24. Beck, T., Gruene, T., Sheldrick, G.M. The magic
triangle goes MAD: Experimental phasing with a bromine
Copyright © 2020  JoVE Journal of Visualized Experiments jove.com December 2020 •  •  e61894 • Page 17 of 19
derivative. Acta Crystallographica Section D: Biological
Crystallography. 66 (4), 374-380 (2010).
25. Beck, T., Da Cunha, C.E., Sheldrick, G.M. How to get
the magic triangle and the MAD triangle into your protein
crystal. Acta Crystallographica Section F: Structural
Biology and Crystallization Communications. 65 (10),
1068-1070 (2009).
26. Berman, H.M. et al. The Protein Data Bank. Nucleic Acids
Research. (2000).
27. Truong, J.Q., Panjikar, S., Shearwin-Whyatt, L., Bruning,
J.B., Shearwin, K.E. Combining random microseed
matrix screening and the magic triangle for the efficient
structure solution of a potential lysin from bacteriophage
P68. Acta Crystallographica Section D: Structural
Biology. 75 (7), 670-681 (2019).
28. Terwilliger, T.C. et al. Decision-making in structure
solution using Bayesian estimates of map quality: The
PHENIX AutoSol wizard. Acta Crystallographica Section
D: Biological Crystallography. 65 (6), 582-601 (2009).
29. Holton, J., Alber, T. Automated protein crystal structure
determination using ELVES. Proceedings of the National
Academy of Sciences of the United States of America.
101 (6), 1537-1542 (2004).
30. Skubák, P., Pannu, N.S. Automatic protein structure
solution from weak X-ray data. Nature Communications.
4 (2013).
31. Sheldrick, G.M. Crystal structure refinement with
SHELXL. Acta Crystallographica Section C: Structural
Chemistry. 71, 3-8 (2015).
32. Schneider, T.R., Sheldrick, G.M. Substructure solution
with SHELXD. Acta Crystallographica Section D:
Biological Crystallography. 58 (10 I), 1772-1779 (2002).
33. Sheldrick, G.M. Macromolecular phasing with SHELXE.
Zeitschrift fur Kristallographie. 217 (12), 644-650 (2002).
34. Benvenuti, M., Mangani, S. Crystallization of soluble
proteins in vapor diffusion for x-ray crystallography.
Nature Protocols. (2007).
35. Beck, T. Sticky triangles : New tools for experimental
phasing of biological macromolecules. (2010).
36. Luft, J.R., DeTitta, G.T. A method to produce microseed
stock for use in the crystallization of biological
macromolecules. Acta Crystallographica Section D:
Biological Crystallography. 55 (5), 988-993 (1999).
37. Teng, T.-Y. Mounting of crystals for macromolecular
crystallography in a free-standing thin film. Journal of
Applied Crystallography. 23 (5), 387-391 (1990).
38. Garman, E.F., Mitchell, E.P. Glycerol concentrations
required for cryoprotection of 50 typical
protein crystallization solutions. Journal of Applied
Crystallography. 29, 584-587 (1996).
39. Garman, E.F., Weik, M. X-ray radiation damage
to biological samples: recent progress. Journal of
Synchrotron Radiation. 26 (4), 907-911 (2019).
40. Garcia-Bonete, M.J., Katona, G. Bayesian machine
learning improves single-wavelength anomalous
diffraction phasing. Acta Crystallographica Section A:
Foundations and Advances. 75, 851-860 (2019).
41. Kabsch, W. XDS. Acta Crystallographica Section D
Biological Crystallography. 66 (2), 125-132 (2010).
42. Evans, P. Scaling and assessment of data quality. Acta
Crystallographica Section D: Biological Crystallography.
62 (1), 72-82 (2006).
43. Evans, P.R., Murshudov, G.N. How good are my data
and what is the resolution? Acta Crystallographica
Copyright © 2020  JoVE Journal of Visualized Experiments jove.com December 2020 •  •  e61894 • Page 18 of 19
Section D: Biological Crystallography. 69 (7), 1204-1214
(2013).
44. Panjikar, S., Parthasarathy, V., Lamzin, V.S., Weiss,
M.S., Tucker, P.A. Auto-Rickshaw: An automated crystal
structure determination platform as an efficient tool for
the validation of an X-ray diffraction experiment. Acta
Crystallographica Section D: Biological Crystallography.
61 (4), 449-457 (2005).
45. Jones, T.A., Thirup, S. Using known substructures in
protein model building and crystallography. The EMBO
journal. 5 (4), 819-822 (1986).
46. Kleywegt, G.J., Jones, T.A. Template convolution to
enhance or detect structural features in macromolecular
electron-density maps. Acta Crystallographica Section
D: Biological Crystallography. 53 (2), 179-185 (1997).
47. Perrakis, A., Morris, R., Lamzin, V.S. Automated
protein model building combined with iterative structure
refinement. Nature Structural Biology. 6 (5), 458-463
(1999).
48. Morris, R.J. et al. Breaking good resolutions with ARP/
wARP. Journal of Synchrotron Radiation. 11 (1), 56-59
(2004).
49. Yao, D.Q. et al. SAD phasing by OASIS-2004:
Case studies of dual-space fragment extension. Acta
Crystallographica Section D: Biological Crystallography.
62 (8), 883-890 (2006).
50. Hao, Q. ABS: A program to determine absolute
configuration and evaluate anomalous scatterer
substructure. Journal of Applied Crystallography. 37 (3),
498-499 (2004).
51. Collaborative Computational Project Number 4 The
CCP4 suite: Programs for protein crystallography. Acta
Crystallographica Section D: Biological Crystallography.
50 (5), 760-763 (1994).
52. Sheldrick, G.M., Hauptman, H.A., Weeks, C.M., Miller,
R., Usón, I. Ab initio phasing. International Tables for
Crystallography. 333-345 (2006).
53. Smith, G.D. Matching selenium-atom peak positions
with a different hand or origin. Journal of Applied
Crystallography. 35 (3), 368-370 (2002).
54. Pannu, N.S., McCoy, A.J., Read, R.J. Application
of the complex multivariate normal distribution
to crystallographic methods with insights into
multiple isomorphous replacement phasing. Acta
Crystallographica - Section D Biological Crystallography.
59 (10), 1801-1808 (2003).
55. Pannu, N.S., Read, R.J. The application of multivariate
statistical techniques improves single-wavelength
anomalous diffraction phasing. Acta Crystallographica
Section D: Biological Crystallography. 60 (1), 22-27
(2004).
56. De La Fortelle, E., Bricogne, G. Maximum-
likelihood heavy-atom parameter refinement for
multiple isomorphous replacement and multiwavelength
anomalous diffraction methods. Methods in Enzymology.
276, 472-494 (1997).
57. Cowtan, K. Joint CCP4 and ESF-EACBM Newsletter
on Protein. Crystallography. 31, 34-38, at <https://
ci.nii.ac.jp/naid/10010645386/en/> (1994).
58. Terwilliger, T.C. Maximum-likelihood density
modification. Acta Crystallographica Section D:
Biological Crystallography. 56 (8), 965-972 (2000).
Copyright © 2020  JoVE Journal of Visualized Experiments jove.com December 2020 •  •  e61894 • Page 19 of 19
59. Read, R.J., McCoy, A.J. Maximum-likelihood
determination of anomalous substructures. Acta
Crystallographica Section D: Structural Biology. (2018).
60. Emsley, P., Lohkamp, B., Scott, W.G., Cowtan,
K. Features and development of Coot. Acta
Crystallographica Section D: Biological Crystallography.
66 (4), 486-501 (2010).
61. Till, M. et al. Improving the success rate of protein
crystallization by random microseed matrix screening.
Journal of visualized experiments : JoVE. (78), e50548
(2013).
62. McPhillips, T.M. et al. Blu-Ice and the distributed control
system: Software for data acquisition and instrument
control at macromolecular crystallography beamlines.
Journal of Synchrotron Radiation. 9 (6), 401-406 (2002).
63. Nagem, R.A.P., Polikarpov, I., Dauter, Z. Phasing on
Rapidly Soaked Ions. Methods in Enzymology. 374,
120-137 (2003).
64. Taylor, G.L. Introduction to phasing. Acta
Crystallographica Section D: Biological Crystallography.
66 (4), 325-338 (2010).
65. Hendrickson, W.A., Ogata, C.M. Phase determination
from multiwavelength anomalous diffraction
measurements. Methods in Enzymology. 276, 494-523
(1997).
66. Doublié, S. Production of Selenomethionyl Proteins
in Prokaryotic and Eukaryotic Expression Systems.
Macromolecular Crystallography Protocols. Methods in
Molecular Biology. 91-108 (2007).
  215 
7 CONCLUSIONS AND FUTURE DIRECTIONS 
7.1.  Bacteriophage 186 as a model for a genetic switch 
Bacteriophage present a unique opportunity to study gene regulatory mechanisms in the 
context of a whole genome. Temperate bacteriophage have been considered to contain a 
genetic “switch” as they choose between the production of new phage virions and the 
dormant persistence of the phage genome within a host bacterium. To understand 
prokaryotic gene regulation, the mechanisms that temperate phages employ to lysogenize 
and lyse their host, and decide between these two fates have been extensively investigated 
over many decades. The most thoroughly studied temperate phage, phage λ, has provided 
many seminal contributions to the fields of prokaryotic transcriptional regulation and 
biological decision making (Ptashne, 2004). However, bacteriophage λ is just a single example 
amongst many of nature’s solutions to creating a genetic switch. Through the study of other 
temperate bacteriophage, alternate gene regulation mechanisms to achieve a bistable switch 
can be uncovered. 
Bacteriophage 186 has used as a useful counterpoint model to bacteriophage λ (Dodd and 
Egan, 2002; Pinkett et al., 2006; Murchland et al., 2014). Prior to this work, work by the 
Shearwin/Dodd/Egan laboratory had provided a detailed picture on the lysis-lysogenic system 
of 186. The specific functions of many gene products involved in decision making, such as 
transcriptional activators and repressors, are known. The transcriptional cascade observed in 
the establishment of the lytic and lysogenic cycles after initial infection had been mapped. 
Refer to Section 1.2.1 for more details. To divert phage development away from the default 
lytic cascade, two key transcriptional regulators, CII and CI, are required. CII establishes the 
initial pool of the immunity repressor CI. After the initial pool of CI is generated, CI activates 
its own transcription and represses the lytic promoter to generate a stable state where lytic 
functions of the phage are shut off (Neufing et al., 1996). The work described in this thesis has 
expanded our knowledge of gene regulation in 186 by providing a structural basis for 
understanding the function of these transcriptional regulators. As Stephen A. Wainwright 
once stated, “Structure without function is a corpse; function without structure is a ghost”.  
Form and function are never separate, even within the biochemical world. The behaviour of 
transcriptional regulators must make sense when considering the structures they adopt.  
7.1.1 Understanding the function of CII in establishment of lysogeny 
CII is a transcriptional activator that is essential for the efficient establishment of lysogeny in 
186. Prior to this work, it was understood that CII activates pE via the recruitment of RNA 
polymerase, with limited structural information to explain its activity. The protein 
oligomerizes into dimers and tetramers, and bind to 7mer half sites at pE, with an unusual 
wider spacing of two turns of the DNA helix apart (Shearwin and Egan, 2000). CII was shown 
to activate pE via interactions with RNA polymerase σ70 and the CTD of the α subunit via two 
epitopes around E46 and R115, respectively (Murchland et al., 2014).  
In Chapter 2, I presented several atomic resolution crystal structures of the CII protein. At the 
time of writing, these structures were novel and there were no known structural homologues 
to 186 CII in the Protein Data Bank. 186 CII homologues are found in genomes across many 
bacterial species, possibly within prophage DNA or remnants of prophage DNA. Thus, the 
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structure of CII could potentially be used as a model to understand a wider family of CII-like 
proteins. Through molecular docking approaches, guided by data from mutagenesis and mass 
spectrometry experiments, a structural model of CII stabilizing RNA polymerase at the pE 
promoter was proposed. In this model, a CII tetramer is positioned at the pE promoter and 
interacts with RNA polymerase via two epitopes. The CII epitope containing E46 and R17 
contacts K593 of the σ70 subunit of RNA polymerase domain 4 positioned around the -35 site 
of pE. E46 forms an ionic interaction with K593. The CII epitope containing R115 is proposed 
to contact residue D280 on the CTD of the α-subunit. α-CTD binds to the minor groove of DNA 
between the pE half sites, with potentially two α-CTDs stabilized by a single CII tetramer. The 
stabilization of multiple subunits of RNA polymerase (two or potentially three subunits) may 
be the key to its potent activation ability. The structure also presents a simple structural 
explanation of the rapid inactivation of CII by proteolysis. The protease RseP is recruited by 
the C-terminal degradation tag (Murchland et al., 2021). Cleavage of the protein disrupts the 
tetramerization interface of the protein and prevents the formation of an active CII tetramer 
to abolish its activity. Recent work from Murchland et al. (2021) suggests that CII’s role in the 
switch is to rapidly equilibrate CI to lysogenic levels and that it is achieved with a potent 
activator with a short half-life. Our work provides to structural basis to understand how CII 
satisfies both of these functions. 
Several aspects of this model require further validation. The contact between α-CTD residue 
D280 and CII residue R115 was inferred from scanning alanine mutagenesis experiments 
(Chapter 2) and an a previous genetic screen of CII (Murchland et al., 2014). However, 
reduction in activity from mutating an α-CTD residue could be indirect, due to destabilization 
of α-CTD, which has been observed in residues in other screens using the same scanning 
alanine mutant library. The possibility of D280 interacting with other residues that are not 
R115 cannot be excluded. As these residues carry the opposite charge, an interaction between 
D280 and R115 is likely to be an ionic interaction. This interaction could be validated using a 
charge swap experiment, where a D280R and D280K mutation would be predicted to restore 
lost activity observed in the R115E mutant of CII (Murchland et al., 2014). 
CII simultaneously stabilizing both α subunits was predicted from the model, as there were no 
physical constraints identified that prevents such a complex from forming. One potential 
experiment that can test this prediction is to determine the region of the promoter that α-
CTD contacts by hydroxyl radical-based DNA cleavage. In these experiments, with methods 
described by Murakami et al. (1997), (p-bromoacetamidobenzyl)-EDTA⋅Fe is conjugated onto 
the RNA polymerase α subunit and incorporated into a RNA polymerase holoenzyme. If α-CTD 
is stabilized in the positions proposed in the model, DNA cleavage would be observed at two 
sites, centering at around -40 and -56 positions at the pE promoter.  
The most direct way to confirm this structural model is to experimentally determine the 
structure of a CII interacting with DNA and/or RNA polymerase. Approaches to solving these 
structures could include X-ray crystallography, small angle X-ray scattering and protein cryo-
electron microscopy. Complexes that potentially could be structurally characterized include 
• CII145 in complex with pE31 or pE35 DNA 
• CII145 in complex with pE DNA and the σ70 subunit of RNA polymerase 
• CII145 in complex with pE DNA and α-CTD 
• CII145 in complex with pE DNA and the RNA polymerase holoenzyme 
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7.1.2 Maintenance of lysogeny by CI 
Pinkett et al. (2006) proposed a structural model to explain the maintenance of lysogeny by 
186 CI. The crystal structure of the 186 CI dimer revealed that it was a two-domain protein, 
with the CTD mediating oligomerization. The crystal structure of the CI-CTD revealed it 
adopted a 14mer ring (heptamer of dimers) in the crystal lattice. This led to the model that CI 
forms a 14mer wheel (Figure 1-15). The positioning of DNA binding domains on the outside of 
the wheel allows phage DNA to wrap on and off the wheel to repress the lytic promoters, 
whilst activating the lysogenic promoter pL (Figure 1-16). Wang et al. (2013) employed atomic 
force microscopy (AFM) to demonstrate 186 pR-pL DNA can wrap around a CI oligomeric disc. 
The formation of a 14mer CI wheel is central to this model of cooperative regulation by 186 
CI. In this thesis, I describe experiments to structurally characterize the intact CI complex to 
validate this model.  
In Chapter 3, CI oligomerization was analyzed by native mass spectrometry. The experiments 
determined that CI forms dimers that sequentially oligomerize to form dimers, tetramers, 
hexamers, octamers, 10mers and 12mers. However, a 14mer species was not identified by 
mass spectrometry and was the first piece of evidence to cast doubt on the 14mer wheel 
model. Chapter 4 describes the structural characterization of the CI-hybrid protein. This 
protein is a translational fusion of the λ CI NTD (residues 1-92) with the 186 CI CTD (residues 
84-192) and was postulated to oligomerize in the same manner as 186 CI. Mass spectrometry 
also revealed that the CI-hybrid protein forms a 12mer oligomer. The CI-hybrid protein 
adopted a 12mer (hexamer of dimers) circular ring assembly in the crystal structure, that is 
very similar to the previously postulated 14mer wheel assembly of CI, but with one less 
dimeric subunit. These results taken together suggest that 186 CI also oligomerizes into a 
12mer ring.  
In Chapter 4, I also discuss the ramifications of updating the model of transcriptional 
regulation with a 12mer CI wheel. pR-pL DNA wrapping on and off a 12mer wheel still 
adequately explains the observed behavior of 186 CI, provided that DNA entering and exiting 
the wheel does not sterically clash to prevent binding of operators to DNA. In the original 
model, DNA entry and exit into and out of the wheel on adjacent dimers of the wheel was 
assumed to be sterically unfavorable in order to adequately explain the transcriptional 
regulation.  
The studies outlined in Chapters 3 and 4 did not yield a structure of a CI wheel nor did they 
investigate interactions between CI and DNA. Solving a crystal structure of full-length CI as a 
higher-order oligomer has proven difficult, with previous attempts described in Chapter 3 and 
Pinkett (2006). An alternate technique to solve the structure of the CI wheel is protein cryo-
electron microscopy (cryoEM). This technique is most amenable for larger protein complexes, 
although there has been some success with sub-100 kDa proteins and complexes (Merk et al., 
2016; Herzik, Wu and Lander, 2019). A 12mer CI wheel has a molecular mass of 248 kDa and 
is a suitable size for cryo-EM.  
As discussed in Chapter 3, 186 CI contains two domains connected via a flexible linker. This 
linker allows the NTD to be move relative to the CTD domains. Flexibility in a protein or 
complex may make solving the structure of the 12mer CI complex via cryo-EM and X-ray 
crystallography prohibitively difficult. Flexible regions of proteins in crystals often impede 
protein crystallization by introducing heterogeneity into the system (Dale, Oefner and D’Arcy, 
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2003). Conformational heterogeneity due to flexibility can adversely affect various cryo-EM 
image processing steps including the alignment, classification and determination of the Euler 
angle. Additionally, flexible domains have lower densities as different species in the ensemble 
are conformationally averaged (Spahn and Penczek, 2009). Restricting the movement of these 
domains could aid in structure determination via cryo-EM and crystallography. This restriction 
could be achieved by complexing 186 DNA (such as pR-pL DNA) with CI to reduce the motions 
of the DNA binding domains. Furthermore, characterizing a CI-DNA complex naturally 
provides structural information on how CI can interact with DNA. This information will help us 
more comprehensively model the 186 genome interacting with the CI wheel to paint a 
detailed picture as to how regulation is achieved at this alternate genetic switch. 
7.2.  Temperature sensitive repressors from phage components 
In Chapter 5, I characterized temperature sensitive mutants of the 186 CI and CI-hybrid 
proteins, which were named 186 CIG22R and hybridts proteins, respectively. These repressors 
allowed for the temperature-controlled expression of genes and are viable alternatives to the 
commonly used λ cI857-pRM-pR temperature-controlled expression systems. This work aimed 
to address two limitations of the λ cI857-based systems. Firstly, efficient induction of the 
promoter in λ cI857 systems require heating the system to 40-42°C (Villaverde et al., 1993). 
These temperatures are often suboptimal for production-based applications, as high 
temperatures can lead to protein misfolding and trigger the heat-shock and stringent stress 
responses, leading to reduced yields. Secondly, many synthetic gene circuits also employ λ cI 
as a transcriptional regulator, making those systems incompatible with λ cI857.  
The temperature-controlled induction of gene expression was measured in three systems, λ 
cI857-pRM-pR, hybridts-pRM-pR and 186 CIG22R-pR-pL. In all three systems, the target promoter 
was tightly repressed at 30°C. At 37°C, the hybridts and 186 CIG22R systems displayed 
significantly more derepression of their target promoters than λ cI857. Thus, these systems 
could be used for induction of gene expression at 37°C, which may reduce the heat stresses 
placed on these systems. In addition, 186 CIG22R acts on the 186 pR promoter, distinct from λ 
cI regulated promoters, allowing it to be used in systems utilizing λ cI. These expression 
systems can also be used at 40°C, where they show close to maximal induction.   
The hybridts repressor could be used to optimize existing λ cI857-pRM-pR system. Our work has 
shown that substituting λ cI857 with hybridts in these systems allows for increased gene 
expression from λ pR at 37°C. However, λ cI857 has been implemented into other temperature 
sensitive expression modules outside the described λ cI857-pRM-pR layout, including some that 
utilize the λpL as the promoter for inducible expression (Table 7-1). It would be valuable to 
know if hybridts also works in these systems and whether it provides any regulatory benefits, 
such as higher induction at lower temperatures.  
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λpL, λ cI857  β-
galactosidase 




λpL, λ cI857 IHF α, β IHF α, β expressed from two different 
plasmids in the same cell. Expression of 
both proteins driven by λpL promoter. λ 
cI857 expressed from an integrated 
prophage 
Nash et al. 
(1987) 
λpRpL, λ cI857 TNF-α λpR and λpL promoters are placed in 
tandem to increase promoter strength. 
λpR, λpL and λ cI857 are all present on 
the same plasmid. 
Menart et al. 
(2003) 
λ cI857-pRM-pR phiX174 lysin 
gene E 
λ cI857, λpRM, λpR elements were present 




λ cI857 has been shown to work in other bacterial systems such as Salmonella enterica, 
Bacillus subtilis, several species of Pseudomonas and Klebsiella pneumoniae (Winstanley et al., 
1989; Breitling, Sorokin and Behnke, 1990; Jawale et al., 2012). One application that has been 
explored is the generation of bacterial ghost vaccines. In the target bacteria, the phiX174 lysin 
gene E is placed under the control of a promoter repressed by λ cI857. Elevating the 
temperature induces the lysin gene, leading to cell lysis. The resulting empty bacterial 
envelopes are investigated as potential vaccines against that bacteria or as an adjuvant in a 
vaccine preparation (Jechlinger et al., 2005; Fu et al., 2021). Future work could investigate the 
feasibility of substituting λ cI857 with hybridts and 186 CIG22R in these systems. The use of 
hybridts and 186 CIG22R could lower the temperatures at which the bacteria lyse, to reduce 
heat induced alterations of surface envelope antigens in bacterial ghost preparations.   
It is impossible to anticipate all the potential use cases of temperature sensitive expression 
systems in advance. These applications with differing temperature requirements could 
require further optimization of existing systems or the development of new systems. The 
hybridts and 186 CIG22R systems could be optimized at the promoter level. The two proteins 
act on different promoters, λ pL and 186 pB, respectively. Substituting with these promoters 
could be used to adjust the promoter strength and potentially shift the induction 
temperatures required. Modified promoters such the tandem λpRpL promoter, described by 
Menart  et al. (2003) could be also tested. Additional tweaking of promoter strength and 
sensitivity to temperature induction could be achieved via the mutagenesis of the promoter 
and repressor binding sites. Strategies to carry this out have been described in Jechlinger et 
al. (1999, 2005) and Rohlhill, Sandoval and Papoutsakis (2017).  
Bacteriophage have been a fruitful source of biological components for synthetic biology. 
Examples include λ CI (Elowitz and Leibier, 2000), T7 RNA polymerase with the T7 promoter 
(Noireaux, Bar-Ziv and Libchaber, 2003; Kim, White and Winfree, 2006), and Bxb1 and Cre 
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recombinases (Friedland et al., 2009; Bonnet, Subsoontorn and Endy, 2012). Our work has 
reiterated this point and used phage components to expand the toolkit of available tunable 
promoter expression systems. Future work in this field could focus on developing new 
temperature-controlled expression systems to cover a wider variety of use cases.  
Temperate bacteriophage themselves present a straightforward resource for generating new 
temperature sensitive transcriptional regulators. Temperate phages plated onto a lawn of 
their host bacteria generate turbid plaques. Many temperate phages, such as λ, 186, TP901-1 
and P2, use an immunity repressor to repress the lytic promoters of the phage (Ptashne et al., 
1980; Lundqvist and Bertani, 1984; Dodd and Egan, 1996; Pedersen, Ligowska and Hammer, 
2010). Inactivation of this immunity repressor results in clear plaques. Mutant phages with a 
temperature sensitive immunity repressor will give rise to clear and turbid plaques when 
grown at the restrictive and permissible temperatures, respectively. λ phage with λ cI857 was 
isolated in this manner (Lieb, 1966). When interpreting results from these plaque assays, 
mutations should be mapped onto the genome as temperature sensitive mutations in other 
lysogeny promoting factors, such as the integrase and CII (in the case of λ and 186) could give 
rise to the same plaque behaviour. A temperature sensitive 186 CII activator could be valuable 
for certain production-based applications. 
In many cases, the soluble expression of protein is favoured by lower culture temperatures 
(Schein and Noteborn, 1988; San-Miguel, Pérez-Bermúdez and Gavidia, 2013). Thus, one of 
the strategies for expressing recalcitrant proteins in bacteria is to lower the culture 
temperature after induction. As it is currently used, in λ cI857, 186 CIG22R and hybridts systems, 
induction of target gene expression requires high induction temperatures. A temperature 
sensitive activator protein, which loses activity at higher temperatures, could be used to 
induce expression of genes at lower temperatures. The minimal basal activity of 186 pE in the 
absence of functional CII in conjunction with the potent activation provided by 186 CII makes 
a temperature sensitive 186 CII/pE system an attractive prospect.  
7.3.  Random microseed matrix screening method to derivatize 
protein- crystals 
X-ray crystallography was used in Chapter 2, 3 and 4 to structurally characterize proteins and 
their complexes. During these experiments, two commonly encountered technical challenges 
were identified. These are the generation of diffraction quality crystals and solving the phase 
problem.  
Firstly, identifying compatible crystallization conditions for a protein is a trial and error process 
that requires laborious screening. Secondly, for a protein without a suitable model for 
molecular replacement, which often is the case when the closest structural homologue 
available shares less than 35% sequence identity to the target protein (Abergel, 2013), 
experimental phasing must be used instead. Experimental phasing requires derivatizing a 
protein crystal with heavy atoms. Finding a compatible heavy atom to incorporate into the 
crystal and suitable derivatization conditions adds another time-consuming screening step to 
the crystallization project.  
In Chapter 6, I present a new approach to simultaneously optimizing crystal growth and 
derivatizing crystals with a heavy atom phasing molecule, tackling both crystallography 
bottlenecks in one step. In this study, two proteins were derivatized at the screening stage 
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using co-crystallization with the heavy atom ligand I3C. Random matrix microseeding 
screening (rMMS) was used to increase the number of hits in the presence of the phasing 
ligand, where many of the resulting crystals showed improved size and morphology. For the 
two tested proteins, a 2.3 and 7-fold increase in the number of hits were observed when I3C 
and microseed was introduced into the screen, relative to the unseeded screen.  Most 
importantly, a crystal from each of these screens was shown to be derivatized with I3C and 
was used successfully in experimental phasing to solve the structure of the protein.  
Often in a structure determination project with a novel protein, it is known in advance that 
derivatization of the crystal is required as molecular replacement is likely to fail. In these cases, 
derivatizing the protein crystal while screening for crystallization conditions could streamline 
the process to obtain a structure by reducing the number of screening steps. The significance 
of this work lies in that it provides a general and straightforward screening method for crystals 
that simultaneously derivatizes them, with initial empirical evidence demonstrating that it 
gives a higher number of crystal hits and derivatized crystals contain sufficient phasing power 
to solve the structures. This technique can also be applied to target proteins with a potential 
molecular replacement template to reduce model bias from molecular replacement, and as a 
backup phasing option if molecular replacement fails.  
One shortcoming of this study was that it was only tested on two relatively small proteins with 
molecular masses 14.3 kDa and 22.8 kDa. Future work could verify that the I3C-rMMS method 
functions with other proteins. There may also exist an upper size limitation on this technique, 
which should be explored. As I3C derivatization is applied to larger proteins and protein 
complexes, the limited number of I3C sites on the protein surface may not provide enough 
anomalous signal to phase the protein. One potential solution is to test rMMS with other 
phasing ligands. Ligands that bind to more sites on the average protein surface could increase 
the available phasing power. However, these ligands also tend to be less specific in binding, 
leading to low occupancy binding sites, increasing the anomalous noise in the data. Thus, 
there is a balance of promiscuity and binding occupancy that needs to be maintained. Ligands 
that have increased phasing power per molecule could also be tested, such as the tantalum 
bromide cluster and B3C. The tantalum bromide cluster contains 6 tantulum metal atoms and 
12 bromide atoms, providing an extremely large phasing power per molecule (Knäblein et al., 
1997). The B3C phasing ligand has the same structure as I3C, except with the iodine atoms 
replaced with bromine atoms (Beck, Gruene and Sheldrick, 2010). B3C can provide an 
increased anomalous phasing signal, as it can be used with the multiwavelength anomalous 
dispersion (MAD) phasing technique. MAD provides additional phasing information when 
compared to the single wavelength anomalous dispersion (SAD) phasing technique which I3C 
is limited to (Rice, Earnest and Brunger, 2000). Tobias Beck, the pioneer of the I3C and B3C 
phasing molecules, in his doctoral dissertation also proposed three other phasing molecules 
that can be tested with rMMS (Beck, 2010). Potentially, a cocktail of phasing ligands could be 
tested. Multiple ligands would increase the collective number of potential binding sites on the 
protein without resorting to low specificity ligands that adds undesirable noise. 
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Glossary
Lysogen A bacterial cell carrying one or more
bacteriophage genomes, either integrated into the host
chromosome or existing as independently replicating extra-
chromosomal elements. A true lysogen is able to exit
lysogeny and re-enter lytic development.
Lysogenic conversion The situation where a bacterial host
acquires a new trait as a direct result of the expression of a
gene or genes encoded by a prophage.
Prophage The lysogenic form of a bacteriophage.
Prophage induction The process of a bacteriophage
exiting lysogeny and entering lytic development, resulting in
lysis of the host cell.
Temperate bacteriophage A bacteriophage capable of
entering either lytic development or lysogeny upon host cell
infection.
Terminally redundant DNA DNA that contains repeated
sequences at each end called terminal repeats. These ends
are used to join the ends of the linear DNA to form circular
DNA.
Transcriptional interference The suppressive influence of
one transcriptional process, directly and in cis on a second
transcriptional process.
Introduction
Bacteriophages (phages) are obligate bacterial parasites. Many phages exhibit a purely lytic lifecycle, where following infection of a
susceptible host, the phage DNA is replicated and the phage hijacks the bacterium’s cellular machinery to produce new virion
particles, which are released upon lysis of the host cell. Other phages, the so-called temperate phages, are able to make a devel-
opmental ‘decision’ between two developmental regimes, the lytic and lysogenic cycles. In lysogeny, the phage persists indefinitely
inside the bacterial host as a prophage, with the phage genome either integrated into the bacterial chromosome or existing extra-
chromosomally (Fig. 1). Lysogeny is a non-bacteriocidal state where the bacteriophage genome replicates without virion production.
In this state, most of the phage genome is transcriptionally inactive, as the expression of lytic functions would be lethal to the host
cell. A bacterial host cell lysogenic for a particular phage is also immune to further infection by the same phage.
Filamentous phage, which have ssDNA genomes packaged into filament-like virions, are able to replicate without killing the host.
Among the filamentous phage, some integrate in the host chromosome, while non-integrative filamentous phage replicate exclusively as
extrachromosomal elements or episomes. Both classes of filamentous phages continually shed viral particles without host cell death,
even while inserted into the bacterial genome as a prophage. Thus, bacteria infected permanently with filamentous phage represent a
form of lysogeny, but don’t meet the definition of true temperate phage, in that there is no stage which brings about host cell lysis.
In this article, we discuss specific examples of how true temperate phage establish and maintain lysogeny. The phenotypic
effects of lysogeny on the host bacterium and the evolutionary impacts of lysogeny are also discussed.
Why Lysogeny?
For a phage to successfully propagate, it must coax its host into manufacturing new virions. These new virions are released through host
cell lysis, and need to infect another host bacterium in order for the phage to continue to propagate. From the phage perspective, during
times of abundant resources and the presence of many host cells, lytic development allows for large numbers of phages to be produced,
to subsequently infect other host cells and thus continue the cycle. However, when resources and/or susceptible host cells are scarce, the
phage can benefit from entering lysogeny until conditions improve. The process of making a choice between the lytic and lysogenic
pathways following host cell infection, is covered in more detail in another article (Golding). While there must be some (small) fitness
cost in replicating extra genomic material, many phages have evolved such that lysogeny can provide a selective advantage to the host cell
in a number of ways. Such benefits may include carrying genes which confer some growth advantage to the host, or by providing
protection from subsequent infection, and potential lysis, by phage from the same or different families.
Persistence of DNA
Integration Into the Chromosome
The long term persistence of phage DNA inside their bacterial host cell is the key feature of a lysogen. Phage have evolved many
mechanisms to achieve this long term persistence. In many cases, such as the paradigm bacteriophage λ, the phage DNA is
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integrated into the bacterial chromosome via site-specific recombination (Fig. 2). The phage-encoded integrase protein is a site-
specific recombinase that recognizes attachment (att) sites on both the phage genome (attP) and the bacterial chromosome (attB).
The integrase catalyses recombination between the attP and attB sites. This process generates two new att sites, attL and attR that
flank the phage genome. When the phage exits lysogeny, the excision machinery, consisting of at least the integrase and a phage-
encoded recombination directionality factor (RDF), and often with additional host factors, recognizes the attL and attR sequences
to catalyse the reverse reaction to excise the prophage genome.
In general, integrase proteins belong to one of two families, the serine integrases or the tyrosine integrases. These proteins use a
catalytic serine or tyrosine, respectively, to carry out the recombination reaction. Serine integrases create a double stranded break in
both the phage and bacterial chromosome, and mediate strand rearrangement to bring them into the recombinant configuration,
followed by strand ligation. Tyrosine recombinases, on the other hand, mediate recombination via a Holliday junction inter-
mediate. Single stranded cuts are made in DNA and rejoined to single stranded DNA from the recombinant partner. Both types of
integrases have been used extensively for biotechnology and molecular biology applications.
Some temperate phage integrate their DNA less specifically into the bacterial genome. Upon infection of a host cell, phage Mu
initially integrates at random into the host chromosome. Only after integration is a decision on lytic or lysogenic development
made. If the lytic pathway is followed, the phage genome undergoes successive rounds of replicative transposition. In each round,
Mu DNA is duplicated, and a range of host genome rearrangements (deletions, inversions, translocations) are introduced. Viral
genomes, along with variably sized segments of the host genome, are packaged directly from the integrated copies dispersed
around the scrambled host genome. Similar to other temperate phages, the Mu lysogenic pathway (termed the latent pathway in
Mu) is followed if the Repc repressor protein accumulates to a sufficiently high concentration. Repc competes for overlapping
operators with DDE-recombinase A, which binds to an internal activation sequence (IAS), to initiate the lytic pathway.
In Mu, the initial integration process occurs by random transposition (Fig. 3). This process utilizes transposition machinery
consisting of phage-encoded and host-supplied components to cleave the Mu DNA and insert it into target sites in the host
genome with little or no target specificity. When Mu injects its DNA into a new host cell, its DNA is linear and flanked by DNA that
was acquired from the previous host from which it was assembled. The phage supplied N protein, injected alongside DNA, non-
covalently circularizes the DNA. To integrate Mu DNA into the chromosome, the phage DNA is nicked by MuA transposase to
generate two 3′ hydroxyl (-OH) ends on both strands at the Mu-Host DNA junctions. The 3′-OH ends attack two phosphodiester
bonds spaced 5 bps apart, which join the 3′-OH to the 5′ phosphate of the host DNA at the attack site. The flanking segments of
DNA from the previous host are removed and the DNA gap is repaired.
A natural consequence of phage DNA integration into the host chromosome is that host DNA replication will also replicate the
prophage DNA. Thus, all daughter cells of a lysogen will inherit the prophage. This form of lysogeny can be extremely stable, with
very low rates of ‘spontaneous’ induction.
Fig. 1 Lytic and lysogenic developmental cycles of a temperate bacteriophage. A bacteriophage infects a bacterial host by injecting its DNA
(red) into the host cell. In the lytic lifecycle, phages produce new virions, lysing the cell to release them. The lysogenic lifecycle has the phage
DNA integrated into the bacterial chromosome or persisting extra-chromosomally. This state is stable, with prophage DNA maintained in
daughter cells over subsequent generations. Most temperate phage can efficiently exit lysogeny to reenter the lytic phase in response to specific
environmental cues.
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Extrachromosomal Persistence of DNA
Some prophages can also maintain their DNA separate from the host chromosome as a plasmid, either circular or linear. A well-
characterized example of a circular extrachromosomal lysogen is bacteriophage P1. Infectious particles of P1 consist of a large
(93 kb) linear double stranded genome with terminal redundancy of 10–15 kb. Upon being injected into the P1 host E. coli, the
ends of the DNA undergo homologous recombination to circularize into an autonomous plasmid. In lysogeny, the prophage/
plasmid copy number is maintained to be the same as the number of bacterial chromosomes. This is achieved through the
expression of P1 proteins involved in origin-specific initiation and partitioning. The phage also uses a toxin-antitoxin system to kill
daughter cells that have failed to receive a P1 molecule upon cell division. The antitoxin is degraded rapidly and needs to be
continually expressed to counteract the toxin’s activity. Loss of the P1 molecule in daughter cells results in a rapid depletion of
antitoxin to a level where the more stable toxin will kill the host cell.
Some prophages, such as E. coli bacteriophage N15 maintain their DNA as a linear plasmid. Similar to linear eukaryotic
chromosomes, this presents a problem as DNA polymerase fails to replicate all the way to the ends of the DNA. Bacteriophage N15
belongs to a group of phages that express a protelomerase to create covalently closed hairpins. After entering the cell, N15 DNA
circularizes through its cohesive termini. The phage encoded protelomerase cuts an inverted sequence in the phage genome and
ligates the phosphodiester bonds of each strand to form two closed hairpin ends (Fig. 4).
The replication of such as linear plasmid also presents mechanistic challenges and requires prophage encoded proteins. In the
case of bacteriophage N15, the phage repA protein is necessary for replication. This multi-domain protein contains domains that
resemble prokaryotic primases and helicases required for DNA replication.
Fig. 2 Prophage DNA can be maintained by site-specific integration into the bacterial chromosome. This reaction is mediated by a phage-
encoded integrase protein (Int). Initially upon injection into the host, the phage DNA is linear. Circularization of the viral DNA occurs through
annealing of complementary ends, followed by ligation. Integrases recognize the attachment sites attP on the viral DNA (dark green) and attB on
the host chromosome (light green) to catalyse the site-specific recombination. This generates two new att sites, attL and attR which flank the viral
DNA in the chromosome. The attachment sites have a conserved core, shown in black. To return to the lytic cycle, the viral DNA must be excised
from the chromosome through a reversal of the site-specific recombination between attL and attR, mediated by the excision machinery, which
include the Int and excisionase (or recombination directionality factor RDF) proteins.
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Maintenance of the Lysogenic State
Temperate phages often contain natural examples of genetic switches which enable the developmental choice between the lytic or
lysogenic lifecycles. The biochemical basis of this decision-making process will be covered in detail in a separate chapter of the
encyclopedia. After entering lysogeny, true lysogens are able to exit back into the lytic cycle, either spontaneously or in response to
Fig. 3 Bacteriophage Mu integrates into the E. coli chromosome via random transposition. Linear Mu DNA is non-covalently circularized via the N
protein. The Mu B transposase generates single stranded nicks at the junctions of the Mu (blue)-prior host DNA (red) sequence, revealing two
3′-OH ends. These ends attack a target site on the E. coli chromosome to join the 3′-OH of Mu DNA to the 5′ phosphate of the host DNA.
Removal of the prior host DNA and subsequent repair of the DNA gap at the host-Mu DNA junction via limited replication results in successful
integration of Mu into the chromosome.
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environmental cues. One strategy to generate such a bistable decision making circuit is through mutually repressing transcription
factors. The most well characterized bacteriophage employing this strategy is bacteriophage λ.
Bacteriophage λ
The bistable regulatory circuit in λ is generated by the CI and Cro repressors, which block each other’s transcription. To maintain
lysogeny, the promoters that drive lytic functions must be repressed, whilst maintaining production of the CI repressor. In general,
the repressor in temperate phages responsible for turning off lytic function is termed the immunity repressor, as it prevents
secondary infections by phage of the same family, by blocking the lytic functions of incoming phage.
λ has a lysogenic promoter, PRM, positioned back to back with the adjacent lytic promoter PR, with a second lytic promoter, pL
located 2.3 kb away (Fig. 5). The transcriptional cascade in λ is such that repression of the early lytic promoters PL and PR will stop
all of the lytic genes from being expressed, pushing the phage into lysogeny. This repression is achieved by the λ CI protein, which
binds to operators at OR and OL operators that overlap the PR and PL promoters, respectively. In the lysogenic state, CI
simultaneously represses transcription from PL and PR, while activating its own expression from PRM.
The lambda CI protein is a two domain protein consisting of an N-terminal DNA binding domain connected by a cleavable
linker to an oligomerization domain. The repressor homodimerizes and these dimers can bind to individual operators. However,
repressor binding is cooperative such that pairs of dimers bound to adjacent operators (primarily OR1-OR2 and OL1-OR2)
interact to improve overall binding affinity. In this state, PR and PL are repressed, whilst PRM is activated by a contact between the
CI dimer bound at OR2 and the σ subunit of RNA polymerase. In this manner, λ CI produces positive feedback to increase its own
expression. A further level of cooperativity also occurs, when a pair of dimers occupying two operators at OR interact with a pair of
dimers bound at OL to form a CI octamer, looping out the intervening B2.3 kb of DNA (Fig. 5). Octamer formation in turn
positions the OL3 and OR3 operators to allow λ CI dimers bound at each of these sites to interact and repress PRM at high levels of
λ CI. This negative autoregulation is thought to limit the repressor levels to allow for efficient prophage induction back into lytic
cycle (Fig. 5(D)).
Cro is the second transcriptional regulator within the lambda genetic switch. The cro gene is the first of the early genes expressed
from PR following phage infection, and is required to enforce prophage induction – the decision point when the phage switches
from lysogeny towards lysis. Upon activation of the host SOS response, the CI repressor is degraded by a mechanism involving
activated RecA improving an intrinsic but normally weak CI self-cleavage activity. Thus the lytic repressors are at least partially de-
repressed and Cro is made. Cro binds as a dimer to the same OL and OR operators as CI, but with different affinity, binding most
Fig. 4 A prophage of bacteriophage N15 maintains its DNA as a linear plasmid with closed hairpin loops. Upon injecting its DNA into E. coli, the
phage initially circularizes through the annealing of complimentary ends. A phage encoded protelomerase binds and cleaves an inverted repeat
sequence (telRL) within the genome. The phosphodiester backbone of single strands are then ligated together to form two hairpin loops, creating
one covalently closed DNA molecule. Linear plasmid replication requires a phage encoded protein, repA.
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strongly to OR3 at the OR operator. This preferential and non-cooperative binding to OR3 dampens CI expression from the PRM
promoter, while leaving the PL and PR promoters active. Thus, Cro repression of PRM is required to prevent re-synthesis of new CI
during prophage induction, which would otherwise re-establish the prophage state.
Bacteriophage 186
Bacteriophage 186 is a temperate bacteriophage of the P2 related family, a group of phages evolutionarily distinct from the
lambdoid phages. 186 and lambda infect the same host (E. coli) and have very similar temperate lifecycles, yet the mechanisms by
which these two phages enter and maintain lysogeny are quite different. In 186, early lytic pR and lysogenic promoters pL are in a
Fig. 5 Regulation of the λ lytic and lysogenic promoters by λ CI involves cooperative interactions at multiple levels. A. The arrangement of early
lytic and lysogenic promoters in bacteriophage λ. The regulation of these promoters is crucial in the lytic-lysogeny decision. Promoters are
depicted as bent arrows. RNA transcripts are depicted as arrows. Early lytic transcripts from PL and PR are shown in yellow. OL and OR operators
are depicted as red bars on the DNA. B. λ CI (depicted as red dumbbells) binds to operators at OL and OR. λ CI dimers at adjacent operators can
further interact to form tetramers, mediated through the CI C-terminal domain. Binding of λ CI blocks transcription from PR and PL, by blocking
RNA polymerase (RNAP) binding. Contacts between the N-terminal domain of CI at OR2 and the sigma subunit of RNAP activates the PRM
promoter to drive expression of λ CI and other lysogenic functions. The lysogenic transcript from PRM is depicted in green. C. The repression of
PR and PL is further enhanced by interactions between CI tetramers at OR and OL, assisted by DNA looping. D. Formation of the CI octamer allows
CI dimers bound at OL3 and OR3 interact cooperatively, to repress PRM and downregulate CI’s own expression.
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convergent arrangement (Fig. 6), rather than divergent as is the case for the λ PR and PRM promoters. A consequence of this
convergent layout is that RNA polymerases either bound at, or elongating from, the switch promoters can potentially collide with
each other. In the absence of the immunity repressor (CI), transcription from the stronger lytic pR promoter represses transcription
from the weaker lysogenic promoter pL by this mechanism of transcriptional interference (TI), favouring the lytic lifecycle.
Conversely, in the presence of CI, pR is efficiently repressed, relieving transcriptional interference, and providing a form of positive
feedback on CI expression.
The 186 CI protein is the immunity repressor responsible for maintenance of lysogeny. Similarly to λ CI, it contains an
N-terminal DNA binding domain and a C-terminal oligomerization domain and binds to its operators as a dimer. Crystal
structures suggest 186 CI forms a wheel consisting of a heptamer of dimers. The repressor’s DNA binding domains face outwards
from this wheel, allowing DNA to wrap around the protein (Fig. 6(B)) to regulate transcription of pR and pL. The CI wheel binds
cooperatively to the three strong operators to repress pR and relieve transcriptional interference on pL. Binding of the weaker CI
operator at pL to the CI wheel is in an equilibrium between wrapped (repressed) and unwrapped (active) forms. There is further
fine tuning of pL promoter activity by the two flanking CI operator sites (FL and FR, located B300 bp away) which can loop to the
wheel and displace pL from the wheel. When the CI operator at pL is displaced by either of the stronger flanking site operators, pL
is transcriptionally active, maintaining CI levels. Interestingly, in phage 186, integrase is also expressed on the lysogenic transcript,
such that integrase is continually present in a lysogen. When prophage induction is triggered, excision of the phage genome
requires only expression of the excisionase (Apl), the first gene of the lytic transcript.
Thus, phage 186 CI repressor maintains an active lysogenic promoter by relieving transcriptional interference on pL, to drive its
own expression and to maintain a stable, self-correcting lysogenic level of CI. The lytic pR promoter is tightly repressed in this state,
leading to low levels of spontaneous induction.
Integration-Dependent Bacteriophage Immunity
A class of temperate mycobacteriophage have been described which use site-specific integration as the key decision point of the
genetic switch. In these phage, the immunity repressor and integrase are expressed from the same promoter Prep. To the right of the
repressor gene, under the control of a separate divergent promoter, PR, is a Cro-like protein. Both the immunity repressor and Cro-
like protein are predicted to have a DNA-binding helix-turn-helix (HTH) motif. Crucially, the bacteriophage attachment site attP is
located within the open reading frame of the immunity repressor (Fig. 7).
Unlike bacteriophages λ and 186, the promoter driving the immunity repressor function is not regulated by the immunity
repressor. Rather, the key step needed to establish lysogeny is the integration of the phage DNA into the host chromosome. Integration
of the phage genome through recombination of attP and attB sites results in a truncated immunity repressor without a short
destabilizing C-terminal tag. This truncated repressor supplies sufficient repression activity to establish lysogeny. The tag, thought to
target the viral repressor for degradation by host proteases, reduces its effective activity below the level required for lysogeny.
Fig. 6 Relief of transcriptional interference is used to activate transcription of lysogenic promoters in bacteriophage 186. A. The early lytic
promoter pR and the lysogenic promoter pL are arranged face-to-face. CI is the 186 immunity repressor. Apl acts as both a repressor of the pR
and pL promoters, and also as the excisionase for phage 186. The 186 CI repressor binding sites are drawn as circles – there are three strong
sites (red) over the pR promoter, a weak operator located over pL (pink) and two distant sites (FL and FR), located B300 bp from pR. B. Model
of transcriptional activation of 186 pL by 186 CI. CI is shown as a wheel-like structure where DNA wraps around the circumference of the wheel.
CI operators are shown as circles. The weak operator at pL is sometimes wrapped to the wheel (left) thus repressing pL, in an equilibrium with a
form (middle) where the pL operator is not bound, allowing pL to be active. The flanking sites FL and FR can compete with pL for binding to the
CI wheel (right), fine tuning the response of the system to CI levels.
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The determining factor of the phage’s developmental fate is the stability of the integrase protein. If conditions favor high
integrase activity, such as high multiplicity of infection (MOI) or when host protease levels are low, integration of the phage
genome is favored. Integration subsequently establishes and maintains lysogeny via immunity repressor stabilization.
Use of a Host Protein as an Immunity Repressor
In most phages, a phage-encoded immunity repressor binds to promoters that drive lytic functions to repress them. GIL01, a phage
that infects Bacillus thuringiensis, is an interesting example of a phage that does not have encode an immunity repressor at all. It
instead uses the B. thuringiensis host LexA repressor as its immunity repressor.
It has been shown that the DNA binding activity of LexA in B. thuringiensis is regulated by GIL01 phage encoded proteins. When
complexed with specific phage proteins, LexA represses lytic promoters by binding to a conserved LexA site within the promoter
region. If these additional phage proteins are not expressed, LexA binding alone is too weak to repress the lytic promoter and
GIL01 is unable to form stable lysogens.
RNA to Maintain Lysogeny
The mechanisms of maintenance of lysogeny that have been described thus far have been based on proteins, responsible for
mediating either repression or integration. However, there are also examples of phage which use RNA-based mechanisms to
maintain a stable lysogenic state.
Lactobacillus casei phage A2 has a similar genetic arrangement to that of the OR region of lambda, with back-to-back promoters
driving expression of CI and Cro repressors. However, in phage A2, the CI and Cro repressors have very similar affinities for their
operators, leading to the expectation that the much stronger lytic pR promoter should dominate, leading to expression of Cro, and
favoring the lytic cycle. However, A2 is able to effectively establish and maintain stable lysogens. It has recently been shown that
the second gene of the A2 lytic transcript encodes an RNA binding protein (gp25) that is able to specifically bind to a region
between the ribosome binding site and cro start codon on the lytic transcript. RNA binding by gp25 thus prevents translation of
Cro, allowing establishment and maintenance of stable lysogens.
P4 is a so-called satellite phage that relies on an unrelated helper phage, such as P2 or 186, to supply the structural
genes needed for its propagation. P4 has the ability to redirect the genetic network of the helper phage in order to
redirect the capsid assembly process for its own purposes. The P4 replicon can exist as a plasmid or can be stably
integrated into the host chromosome as a lysogen. The integrated lysogenic form is maintained by an RNA-based
mechanism. In a P4 lysogen, transcription from a constitutive early promoter generates a B300 nucleotide transcript that is
Fig. 7 The organization of integrase (int), immunity repressor (rep) and cro-like protein (cro) genes in integration-dependent immunity systems.
Promoters are shown as bent arrows. Site-specific attachment sites are shown as green boxes. The attP attachment site lies within the rep open
reading frame. Site specific recombination of attP with attB results in a truncated repressor gene within the bacterial chromosome. This truncated
gene encodes for a more stable immunity repressor, driving the phage towards lysogeny.
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processed to form the CI RNA. The CI RNA interacts with two specific regions in the untranslated leader sequence of the
nascent transcript to mediate transcriptional termination, prevent expression of the P4 replication functions and thus,
maintain lysogeny.
Prophage Induction
Established lysogens are generally stable with low probabilities of reverting back to the lytic state. Certain environmental stresses
can stimulate the prophage to revert to the lytic state. This process is called prophage induction. The immunity repressor must be
degraded or otherwise inactivated during prophage induction in order to establish lytic gene expression.
Many temperate phages are inducible by DNA damage, such as through mitomycin C treatment or UV irradiation. Such DNA
damage results in activation of the host SOS response, a global cascade of gene expression centered on DNA repair. As explained
previously, the stress response genes are under the control of the host LexA protein. LexA contains a labile linker region that can by
cleaved by a C-terminal protease domain within LexA itself. In the SOS response, the activation of co-protease RecA as a result of
the accumulation of single stranded DNA, promotes the auto-proteolysis of the host LexA repressor. Phage GIL01, which relies on
LexA to directly repress lytic genes, will undergo prophage induction simply due to the removal of LexA. Some phage repressors,
such as λ CI repressor, have structural similarity to LexA, and undergo similar RecA-stimulated self-cleavage. Inactivation of CI
allows the expression of lytic genes, including the genes for excision and replication.
Other phages, such as bacteriophage 186, express specific anti-repressor proteins, which complex with their cognate repressor to
relieve repression of the lytic genes. For example, bacteriophage 186 expresses the anti-repressor Tum, which is in turn under the
control of a LexA repressible promoter. Upon activation of the SOS response, RecA mediated proteolysis of LexA results in
expression of the Tum anti-repressor, which inactivates 186 CI, to drive prophage induction. The related coliphage P2 does not
code for an anti-repressor, and does not induce in response to DNA damage. However, it has a somewhat higher level of
spontaneous induction than 186, which must be sufficient for it to sustain a viable number of free phage.
The satellite phage P4, which uses an RNA based transcriptional termination mechanism for maintaining lysogeny, is induced
by transcription from an alternative promoter activated by a protein from the helper phage. Translation of nested genes within this
longer transcript leads to suppression of the CI RNA mediated termination, and expression of the P4 genes needed for replication.
Evolutionary and Phenotypical Effects of Lysogeny
It is estimated that the number of phage outnumber bacteria in the biosphere by at least an order of magnitude. Thus, it is
unsurprising that phages have a large effect on the evolution of their hosts and play a significant role in shaping bacterial
communities in almost all ecosystems. Here, we discuss how lysogeny has altered the phenotype and evolution of its hosts.
Lysogenic Conversion
Lysogenic conversion describes the situation where a bacterial host acquires a new trait as a direct result of the expression a gene
encoded by a lysogen. Clinically relevant examples include the acquisition of virulence factors by bacterial pathogens. Many of the
toxins contributing to virulence in bacteria such as Staphylococcus aureus, Shigella spp., Salmonella enterica and pathogenic E. coli have been
acquired through lysogenic conversion. E. coli O157:H7, a causative agent of food poisoning, harbors Sp5 and Sp15 – two Shiga toxin
expressing prophages. Vibrio cholera, some strains of which cause Asiatic cholera, acquired the cholera toxin from its CTXϕ prophage.
Besides toxins, other phage-encoded virulence factors include adhesion factors, superantigens and factors that aid immune
system invasion. Various examples of phage-encoded virulence factors are summarized in Table 1.
In many cases, the virulence genes are arranged as a cassette flanked by a σ70 promoter on one side and a transcription
terminator on the other. Such a configuration reduces interference with the prophage genes adjacent to the cassette. It has been
postulated that virulence genes confer some fitness advantage to their host, either offensive (e.g., toxin production, invasins),
defensive (e.g., detoxification) or survival (such as improved nutrient uptake).
Very recently, a type of temperate filamentous bacteriophage that infects and integrates into Pseudomonas aeruginosa (Pa) was
found to be associated with chronic human wound infections. In mice, phage-infected Pseudomonas aeruginosa led to more severe
and longer-lasting wounds compared to wounds colonized by Pa alone. The authors showed that uptake of phage-infected
Pseudomonas aeruginosa by cells of the immune system resulted in phage RNA production, inappropriate antiviral immune
responses and suppression of bacterial clearance.
Gene Disruption
Prophage integration into the host chromosome can alter bacterial phenotype by disruption of an open reading frame. The
integration of phage may also disrupt sequences with regulatory roles within an intergenic region, altering how downstream genes
are regulated. Prominent loci for attB phage integration sites are within tRNA open reading frames. The loss of a functional tRNA
could potentially lead to a reduction in host fitness, so many phage have evolved such that integration will reconstitute a
functional tRNA gene. This holds true for many other attB sites within important genes.
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Table 1 Non-exhaustive list of phage-encoded virulence factors
Protein Phage Bacterial host Gene
Extracellular toxins
Diphtheria toxin β-Phage C. diphtheriae tox
Neurotoxin Phage C1 C. botulinum C1
Shiga toxins H-19B E. coli stx1, stx2
Enterohaemolysin ϕFC3208 E. coli hly2
Cytotoxin ϕCTX P. aeruginosa ctx
Enterotoxin NA S. aureus see, sel
Enterotoxin P ϕN315 S. aureus sep
Enterotoxin A ϕ13 S. aureus entA
Enterotoxin A ϕMu50A S. aureus sea
Exfoliative toxin A ϕETA S. aureus eta
Toxin type A T12 S. pyogenes speA
Toxin type C CS112 S. pyogenes speC
Cholera toxin CTXϕ V. cholerae ctxAB
Enterotoxin CTXϕ V. cholerae ace, zot
Leukocidin fPVL S. aureus pvl
Superantigens 8232.1 S. pyogenes speA1, speA3, speC, speI, speH,
speM, speL, speK, ssa
Cytolethal distending toxin Unnamed E. coli cdt
Proteins altering antigenicity
Membrane proteins Pnm1 N. meningitidis Mu-like
Glucosylation ɛ34 S. enterica rfb
Glucosylation P22 S. enterica gtr
O-antigen acetylase Sf6 S. flexneri oac
Glucosyl transferase SfII, SfV, SfX S. flexneri gtrII
Effector proteins involved in invasion
Type III effector SopEϕ S. enterica sopE
Type III effector GIFSY-2 S. enterica sseI (gtgB)
Type III effector GIFSY-3 S. enterica sspH1
Enzymes
Superoxide dismutase Sp4, 10 E. coli O157 sodC
Superoxide dismutase GIFSY-2 S. enterica sodC-I
Superoxide dismutase Fels-1 S. enterica sodC-III
Neuraminidase Fels-1 S. enterica nanH
Hyaluronidase H4489A S. pyogenes hylP
Leukocidin ϕPVL S. aureus pvl
Staphylokinase ϕ13 S. aureus sak
Phospholipase 315.4 S. pyogenes sla
DNase/streptodornase 315.6, 8232.5 S. pyogenes sdn, sda
Serum resistance
OMP λ E. coli bor
OMP λ-like E. coli eib
Adhesions for bacterial host attachment
Vir MAV1 M. arthritidis vir
Phage coat proteins SM1 S. mitis pblA, pblB
Others
Mitogenic factors 370.1, 370.3, 315.3 S. pyogenes mf2, mf3, mf4
Mitogenic factor Unnamed P. multocida toxA
Mitogenic factor phisc 1 S. canis Unnamed
Virulence GIFSY-2 S. enterica gtgE
Antivirulence GIFSY-2, Fels-1 S. enterica grvA
Note: Table adapted and extended from Brüssow, H., Canchaya, C., Hardt, W., 2004. Phages and the evolution of bacterial pathogens: From genomic rearrangements to lysogenic
conversion. Microbiology and Molecular Biology Reviews 68 (3), 560–602.
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There are cases where prophage integration does not reconstitute a functional gene and leads to loss of protein function. For example,
the integration of L54a and ϕ13 phages into the S. aureus chromosome leads to a loss of a functional lipase and β-toxin, respectively.
Genomic Rearrangement
Bacteria harboring multiple prophages with similar DNA sequences can give rise to homologous recombination events to cause
large genomic rearrangements. The location of rearrangements in the chromosome are often correlated with the loci of prophages.
For example, from a sequence alignment, it was observed that the genomic differences between an American and Japanese S.
pyrogenes M3 isolate could be largely explained by two sequential inversions. One of these inversions occurred between the lysis
modules of two prophages.
Genomic rearrangements may also aid phage evolution. In the example of S. pyrogenes, the lysogenic conversion genes were
outside of the inversion region. The inversion event shuffled virulence genes between the prophages. This could lead to new
prophages with altered host specificity and behaviors.
Conclusion
Lysogeny can change the phenotype, fitness and evolution of the bacterial host cell. In the case of bacterial pathogens, prophages
allow the acquisition of new traits such as virulence factors which in turn may improve the host’s fitness. This is emphasized by the
observation that prophages have played a vital role in the emergence of several clinically relevant human pathogens, such as the
food-borne pathogen E. coli O157:H7 and cholera causing V. cholerae. Prophages also drive bacterial evolution through the
introduction of new genes, the disruption of existing genes and mediating large genomic rearrangements within the host.
In the laboratory, temperate bacteriophages have provided numerous tools and reagents for molecular biology, and have been
used as models of regulatory networks and biological switches. The study of bacteriophages λ, P2 and its relatives, Mu, P1, N15
amongst others have provided many seminal contributions to these fields. This article has touched on several of these mechanisms
and simultaneously highlighted the diversity in means for achieving the persistence of DNA, maintaining the prophage in a
quiescent state and for exiting lysogeny. As the number of bacterial genomes sequenced continues to grow, new prophages using
novel mechanisms to achieve these lysogenic functions will no doubt be discovered.
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APPENDIX B: EXPERIMENTAL DETERMINATION OF 
186 CI EXTINCTION COEFFICIENT 
B.1 Introduction 
Accurate knowledge of protein concentration is important when analysing small angle X-ray 
scattering (SAXS) data. Errors in protein concentration would result in proportionate errors in 
the estimation of molecular weight of the protein (Chapter 3).  
Knowledge of the extinction coefficient of a protein allows its concentration in solution to be 
determined via UV spectroscopy. The Beer-Lambert law (equation 6) is used to related UV 
absorbance of the protein to its concentration 
𝐴280 𝑛𝑚 = 𝜀280 𝑛𝑚  × 𝑐 ×  𝑙 (Equation 6) 
where A280nm is the absorbance of the protein at 280 nm, ε280 nm is the extinction coefficient of the 
protein at 280 nm, c is the concentration of the protein and l is the pathlength of protein solution 
the light travels through.  
The extinction coefficient of 186 CI-His6 was estimated theoretically to be 23950 M-1cm-1 
(assuming all cysteine residues are reduced) from its primary sequence using the Edelhoch 
method (Edelhoch, 1967), implemented into the ProtParam webserver (Gasteiger et al., 2005). 
This calculates the extinction coefficient of a denatured protein as a linear combination of the 
extinction coefficients of major chromophores phenylalanine, tyrosine, tryptophan and cysteine. 
This is summarised in equation 7 
𝜀𝑀,𝐺𝑑𝑛.𝐻𝐶𝑙 =  𝑎𝜀𝑝ℎ𝑒𝑛𝑦𝑙𝑎𝑙𝑎𝑛𝑖𝑛𝑒 +  𝑏𝜀𝑡𝑦𝑟𝑜𝑠𝑖𝑛𝑒 +  𝑐𝜀𝑡𝑟𝑦𝑝𝑡𝑜𝑝ℎ𝑎𝑛 + 𝑑𝜀𝑐𝑦𝑠𝑡𝑒𝑖𝑛𝑒 (Equation 7) 
where a, b, c and d are the number of phenylalanine, tyrosine, tryptophan and cysteine, 
respectively. However, this implicitly assumes that the protein is in a denatured state where all 
the aromatic groups are exposed to solvent. A spectral shift could be observed in the 
chromophores within the native structure depending on if the chromophore is buried or present 
on the surface of the protein. 
The extinction coefficient of the native 186 CI protein was determined by UV-spectroscopy.  
B.2 Methods 
The sample of 186 CI-His6 used for SAXS analysis (Chapter 3) was also used to determine the 
extinction coefficient of native 186 CI-His6. The estimated protein concentration measured via 
UV-spectroscopy, using the denatured protein extinction coefficient on native protein, was 8.7 
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mg/mL. An aliquot of 186 CI and the corresponding matched buffer (from the final dialysis of the 
protein) was thawed in an ice bath. The protein was denatured by adding the protein solution to 
concentrated solutions of guanidine hydrochloride.  
The protein and buffer solutions made are summarised in Table B- 1.  
Table B- 1: Protein and buffer solutions. 
Sample ID Solution constituents 
Sample 1  
(blank for sample 2) 
10 μL matched buffer + 90 μL of 7.5 M guanidine hydrochloride 
Sample 2 10 μL CI + 90 μL of 7.5 M guanidine hydrochloride 
Sample 3 10 μL CI + 90 μL matched buffer 
Sample 4  
(blank for sample 5) 
18 μL matched buffer + 82 μL of 7.5 M guanidine hydrochloride 
Sample 5 9 μL CI + 9 μL matched buffer + 82 μL of 7.5 M guanidine 
hydrochloride 
Sample 6 9 μL CI + 91 μL of matched buffer 
  
The UV absorbance for the samples was measured using a Nanodrop 2000 spectrophotometer 
(Thermo Fisher Scientific) with the UV wavelength set to 280 nm (Table B- 3). Each reading was 
made 4 times with independently prepared samples. The blanking solutions used for each 
sample is described in Table B- 2. 
Table B- 2: The buffer used to blank the spectrophotometer for different samples.  
Sample measured Blanking buffer 
Sample 2 Sample 1 
Sample 3 Matched buffer 
Sample 5 Sample 4 
Sample 6 Matched buffer 
B.3 Results 
Samples 2 and 3, along with samples 5 and 6 have the same concentration of 186 CI protein. The 
difference is that one sample contains high concentrations of guanidine hydrochloride which 
denatures the protein. Thus, the difference in UV absorbance between denatured and native 
sample can be used to calculate the extinction coefficient of native protein (Table B-3). 
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Table B- 3: Measured absorbance of native and denatured samples of 186 CI at 280 nm. Errors represent standard 
error in the mean (n=4) 
Sample measured Absorbance at 280 nm  
Sample 2 (denatured) 0.751±0.01 
Sample 3 (native) 0.729±0.02 
Sample 5 (denatured) 0.654±0.003 
Sample 6 (native) 0.618±0.01 
 





 (Equation 8) 
Anative and Adenature denote the absorbance of native and denatured protein, respectively. εnative and 
εdenatured are the extinction coefficient of native and denatured protein, respectively. εdenatured was 
estimated to be 23950 M-1cm-1 using the Edelhoch method, as described in Section B.1. 
Using results from Table B- 3, the extinction coefficient of 186 CI-His6 was calculated to be 
23000 ± 1000 M-1cm-1 (using samples 2 and 3) and 22900 ± 600 M-1cm-1 (using samples 5 and 
6). 
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